<SEC-DOCUMENT>0001193125-25-144290.txt : 20250623
<SEC-HEADER>0001193125-25-144290.hdr.sgml : 20250623
<ACCEPTANCE-DATETIME>20250623092449
ACCESSION NUMBER:		0001193125-25-144290
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20250622
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250623
DATE AS OF CHANGE:		20250623

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ILLUMINA, INC.
		CENTRAL INDEX KEY:			0001110803
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				330804655
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1228

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35406
		FILM NUMBER:		251063164

	BUSINESS ADDRESS:	
		STREET 1:		5200 ILLUMINA WAY
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92122
		BUSINESS PHONE:		8582024500

	MAIL ADDRESS:	
		STREET 1:		5200 ILLUMINA WAY
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92122

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ILLUMINA INC
		DATE OF NAME CHANGE:	20000331
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d66921d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ilmn="http://www.illumina.com/20250622" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2025-06-22_to_2025-06-22" id="ixv-297">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2025-06-22_to_2025-06-22">0001110803</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="ilmn-20250622.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2025-06-22_to_2025-06-22"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-06-22</xbrli:startDate> <xbrli:endDate>2025-06-22</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:6pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">Form <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2025-06-22_to_2025-06-22" id="ixv-308">8-K</ix:nonNumeric></span></p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Current Report</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2025-06-22_to_2025-06-22" format="ixt:datemonthdayyearen" id="ixv-309">June&#160;22, 2025</ix:nonNumeric></p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">
<img src="g66921g0622152128020.jpg" alt="LOGO"/></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2025-06-22_to_2025-06-22" id="ixv-310">Illumina, Inc.</ix:nonNumeric> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2025-06-22_to_2025-06-22" id="ixv-311">001-35406</ix:nonNumeric></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission File Number)</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:50%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:48%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2025-06-22_to_2025-06-22" format="ixt-sec:stateprovnameen" id="ixv-312">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2025-06-22_to_2025-06-22" id="ixv-313">33-0804655</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(State or other jurisdiction of incorporation)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(I.R.S. Employer Identification No.)</span></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2025-06-22_to_2025-06-22" id="ixv-314">5200 Illumina Way</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2025-06-22_to_2025-06-22" id="ixv-315">San Diego</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2025-06-22_to_2025-06-22" id="ixv-316">CA</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2025-06-22_to_2025-06-22" id="ixv-317">92122</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of principal executive offices) (Zip code)</p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2025-06-22_to_2025-06-22" id="ixv-318">(858)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2025-06-22_to_2025-06-22" id="ixv-319">202-4500</ix:nonNumeric></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s telephone number, including area code)</p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">N/A</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2025-06-22_to_2025-06-22" format="ixt-sec:boolballotbox" id="ixv-320">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2025-06-22_to_2025-06-22" format="ixt-sec:boolballotbox" id="ixv-321">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2025-06-22_to_2025-06-22" format="ixt-sec:boolballotbox" id="ixv-322">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2025-06-22_to_2025-06-22" format="ixt-sec:boolballotbox" id="ixv-323">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2025-06-22_to_2025-06-22" id="ixv-324">Common Stock, $0.01 par value</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2025-06-22_to_2025-06-22" id="ixv-325">ILMN</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2025-06-22_to_2025-06-22" format="ixt-sec:exchnameen" id="ixv-326">The Nasdaq Global Select Market</ix:nonNumeric></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Emerging growth company &#8194;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2025-06-22_to_2025-06-22" format="ixt-sec:boolballotbox" id="ixv-327">&#9744;</ix:nonNumeric></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13a of the Exchange Act.&#8194;&#9744;</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;1.01</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry into a Material Definitive Agreement. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On June&#160;22, 2025, Illumina, Inc. (the &#8220;Company&#8221;) and Standard BioTools Inc. (&#8220;Standard BioTools&#8221;), a Delaware corporation, entered into a Stock Purchase Agreement (the &#8220;Purchase Agreement&#8221;). Pursuant to the Purchase Agreement, the Company will acquire (the &#8220;Acquisition&#8221;) from Standard BioTools (i)&#160;all of the issued and outstanding shares in the capital stock of SomaLogic, Inc. (&#8220;SomaLogic&#8221;), a Delaware corporation, (ii)&#160;all of the limited liability company interests in Sengenics Corporation LLC, a Delaware limited liability company, and (iii)&#160;all of the ordinary shares of Sengenics Corporation Pte Ltd, a private company limited by shares organized under the laws of Singapore (together with SomaLogic, Sengenics Corporation LLC and each of their respective subsidiaries, the &#8220;Group Companies&#8221;). The Company will acquire Standard BioTools&#8217;s aptamer-based and functional proteomics business, which includes KREX, Single SOMAmer, translational and diagnostic assays but excludes Standard BioTools&#8217;s mass cytometry and microfluidics businesses (the &#8220;Business&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the terms and conditions set forth in the Purchase Agreement, the Company will pay to Standard BioTools at the closing (the &#8220;Closing&#8221;) of the transactions contemplated therein $350,000,000 in cash, subject to customary adjustments. The Purchase Agreement further provides for, in connection with the revenues generated from certain products and services, (i)&#160;royalty streams and (ii)&#160;up to $75,000,000 in potential milestone payments to Standard BioTools. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Purchase Agreement also contemplates that, immediately prior to or at the Closing, the Company and Standard BioTools will enter into several ancillary agreements, including (i)&#160;a transition services agreement, pursuant to which Standard BioTools or its affiliates will provide, or cause to be provided, certain transition services for a period following the Closing, subject to the terms and conditions set forth therein and (ii)&#160;a license agreement, pursuant to which the Company will grant to Standard BioTools a <span style="white-space:nowrap">non-transferable,</span> <span style="white-space:nowrap">non-sublicensable</span> license to certain intellectual property owned by the Company, subject to the terms and conditions set forth therein. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Purchase Agreement contains customary representations and warranties of each of the Company and Standard BioTools relating to their respective businesses, in each case generally subject to customary materiality qualifiers. Additionally, the Purchase Agreement provides for customary <span style="white-space:nowrap">pre-Closing</span> covenants of the Company and Standard BioTools, including covenants of Standard BioTools relating to conducting its business in the ordinary course and refraining from taking certain actions without the Company&#8217;s consent. The Company and Standard BioTools also agreed to use their respective reasonable best efforts to cause the Acquisition to be consummated and to obtain any required regulatory approvals, subject to certain exceptions. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Closing is subject to customary closing conditions, including (i)&#160;the expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the receipt of any other approvals, if necessary, (ii)&#160;the absence of any law or order enjoining, restraining, preventing or prohibiting the Acquisition, (iii)&#160;subject to certain materiality qualifiers, the accuracy of the representations and warranties made by the Company and Standard BioTools, respectively, (iv)&#160;the performance in all material respects by the Company, the Group Companies and Standard BioTools of their respective obligations under the Purchase Agreement, (v)&#160;the absence of a material adverse effect with respect to the Group Companies, taken as a whole, or the Business, after the date of the Purchase Agreement, (vi)&#160;the absence of any law or order imposing certain remedial actions to be taken by Purchaser or Seller, (vii)&#160;the absence of any pending legal proceeding under certain regulatory laws that would reasonably be expected to result in any law or order that would enjoin, restrain, prevent or prohibit the Acquisition and (viii)&#160;other customary conditions. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Purchase Agreement contains certain termination rights for each of the Company and Standard BioTools, including a termination right for each of the Company and Standard BioTools if the Closing shall not have been consummated on or before 11:59&#160;p.m. New York City time on March 23, 2026, subject to three automatic three-month extensions for certain limited purposes in connection with obtaining certain required regulatory clearances. Upon termination of the Purchase Agreement under specified circumstances relating to the failure to obtain certain regulatory clearances, the Company would be required to pay Standard BioTools a termination fee of $14,500,000. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing summary description of the Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the copy of the Purchase Agreement filed as Exhibit 2.1 to this Current Report on Form <span style="white-space:nowrap">8-K,</span> which is incorporated herein by reference. It is not intended to provide any other factual information about the Company, Standard BioTools or any of their respective affiliates. In addition, the representations, warranties and covenants contained in the Purchase Agreement were made only for purposes of the Purchase Agreement as of the specific date therein, were solely for the benefit of the parties to the Purchase Agreement, are subject to qualifications and limitations agreed upon by the parties thereto, including being qualified by confidential disclosures made for the purposes of allocating risk among the parties to the Purchase Agreement instead of establishing these matters as facts, and may be subject to standards of materiality applicable to the contracting parties that differ from those applicable to investors or reports and other documents filed with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;). Investors should not rely on the representations, warranties and covenants or any descriptions thereof as characterizations of the actual state of facts or condition of the parties thereto or any of their respective subsidiaries or affiliates. Moreover, information concerning the subject matter of representations and warranties may change after the date of the Purchase Agreement, which subsequent information may or may not be fully reflected in the Company&#8217;s public disclosures. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;8.01</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Events. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On June&#160;23, 2025, the Company issued a press release announcing its entry into the Purchase Agreement. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and is incorporated by reference herein. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Cautionary Notes on Forward-Looking Statements </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This communication contains &#8220;forward-looking statements&#8221; within the meaning of the federal securities laws, including Section&#160;27A of the Securities Act of 1933, as amended, and Section&#160;21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;seek,&#8221; &#8220;see,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;may,&#8221; &#8220;target,&#8221; similar expressions and variations or negatives of these words. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the consummation of the proposed transaction and the anticipated benefits thereof. These and other forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements, including the failure to consummate the proposed transaction or to make any filing or take other action required to consummate such transaction in a timely matter or at all. Important risk factors that may cause such a difference include, but are not limited to: (i)&#160;the completion of the proposed transaction on the anticipated terms and timeline, or at all, including the ability of the parties to obtain required regulatory approvals &#8211; such as under the Hart-Scott-Rodino Act in the United States or from government authorities that may have or assert jurisdiction outside the United States &#8211; and to satisfy other conditions to Closing; (ii)&#160;the future conduct and growth of the business and the markets in which we operate, including the proteomics market; (iii)&#160;the success of products and services competitive with our own; (iv)&#160;our ability to successfully integrate the Business into our existing operations and the Business&#8217;s technology and products into our portfolio; (v)&#160;our ability to sell the products and further develop the Business&#8217;s technology; (vi)&#160;our ability to successfully manage partner and customer relationships in the proteomics market; (vii)&#160;our ability to manufacture robust instrumentation and consumables including the Business&#8217;s products; (viii)&#160;challenges inherent in developing, manufacturing, and launching new products and services, including expanding or modifying manufacturing operations and reliance on third-party suppliers for critical components; (ix)&#160;challenges inherent in developing, manufacturing, and launching new products and services; and (x)&#160;customer uptake of, and satisfaction with, new products and services, together with other factors detailed in our filings with the SEC, including our most recent filings on Forms <span style="white-space:nowrap">10-K</span> and <span style="white-space:nowrap">10-Q,</span> or in information disclosed in public conference calls, the date and time of which are released beforehand. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While the list of factors presented here is considered representative, it should not be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in any forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
liability to third parties and similar risks, any of which could have a material adverse effect on the Company&#8217;s financial condition, results of operations, credit rating or liquidity. The Company does not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d)<span style="font-style:italic"> Exhibits.</span> </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border-spacing:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:5%"/>
<td style="width:92%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit<br/>Number</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description of Exhibit</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8194;2.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d66921dex21.htm">Stock Purchase Agreement, dated June&#160;22, 2025, between Illumina, Inc. and Standard BioTools Inc. *++ </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d66921dex991.htm">Press Release, dated June&#160;23, 2025, issued by Illumina, Inc. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
</table> <div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">*</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Certain schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation <span style="white-space:nowrap">S-K.</span> A copy of any omitted schedule or exhibit will be furnished supplementally to the SEC upon request. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">++</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Certain confidential information, marked by brackets and asterisks, has been omitted pursuant to Item 601(b)(2) of <span style="white-space:nowrap">Regulation&#160;S-K.</span> A copy of any omitted schedule or exhibit will be furnished supplementally to the SEC upon request. </p></td></tr></table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0">


<tr>

<td style="width:44%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:5%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:44%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">ILLUMINA, INC.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: June&#160;23, 2025</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ ANKUR DHINGRA</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Ankur Dhingra</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Chief Financial Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>d66921dex21.htm
<DESCRIPTION>EX-2.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-2.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit&nbsp;2.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS
AS PRIVATE OR CONFIDENTIAL. REDACTED INFORMATION IS INDICATED BY [* * *]. </B></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">STOCK PURCHASE AGREEMENT </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">dated as of June&nbsp;22, 2025 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">by and between </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ILLUMINA, INC.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">STANDARD BIOTOOLS INC.
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>TABLE OF CONTENTS </U></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">Page</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE I THE STOCK PURCHASE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Stock Purchase</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Closing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Closing Deliveries and Payments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Withholding Rights</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE II Consideration; Post-Closing Adjustment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Consideration</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Final Closing Balance Sheet Calculation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Post-Closing Adjustment Payment</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Earnout Consideration</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Royalty Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>License Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Single SOMAmer Royalty Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE III REPRESENTATIONS AND WARRANTIES RELATING TO SELLER AND THE SHARES</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Organization</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Authority; Noncontravention</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Governmental Approvals</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>The Shares</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Brokers and Other Advisors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Opinions of Financial Advisors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Solvency</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Acknowledgement by Seller; No Reliance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE IV Representations and Warranties Relating to the Group Companies</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Organization, Standing and Organizational Power</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Subsidiaries; Capitalization</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Financial Statements; Undisclosed Liabilities; Internal Controls</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Absence of Certain Changes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Legal Proceedings</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Compliance With Laws; Permits</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Certain Business Practices</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Tax Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-i- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Employee Benefits Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Environmental Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Intellectual Property</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Privacy and Data Security</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Customers and Suppliers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.14</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Real Estate</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.15</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Contracts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.16</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Insurance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.17</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Affiliate Transactions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.18</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Takeover Statutes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.19</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Assets and Liabilities of the Group Companies</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE V Representations and Warranties of Purchaser</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Organization, Standing and Organizational Power of Purchaser</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Authority; Noncontravention</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Governmental Approvals</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Brokers and Other Advisors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Interested Stockholder</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Sufficient Funds</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Legal Proceedings</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Investment Representation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Acknowledgement by Purchaser; No Reliance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE VI Covenants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36<BR></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Conduct of Business</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Invoices</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Exclusivity</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Reasonable Best Efforts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Public Announcements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Access to Information; Contact with Employees, Customers and Suppliers; Confidentiality</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Access to Books and Records</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Indemnification and Insurance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Control of Other Party&#146;s Business</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Employee Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Key Business Employees</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Confidentiality</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-ii- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Transactions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.14</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Post-Closing Payments; Mail Handling</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.15</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><FONT STYLE="white-space:nowrap">Non-Solicit</FONT> and <FONT STYLE="white-space:nowrap">No-Hire</FONT> of Employees; <FONT STYLE="white-space:nowrap">Non-Competition</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.16</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Intercompany Accounts; Intercompany Arrangements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.17</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Wrong Pockets</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.18</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Representation and Warranty Insurance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.19</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Ancillary Agreements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.20</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Use of Seller Marks</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.21</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Further Assurances</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.22</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Specified Actions and Obligations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE VII Conditions Precedent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Conditions to Each Party&#146;s Obligation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Conditions to Obligation of Purchaser</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Conditions to Obligation of Seller</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Frustration of Closing Conditions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE&nbsp;VIII&nbsp;Termination</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Termination</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Effect of Termination</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE IX INDEMNIFICATION</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Survival</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Indemnification</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Indemnification Procedures</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Final Resolution</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Calculation of Damages</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Mitigation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Representation and Warranty Insurance Policy</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Remedies</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE X Certain Tax Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Transfer Taxes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Section&nbsp;338(h)(10) Election</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Other Tax Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Purchase Price Allocation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Tax Dispute Resolution</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Cooperation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-iii- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Tax Treatment</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE XI MISCELLANEOUS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Release</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Fees and Expenses</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Amendment or Supplement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Waiver</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Assignment</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Counterparts; Electronic Signatures</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Entire Agreement; Third-Party Beneficiaries</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Governing Law; Jurisdiction</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Specific Enforcement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>WAIVER OF JURY TRIAL</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Notices</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Severability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Definitions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.14</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Interpretation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.15</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Recourse</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.16</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Provision Respecting Legal Representation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBITS </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibit&nbsp;A &#150; Earnout Consideration </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibit&nbsp;B
&#150; Form of Royalty Agreement </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibit&nbsp;C &#150; Form of Transition Services Agreement </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibit&nbsp;D &#150; Form of License Agreement </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibit&nbsp;E
&#150; Form of Single SOMAmer Royalty Agreement </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SCHEDULES </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Schedule&nbsp;1&nbsp;&#150; Accounting Principles </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-iv- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>STOCK PURCHASE AGREEMENT </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Stock Purchase Agreement, dated as of June 22, 2025 (this &#147;<U>Agreement</U>&#148;), is entered into by and between Illumina, Inc., a
Delaware corporation (&#147;<U>Purchaser</U>&#148;), and Standard BioTools Inc., a Delaware corporation (&#147;<U>Seller</U>&#148;). Defined terms used herein have the meanings set forth in <U>Section</U><U></U><U>&nbsp;11.13</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>W</U> <U>I</U> <U>T</U> <U>N</U> <U>E</U> <U>S</U> <U>S</U> <U>E</U> <U>T</U> <U>H</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Seller is the record and beneficial owner of (i)&nbsp;all of the issued and outstanding shares in the capital stock of SomaLogic,
Inc., a Delaware corporation (the &#147;<U>Company</U>&#148;), (ii) all of the limited liability company interests in Sengenics Corporation LLC, a Delaware limited liability company, and (iii)&nbsp;all of the ordinary shares of Sengenics Corporation
Pte Ltd, a private company limited by shares organized under the laws of Singapore (such shares, ordinary shares and limited liability company interests, collectively, the &#147;<U>Shares</U>&#148;); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company, the Company Subsidiaries and the Sengenics Entities (collectively, the &#147;<U>Group Companies</U>&#148;) own and
operate Seller&#146;s aptamer-based and functional proteomics business, which includes KREX, Single SOMAmer, translational and diagnostic assays but excludes Seller&#146;s mass cytometry and microfluidics businesses (the
&#147;<U>Business</U>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, on the terms and subject to the conditions set forth in this Agreement, Purchaser desires to
purchase from Seller, and Seller desires to sell to Purchaser, all of the issued and outstanding Shares; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Board of
Directors of Seller (the &#147;<U>Seller Board</U>&#148;) established a special committee of the Seller Board consisting solely of &#147;disinterested directors&#148; (as defined in Section&nbsp;144(e)(4) of the DGCL) (the &#147;<U>Special
Committee</U>&#148;) and delegated to the Special Committee the full power and authority of the Seller Board, to the maximum extent permitted by applicable law, to, among other things, (i)&nbsp;explore, consider, evaluate, review, negotiate and
approve or reject the Transactions and (ii)&nbsp;determine whether the Transactions are advisable, fair to and in the best interest of Seller and its stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the representations, warranties, covenants and agreements contained in this Agreement and other good and
valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound, the Parties hereby agree as follows: </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>THE STOCK
PURCHASE </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;1.1 </U></B><B><U>Stock Purchase</U></B>.<B> </B>Upon the terms and
subject to the conditions set forth in this Agreement, at the Closing, Seller shall sell, assign, transfer and deliver to Purchaser (or one or more of its designed Affiliates), and Purchaser (or one or more of its designed Affiliates) shall
purchase, acquire and accept delivery from Seller of, the Shares, free and clear of all Liens (except for transfer restrictions of general applicability as may be provided under applicable </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-1- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
securities Laws). In consideration for the foregoing sale of the Shares, at the Closing, Purchaser shall pay or cause to be paid to Seller the Closing Aggregate Consideration by wire transfer of
immediately available funds to the Seller Closing Account. The purchase and sale of the Shares pursuant to the terms of this Agreement and the consummation of the other transactions contemplated hereby are collectively referred to in this Agreement
as the &#147;<U>Transactions</U>&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;1.2 </U></B><B><U>Closing</U></B>. The closing of
the Transactions (the &#147;Closing&#148;) shall take place remotely by exchange of documents and signatures (or their electronic counterparts) (a)&nbsp;on the day that is three Business Days following the satisfaction or waiver (to the extent
permitted by applicable Law) by the Party entitled to the benefit of such conditions at the Closing of the conditions set forth in <U>Article</U><U></U><U>&nbsp;VII</U> (other than those conditions that by their nature are to be satisfied at the
Closing, but subject to the satisfaction or waiver (by the Party entitled to the benefit of such conditions) at the Closing of those conditions), or (b)&nbsp;on such other date, time or place as is agreed to in writing by the Parties. The date on
which the Closing occurs is referred to herein as the &#147;Closing Date&#148;. The Parties agree that solely for accounting purposes the &#147;Closing&#148; will be deemed to have occurred at 12:01 a.m. New York City time on the Closing Date (it
being understood that such deemed time of the Closing shall not affect any of the other terms and provisions of this Agreement and shall not affect the calculation of the Closing Aggregate Consideration or the Final Closing Aggregate Consideration
or the components thereof). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U><U></U><U>&nbsp;1.3 </U><U>Closing Deliveries and Payments.</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Seller Closing Deliverables</U>. At the Closing, Seller shall deliver, or cause to be delivered, to Purchaser the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) stock (or equivalent) certificates representing all of the Shares (if the Shares are certificated) duly endorsed in blank
or accompanied by stock powers duly endorsed in blank in proper form for transfer, and other proper documents of assignments for all of the Shares to evidence transfer to Purchaser and/or its designed Affiliates; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) the certificate required to be delivered pursuant to <U>Section</U><U></U><U>&nbsp;7.2(d)</U>; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) duly executed counterparts of each Ancillary Agreement to which Seller or any Group Company is a party; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) a duly executed IRS Form <FONT STYLE="white-space:nowrap">W-9</FONT> of Seller. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Purchaser Closing Deliverables</U>. At the Closing, Purchaser shall deliver, or cause to be delivered, to Seller the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) the Closing Aggregate Consideration by wire transfer of immediately available funds to the Seller Closing Account; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) the certificate required to be delivered pursuant to <U>Section</U><U></U><U>&nbsp;7.3(c)</U>; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) duly executed counterparts of each Ancillary Agreement to which Purchaser is a party. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Transaction Expenses Payment</U>. At the Closing, Purchaser shall pay, or cause to be
paid (i)&nbsp;on behalf of the Group Companies, all Specified Transaction Expenses and (ii)&nbsp;the remaining portion of any Shared Expenses that remain unpaid as of immediately prior to the Closing, in each case in accordance with the Preliminary
Closing Statement and the Invoices therefor furnished to Purchaser pursuant to <U>Section</U><U></U><U>&nbsp;6.2</U>; <I>provided</I> that if Purchaser has not received an Invoice for any Specified Transaction Expenses or Shared Expenses at least
three Business Days prior to the Closing Date in accordance with <U>Section</U><U></U><U>&nbsp;6.2</U> but such Specified Transaction Expenses or Shared Expenses are reflected in the Closing Aggregate Consideration or the Final Closing Aggregate
Consideration, Purchaser shall pay, or cause to be paid, such Specified Transaction Expenses or Shared Expenses, as applicable, promptly following Purchaser&#146;s receipt of such Invoice; <I>provided</I>, <I>further</I>, that Seller shall use
reasonable best efforts to deliver any such Invoice within 180 days following the Closing Date. In the case of any Transaction Expenses that are payable to Continuing Employees, Purchaser shall cause the applicable Group Company to make payment of
such expenses to such Continuing Employees through payroll of the applicable Group Company as soon as practicable after the Closing (and in any event at or prior to the second regularly scheduled payroll of the applicable Group Company following the
Closing). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Resignations</U>. At the Closing, Seller shall deliver resignations from the directors and managers (and, if requested
by Purchaser at least three Business Days prior to the Closing Date, any officers) of each Group Company effective as of the Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;1.4 </U></B><B><U>Withholding Rights</U></B>. Purchaser, Seller and their respective Affiliates
shall be entitled to deduct and withhold from any payment made pursuant to this Agreement any amounts as are required to be deducted and withheld with respect to the making of such payment under applicable Tax Laws; <I>provided</I> that, other than
with respect to compensatory payments, the Person intending to withhold or deduct shall provide the Person in respect of whom such withholding or deduction would be made (a)&nbsp;written notice of its intent to withhold at least 15&nbsp;days prior
to withholding or deducting any amount pursuant to this <U>Section</U><U></U><U>&nbsp;1.4</U> and (b)&nbsp;a reasonable opportunity to deliver such documentation that establishes a basis to reduce the amount of, or eliminate the necessity for, such
withholding. The Parties shall reasonably cooperate to eliminate or minimize any such withholding in accordance with applicable Tax Laws. The Party withholding or deducting any amount pursuant to this <U>Section</U><U></U><U>&nbsp;1.4</U> shall
timely remit such amount to the appropriate Governmental Authority. To the extent amounts are so withheld and timely paid over to the appropriate Governmental Authority, the withheld amounts shall be treated for all purposes of this Agreement as
having been paid to the Person in respect of which such deduction and withholding was made. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Consideration; Post-Closing Adjustment </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;2.1 </U></B><B><U>Consideration</U></B>. (a)&nbsp;At or prior to the close of business on the
date which is two&nbsp;Business Days prior to the Closing Date, Seller shall prepare and deliver to Purchaser a written statement (the &#147;<U>Preliminary Closing Statement</U>&#148;) setting forth: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Seller&#146;s good faith estimates of (A)&nbsp;the Cash Amount (the &#147;<U>Estimated Cash Amount</U>&#148;), (B)&nbsp;the
Indebtedness Amount (the &#147;<U>Estimated Indebtedness Amount</U>&#148;), (C)&nbsp;the Net Working Capital Amount (the &#147;<U>Estimated Net Working Capital Amount</U>&#148;) and (D)&nbsp;the Transaction Expenses (the &#147;<U>Estimated
Transaction Expenses</U>&#148;) (including a reasonably detailed summary of the calculations made to arrive at such amounts); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) a list of and, as applicable and to the extent received from the
applicable payee, payment instructions for the payment of, the Estimated Transaction Expenses; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) the calculation of
the Closing Aggregate Consideration; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) a designation of a bank account (the &#147;<U>Seller Closing
Account</U>&#148;), and payment instructions therefor, for the payment of the Closing Aggregate Consideration by Purchaser at the Closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Estimated
Cash Amount, Estimated Indebtedness Amount, Estimated Transaction Expenses and Estimated Net Working Capital Amount in the Preliminary Closing Statement shall be prepared and calculated in accordance with the definitions of the applicable terms set
forth in this Agreement, including the Accounting Principles as applicable. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) At least five Business Days prior to the Closing Date,
Seller shall deliver to Purchaser a draft of the Preliminary Closing Statement for information purposes only (which shall not be considered the Preliminary Closing Statement for any purposes hereunder). Purchaser shall be entitled to review the
draft Preliminary Closing Statement upon its delivery pursuant to this <U>Section</U><U></U><U>&nbsp;2.1(b)</U>, and, in connection therewith, at the reasonable request of Purchaser, (i)&nbsp;Purchaser and its Representatives shall be permitted
reasonable access during normal business hours to review and obtain copies of the Group Companies&#146; books and records and any work papers (subject to the execution of customary work paper access letters if requested by the Group Companies&#146;
accountant) related to the preparation of the Preliminary Closing Statement; <U>provided</U> that in no event shall the exercise of the rights granted to Purchaser and its Representatives pursuant to this clause (i)&nbsp;be a basis to delay or
prevent the Closing; and (ii)&nbsp;Seller shall make available its and the Group Companies&#146; personnel and accountants to advise and assist Purchaser in its review of the draft Preliminary Closing Statement. Seller shall review any comments
proposed by Purchaser with respect to the draft Preliminary Closing Statement and shall consider, in good faith, any appropriate changes thereto prior to the delivery of the Preliminary Closing Statement pursuant to
<U>Section</U><U></U><U>&nbsp;2.1(a)</U>. For the avoidance of doubt, Purchaser&#146;s failure to propose any change with respect to the draft Preliminary Closing Statement shall not impact Purchaser&#146;s rights with respect to proposing such
change, or any other change, in the Proposed Closing Statement in accordance with <U>Section</U><U></U><U>&nbsp;2.2</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) For purposes
of this Agreement, the term &#147;<U>Closing Aggregate Consideration</U>&#148; means (i)&nbsp;the Base Consideration, <U>plus</U> (ii)&nbsp;the Estimated Cash Amount, <U>minus</U> (iii)&nbsp;the Estimated Indebtedness Amount, <U>plus</U>
(iv)&nbsp;the amount, if any, by which the Estimated Net Working Capital Amount is greater than the Target Net Working Capital Amount, <U>minus</U> (v)&nbsp;the amount, if any, by which the Target Net Working Capital Amount is greater than the
Estimated Net Working Capital Amount, <U>minus</U> (vi)&nbsp;the Estimated Transaction Expenses. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) For purposes of this Agreement, the term &#147;<U>Final Closing Aggregate
Consideration</U>&#148; means (i)&nbsp;the Base Consideration, <U>plus</U> (ii)&nbsp;the Cash Amount as finally determined pursuant to <U>Section</U><U></U><U>&nbsp;2.2</U>, <U>minus</U> (iii)&nbsp;the Indebtedness Amount as finally determined
pursuant to <U>Section</U><U></U><U>&nbsp;2.2</U>, <U>plus</U> (iv)&nbsp;the amount, if any, by which the Net Working Capital Amount as finally determined pursuant to <U>Section</U><U></U><U>&nbsp;2.2</U> is greater than the Target Net Working
Capital Amount, <U>minus</U> (v)&nbsp;the amount, if any, by which the Target Net Working Capital Amount is greater than the Net Working Capital Amount as finally determined pursuant to <U>Section</U><U></U><U>&nbsp;2.2</U>, <U>minus</U>
(vi)&nbsp;the Transaction Expenses, as finally determined pursuant to <U>Section</U><U></U><U>&nbsp;2.2</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;2.2 </U></B><B><U>Final Closing Balance Sheet Calculation</U></B>. (a)&nbsp;As promptly as
reasonably practicable, but in any event within 75&nbsp;days after the Closing Date, Purchaser shall deliver to Seller a statement, together with reasonable supporting detail, showing the calculation of the Cash Amount, Indebtedness Amount, Net
Working Capital Amount and Transaction Expenses (the &#147;<U>Proposed Closing Statement</U>&#148;). The Cash Amount, Indebtedness Amount, Transaction Expenses and Net Working Capital Amount in the Proposed Closing Statement shall be prepared and
calculated in accordance with the definitions of the applicable terms set forth in this Agreement, including the Accounting Principles as applicable. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Seller and its Representatives shall be permitted reasonable access during normal business hours to review and obtain copies of the Group
Companies&#146; books and records and any work papers (subject to the execution of customary work paper access letters if requested by the Group Companies&#146; accountant) related to the preparation of the Proposed Closing Statement and the
adjustments contemplated thereby. At the reasonable request of Seller, Purchaser shall make available its and the Group Companies&#146; personnel and accountants to advise and assist Seller and its Representatives in their review of the Proposed
Closing Statement and any objections or disputes with respect thereto. If Seller has any objections to the Proposed Closing Statement, Seller shall deliver to Purchaser a statement setting forth its objections thereto, which statement shall indicate
each disputed item and the amount and the basis for Seller&#146;s disagreement therewith, giving reasonable detail in support thereof (an &#147;<U>Objections Statement</U>&#148;). The Objections Statement shall only include disagreements based on
mathematical errors or based on the Cash Amount, Indebtedness Amount, Transaction Expenses and Net Working Capital Amount not being calculated in accordance with the definitions of the applicable terms set forth in this Agreement, including the
Accounting Principles as applicable. If an Objections Statement is not delivered to Purchaser within 45&nbsp;days after delivery of the Proposed Closing Statement to Seller, the Proposed Closing Statement shall be final, binding and <FONT
STYLE="white-space:nowrap">non-appealable</FONT> by the Parties, and if an Objections Statement is so delivered, any matters not specifically disputed therein shall be final, binding and <FONT STYLE="white-space:nowrap">non-appealable</FONT> by the
Parties. Seller and Purchaser shall negotiate in good faith to resolve the matters contained in the Objections Statement within 30&nbsp;days after Purchaser&#146;s receipt thereof or such longer period as the Parties may mutually agree (the
&#147;<U>Final Closing Consideration Resolution Period</U>&#148;). If Purchaser and Seller reach a resolution with respect to such matters on or before the final day of the Final Closing Consideration Resolution Period, then the Proposed Closing
Statement, as modified by such resolution, shall be final, conclusive and binding for all purposes hereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) If such a resolution is
not reached on or before the final day of the Final Closing Consideration Resolution Period, Seller and Purchaser shall submit such dispute to BDO USA, P.C., or if BDO USA, P.C. is unable or unwilling to serve in such capacity, another independent
accounting firm of national reputation with significant experience related to purchase price adjustments that is mutually selected by Purchaser and Seller; <I>provided</I> that if Purchaser and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Seller cannot agree to such an accounting firm within 45&nbsp;days following the delivery of an Objections Statement, then, within 15&nbsp;days thereafter, each of Purchaser and Seller shall
designate such an independent accounting firm and the two independent accounting firms selected by the Parties shall, within 15&nbsp;days after their selection, select a third independent accounting firm of national reputation with significant
experience related to purchase price adjustments to serve as the independent accounting firm to resolve the Parties&#146; dispute (any such firm, the &#147;<U>Valuation Firm</U>&#148;). The Valuation Firm shall act as an expert and not as
arbitrator, shall only consider the disputed matters that were properly included in the Objections Statement and shall make a final determination of the Cash Amount, Indebtedness Amount, Transaction Expenses, Net Working Capital Amount and the
resulting Final Closing Aggregate Consideration calculated with reference to such amounts (solely to the extent such amounts are in dispute), in accordance with the definitions of the applicable terms set forth in this Agreement, including the
Accounting Principles as applicable. The resolution of the dispute by the Valuation Firm shall be based solely on the written submissions made by or on behalf of the Parties (and not by independent review), and neither Party nor its Representatives
shall have any <I>ex parte</I> communications or meetings with the Valuation Firm concerning the subject matter hereof without the prior written consent of the other Party. The Valuation Firm may not assign a value to any item in dispute greater
than the greatest value for such item assigned by any Party in the Proposed Closing Statement or an Objections Statement or less than the smallest value for such item assigned by any Party in the Proposed Closing Statement or an Objections
Statement. The Valuation Firm will not consider any settlement or negotiations offers exchanged between the Parties prior to retention of the Valuation Firm. The Parties shall cooperate with the Valuation Firm during the term of its engagement. The
Valuation Firm shall deliver to Purchaser and Seller, as promptly as practicable and in any event within 60&nbsp;days after submission of any dispute to the Valuation Firm, a written report setting forth the resolution of such dispute determined in
accordance with the terms herein; <I>provided</I> that any failure of the Valuation Firm to strictly conform to any deadline or time period contained within this <U>Section</U><U></U><U>&nbsp;2.2</U> shall not render the determination of the
Valuation Firm invalid and shall not be a basis for seeking to overturn any determination rendered by the Valuation Firm. The determination of the Cash Amount, Indebtedness Amount, Transaction Expenses, Net Working Capital Amount and the resulting
Final Closing Aggregate Consideration calculated with reference thereto, in each case in the manner contemplated by this <U>Section</U><U></U><U>&nbsp;2.2</U>, shall become final and binding on the Parties on the date the Valuation Firm delivers its
final resolution in writing to the Parties, absent a showing of manifest error, and an Order may be entered in respect thereof in any court of competent jurisdiction, subject to <U>Section</U><U></U><U>&nbsp;11.8</U>. The fees, costs and expenses of
the Valuation Firm shall be borne by the Parties in proportion to the relative amount by which each Party&#146;s determination has been modified. For example, if Seller challenges the calculation of the Net Working Capital Amount by an amount of
$100,000, but the Valuation Firm determines that Seller has a valid claim for only $40,000, then Purchaser shall bear 40% of the fees, costs and expenses of the Valuation Firm and Seller shall bear the other 60% of such fees, costs and expenses.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;2.3 </U></B><B><U>Post-Closing Adjustment Payment</U></B>. If the Final Closing Aggregate
Consideration is greater than or equal to the Closing Aggregate Consideration, Purchaser shall promptly (but in any event within three&nbsp;Business Days of the determination of the Final Closing Aggregate Consideration) pay to Seller the amount of
such excess by wire transfer of immediately available funds to the Seller Closing Account (or such other bank account as Seller may designate in writing to Purchaser (any such designation to be made at least three Business Days prior to the date of
any such payment)). If the Final Closing Aggregate Consideration is less than the Closing </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Aggregate Consideration, Seller shall promptly (but in any event within three&nbsp;Business Days of the determination of the Final Closing Aggregate Consideration) pay to Purchaser the absolute
value of such difference by wire transfer of immediately available funds to the bank account designated in writing by Purchaser to Seller (such designation to be made at least three Business Days prior to the date of any such payment). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;2.4 </U></B><B><U>Earnout Consideration</U></B>. Seller shall be entitled to receive earnout
payments from Purchaser to the extent earned in accordance with the terms of <U>Exhibit</U><U></U><U>&nbsp;A</U> attached to this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;2.5 </U></B><B><U>Royalty Agreement</U></B>. Seller shall be entitled to receive a royalty
stream from Purchaser in accordance with the terms of the Royalty Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;2.6
</U></B><B><U>License Agreement</U></B>. Seller shall be entitled to receive a license from Purchaser in accordance with the terms of the License Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;2.7 </U></B><B><U>Single SOMAmer Royalty Agreement</U></B>. Seller shall be entitled to receive
a royalty stream from Purchaser in accordance with the terms of the Single SOMAmer Royalty Agreement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>REPRESENTATIONS AND WARRANTIES RELATING TO SELLER AND THE SHARES </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Seller represents and warrants to Purchaser that, except as disclosed in the disclosure letter delivered to Purchaser simultaneously with the
execution of this Agreement (the &#147;<U>Disclosure Letter</U>&#148;): </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;3.1
</U></B><B><U>Organization</U></B>. Seller is a corporation duly organized, validly existing and in good standing under the Laws of the State of Delaware. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;3.2 </U></B><B><U>Authority; Noncontravention</U></B>. (a)&nbsp;Seller has all necessary
corporate power and authority to execute and deliver this Agreement and all other agreements and documents contemplated hereby to which it is a party and perform its obligations hereunder and thereunder and to consummate the Transactions. The
execution and delivery of this Agreement by Seller and performance by Seller of its obligations under this Agreement and the consummation by Seller of the Transactions, have been duly authorized and approved by all requisite corporate action by
Seller, and no other action on the part of Seller, the Seller Board, any duly authorized committee of the Seller Board (including the Special Committee) or the stockholders of Seller is necessary to authorize the execution and delivery of and
performance by Seller under this Agreement and the consummation by Seller of the Transactions. This Agreement has been duly executed and delivered by Seller and, assuming due authorization, execution and delivery hereof by Purchaser, constitutes a
legal, valid and binding obligation of Seller, enforceable against Seller in accordance with its terms, except that such enforceability (i)&nbsp;may be limited by bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and other
similar Laws of general application affecting or relating to the enforcement of creditors&#146; rights generally and (ii)&nbsp;is subject to general principles of equity, whether considered in a proceeding at law or in equity (the &#147;Bankruptcy
and Equity Exception&#148;). No vote or approval of the holders of any class or series of capital stock or other equity interests of Seller is necessary to adopt this Agreement or to approve the consummation of the Transactions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) At a meeting duly called and held, the Special Committee has unanimously
(i)&nbsp;determined that this Agreement and the Transactions are fair to, advisable and in the best interests of Seller and its stockholders, (ii)&nbsp;approved the execution and delivery by Seller of, and performance by Seller of its obligations
under, this Agreement and the consummation by Seller of the Transactions and (iii)&nbsp;resolved to recommend that the Seller Board approve the execution and delivery by Seller of, and performance by Seller of its obligations under, this Agreement
and the consummation by Seller of the Transactions. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) At a meeting duly called and held, the Seller Board (acting upon the
recommendation of the Special Committee) has unanimously (i)&nbsp;determined that this Agreement and the Transactions are fair to, advisable and in the best interests of Seller and its stockholders and (ii)&nbsp;approved the execution and delivery
by Seller of, and performance by Seller of its obligations under, this Agreement and the consummation by Seller of the Transactions. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)
Neither the execution and delivery of this Agreement by Seller, nor the consummation by Seller of the Transactions, nor compliance by Seller or the Group Companies with any of the terms or provisions hereof, shall (i)&nbsp;conflict with or violate
any provision of the certificate of incorporation and bylaws of Seller or any Group Company Charter Document, (ii)&nbsp;assuming that each of the consents, authorizations and approvals referred to in <U>Section</U><U></U><U>&nbsp;3.3</U> are
received (and any condition precedent to any such consent, authorization or approval has been satisfied) and each of the filings referred to in <U>Section</U><U></U><U>&nbsp;3.3</U> are made and any applicable waiting periods referred to therein
have expired, violate any Law or Order applicable to Seller or any Group Company or (iii)&nbsp;result in any breach of, or constitute a default (with or without notice or lapse of time, or both) under, or give rise to any right of termination,
amendment, acceleration or cancellation of, or result in any material or increased, additional, accelerated or guaranteed rights or entitlements of any Person under, any Contract to which Seller or any Group Company is a party, or result in the
creation of a Lien, other than any Permitted Lien, upon any of the properties or assets of Seller or any Group Company, except, in the case of <U>clauses</U><U></U><U>&nbsp;(ii)</U> or <U>(iii)</U>&nbsp;above, as would not, individually or in the
aggregate, reasonably be expected to prevent, materially impair or materially delay the consummation by Seller of the Transactions or to have a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;3.3 </U></B><B><U>Governmental Approvals</U></B>. Except for&nbsp;filings required under, and
compliance with other applicable requirements of, the HSR Act, the Regulatory Laws, the Securities Act, the Exchange Act, state securities or blue sky laws and the rules of NASDAQ, no material consents or approvals of, or material filings,
declarations or registrations with, any Governmental Authority are necessary for the execution and delivery of this Agreement by Seller and the consummation by Seller of the Transactions, other than as would not, individually or in the aggregate,
reasonably be expected to reasonably be expected to prevent, materially impair or materially delay the consummation by Seller of the Transactions or to have a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;3.4 </U></B><B><U>The Shares</U></B>. Seller
is the record and beneficial owner of, and has good and valid title to, all of the Shares, free and clear of all Liens (other than transfer restrictions under applicable securities Laws). Seller has the exclusive right to dispose of the Shares as
provided in this Agreement. Assuming Purchaser has the requisite power and authority to be the lawful owner of the Shares, upon delivery to Purchaser at the Closing of the items described in <U>Section</U><U></U><U>&nbsp;1.3(a)</U> and upon
Seller&#146;s receipt of the Closing Aggregate Consideration, good and valid title to the Shares will pass to Purchaser, free and clear of any Liens (other than transfer restrictions under the applicable securities Laws). All outstanding Shares have
been duly authorized and validly issued and, to the extent such concepts are applicable thereto, are fully paid, <FONT STYLE="white-space:nowrap">non-assessable</FONT> and free of preemptive rights or similar rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;3.5 </U></B><B><U>Brokers and Other Advisors</U></B>. No broker, investment banker, financial
advisor, intermediary, finder or other Person is entitled to any broker&#146;s, finder&#146;s or financial advisor&#146;s fee or other similar fee or commission, or the reimbursement of expenses, directly or indirectly, in connection with the
Transactions based upon arrangements made by or on behalf of Seller or any of its Affiliates for which Purchaser or any of its Affiliates (including, after the Closing, the Group Companies) will be liable following the Closing other than any such
fees or expenses that constitute Transaction Expenses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;3.6 </U></B><B><U>Opinions of
Financial Advisors</U></B><B>. </B>(a) The Special Committee (in such capacity) has received the oral opinion (to be subsequently confirmed in writing) of UBS Securities LLC, as financial advisor to the Special Committee, on or prior to the date of
this Agreement, that, as of the date of this Agreement and based upon and subject to the matters set forth therein, including the various assumptions made, procedures followed, matters considered and qualifications and limitations set forth therein,
the Base Consideration to be received by Seller pursuant to this Agreement is fair, from a financial point of view, to Seller. Seller shall, promptly following the execution of this Agreement by each Party, furnish a copy of such opinion to
Purchaser solely for informational purposes (it being expressly agreed that such opinion is for the benefit of the Special Committee and that none of Purchaser, its Affiliates or their respective Representatives shall have the right to rely on such
opinion). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Seller Board (in such capacity) has received the oral opinion (to be subsequently confirmed in writing) of Centerview
Partners LLC, as financial advisor to the Seller Board, on or prior to the date of this Agreement, that, as of the date of this Agreement and based upon and subject to the matters set forth therein, including the various assumptions made, procedures
followed, matters considered and qualifications and limitations set forth therein, the Base Consideration to be received by Seller pursuant to this Agreement is fair, from a financial point of view, to Seller. Seller shall, promptly following the
execution of this Agreement by each Party, furnish a copy of such opinion to Purchaser solely for informational purposes (it being expressly agreed that such opinion is for the benefit of the Seller Board and that none of Purchaser, its Affiliates
or their respective Representatives shall have the right to rely on such opinion). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;3.7
</U></B><B><U>Solvency</U></B>. Assuming (a)&nbsp;that the representations and warranties of Purchaser contained in this Agreement are true and correct in all material respects, (b)&nbsp;the compliance and performance by Purchaser of its obligations
hereunder in all material respects and (c)&nbsp;the satisfaction of the conditions to Seller&#146;s obligations to close in <U>Article</U><U></U><U>&nbsp;VII</U>, immediately after giving effect to the Transactions, the members of the Seller Group,
on a consolidated basis </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(i)&nbsp;will be able to pay their respective debts (fixed or contingent, matured or unmatured) as they become due, (ii)&nbsp;will own property that has a fair saleable value greater than the
amounts required to pay their respective debts (including a reasonable estimate of the amount of all contingent liabilities) and (iii)&nbsp;will have adequate capital to carry on their respective businesses. No transfer of property is being made and
no obligation is being incurred in connection with the Transactions by any member of the Seller Group with the intent to hinder, delay or defraud either present or future creditors of any member of the Seller Group. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;3.8 </U></B><B><U>Acknowledgement by Seller; No Reliance</U></B>. Seller acknowledges and
agrees that: (i)&nbsp;the express representations and warranties of Purchaser set forth in <U>Article</U><U></U><U>&nbsp;V</U> of this Agreement, the certificate delivered pursuant to <U>Section</U><U></U><U>&nbsp;7.3(c)</U> and as may be set forth
in the Ancillary Agreements constitute the sole and exclusive representations and warranties of Purchaser in connection with the Transactions, (ii)&nbsp;except for such express representations and warranties, neither Purchaser nor any other Person
makes, or has made, any other express or implied representation or warranty with respect to Purchaser or the Transactions and all other representations and warranties of any kind or nature, expressed or implied (including any relating to the future
or historical financial condition, results of operations, assets or liabilities of the Group Companies or the Business), are specifically disclaimed by Purchaser and (iii)&nbsp;such disclaimer is agreed by Seller and Seller agrees that it and its
Affiliates are not relying on any representations and warranties in connection with the Transactions except the express representations and warranties of Purchaser set forth in <U>Article</U><U></U><U>&nbsp;V</U> of this Agreement, the certificate
delivered pursuant to <U>Section</U><U></U><U>&nbsp;7.3(c)</U> or as may be set forth in the Ancillary Agreements. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Representations and Warranties Relating to the Group Companies </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Seller represents and warrants to Purchaser that, except as disclosed in the Disclosure Letter: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;4.1 </U></B><B><U>Organization, Standing and Organizational Power</U></B>. (a)&nbsp;Each Group
Company is duly organized, validly existing and in good standing under the Laws of the jurisdiction of its organization and has all requisite corporate or other organizational power and authority necessary to own or lease all of its material
properties and assets and to carry on its business in all material respects as it is now being conducted. Each Group Company is qualified and licensed to do business and to operate under an assumed name and is in good standing in every jurisdiction
in which its ownership or lease of properties or assets, or the nature of its business, makes such qualification or licensing necessary, except where the failure to be so qualified, licensed or in good standing, individually or in the aggregate,
would not reasonably be expected to prevent, materially impair or materially delay the consummation by Seller of the Transactions or to have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) True and complete copies of the Group Company Charter Documents, as in effect on the date hereof, have been provided to Purchaser. The
Group Company Charter Documents are in full force and effect and no Group Company is in default (with or without notice or the lapse of time, or both) under, or in breach or violation in any material respect of, any provision of its Group Company
Charter Documents. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;4.2 </U></B><B><U>Subsidiaries;
Capitalization</U></B>. (a)<U>&nbsp;Section</U><U></U><U>&nbsp;4.2(a)</U> of the Disclosure Letter sets forth, as of the date of this Agreement, for each Group Company: (i)&nbsp;its name and assumed name(s) (if any) in each relevant jurisdiction,
(ii)&nbsp;its jurisdiction of organization, (iii)&nbsp;its authorized capitalization, (iv)&nbsp;its issued and outstanding capital stock or other equity interests and (v)&nbsp;the holder(s) of its entire capital stock or other equity interests.
Except for the Group Companies set forth in <U>Section</U><U></U><U>&nbsp;4.2(a)</U> of the Disclosure Letter, there are no other corporations, limited liability companies, partnerships, joint ventures, associations or other entities or Persons in
which any Group Company owns, of record or beneficially, any direct or indirect capital stock or other equity interest or any right (contingent or otherwise) to acquire any such capital stock or equity interest. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) All the outstanding shares of capital stock of, or other equity interests in, each Company Subsidiary and Sengenics Malaysia have been duly
authorized and validly issued and, to the extent such concepts are applicable thereto, are fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> and free and clear of preemptive rights or similar rights, and are owned directly or
indirectly by a Group Company, free and clear of all Liens, except for transfer restrictions of general applicability as may be provided under applicable securities Laws and Permitted Liens. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) No Group Company has any (i)&nbsp;capital stock or other equity interests, (ii)&nbsp;securities or rights convertible into, exchangeable or
exercisable for, or evidencing the right to subscribe for any capital stock or other equity interests, (iii)&nbsp;rights, warrants or options to purchase any capital stock or other equity interests or (iv)&nbsp;&#147;phantom&#148; units or rights,
stock appreciation rights, performance stock units or other rights that are linked in any way to the price or value of any capital stock or other equity interests, in each case issued, outstanding or reserved for issuance. There are no bonds,
debentures, notes or other Indebtedness of any Group Company having the right to vote (or convertible into or exercisable or exchangeable for securities of any Group Company having the right to vote) on any matters on which holders of the shares of
capital stock of, or other equity interests in, such Group Company are entitled to vote. There are no accrued or declared but unpaid dividends or distributions with respect to any capital stock or other equity interests of any Group Company. There
are no agreements or other obligations, contingent or otherwise, (i)&nbsp;that require any Group Company to repurchase, redeem or otherwise acquire any of such Group Company&#146;s capital stock or other equity securities that would survive the
Closing, (ii)&nbsp;with respect to the voting of any voting interests in any Group Company to which a Group Company is a party, including any voting trust agreement, (iii)&nbsp;restricting dividend rights with respect to, or the transfer or
disposition of, capital stock or other equity securities in any Group Company to which a Group Company is a party (including the Shares) or (iv)&nbsp;providing for registration rights or similar rights with respect to capital stock or other equity
securities in any Group Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;4.3 </U></B><B><U>Financial Statements; Undisclosed
Liabilities; Internal Controls</U></B>. (a)&nbsp;Seller has furnished to Purchaser (i)&nbsp;the unaudited <FONT STYLE="white-space:nowrap">carve-out</FONT> balance sheet of the Business as of December&nbsp;31, 2024 and the related <FONT
STYLE="white-space:nowrap">carve-out</FONT> income statement of the Business for the <FONT STYLE="white-space:nowrap">12-month</FONT> period then ended and (ii)&nbsp;the unaudited <FONT STYLE="white-space:nowrap">carve-out</FONT> interim balance
sheet of the Business as of March&nbsp;31, 2025 (the &#147;<U>Latest Business Balance Sheet</U>&#148;) and the related <FONT STYLE="white-space:nowrap">carve-out</FONT> interim income statement of the Business for the three-month period then ended
(the financial statements referred to in clauses&nbsp;(i)&nbsp;and (ii), collectively, the &#147;<U>Business Financial Statements</U>&#148;). The Business Financial Statements (A)&nbsp;have been extracted from the financial statements of Seller,
which were </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
prepared in all material respects in accordance with GAAP, consistently applied, and (B)&nbsp;taking into account the purposes for which they were prepared and subject to the remainder of this
<U>Section</U><U></U><U>&nbsp;4.3(a)</U>, present fairly in all material respects the financial condition and results of operations of the Business as of the times and for the periods referred to therein. Notwithstanding anything to the contrary in
this <U>Section</U><U></U><U>&nbsp;4.3</U>, Purchaser acknowledges that the Business has not been operated as a separate stand-alone entity but rather has been operated within Seller and has been reporting its results as part of the consolidated
financial statements of Seller. As a result, Purchaser acknowledges that the Business Financial Statements (x)&nbsp;include certain costs incurred by Seller that have been allocated to the Business, (y)&nbsp;do not include certain costs necessary to
operate the Business on a stand-alone basis and (z)&nbsp;are not necessarily indicative of what the financial position or results of operations of the Business on a stand-alone basis have been in any past period or at any past date or will be in the
future. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) No Group Company has any liability, indebtedness, commitment or obligation of any type, whether accrued or unaccrued,
absolute or contingent or matured or unmatured, and whether or not of the type required to be recorded in accordance with GAAP, except for those (i)&nbsp;reflected or reserved against on the Latest Business Balance Sheet, (ii)&nbsp;incurred after
the date of the Latest Business Balance Sheet in the ordinary course of business and not resulting from breach of Contract or violation of applicable Law, (iii)&nbsp;incurred in connection with the Transactions or otherwise contemplated by this
Agreement, (iv)&nbsp;incurred following the date of this Agreement in compliance with (and to the extent addressed by) <U>Section</U><U></U><U>&nbsp;6.1(b)</U>, (v)&nbsp;that are executory performance obligations under a Contract to which a Group
Company is a party or otherwise bound and that do not result from a breach of such Contract or (vi)&nbsp;that would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Seller maintains a system of internal accounting controls that are applicable to the Group Companies and that are designed to provide
reasonable assurance that all transactions are, in all material respects, (i)&nbsp;executed in accordance with management&#146;s general or specific authorizations and (ii)&nbsp;recorded as necessary to permit the materially correct preparation of
financial statements in accordance with GAAP. From June&nbsp;1, 2022 to the date of this Agreement, no director, manager or officer of any Group Company has received or otherwise had or obtained knowledge of (A)&nbsp;any material weakness or
significant deficiency regarding the accounting or auditing practices, procedures, methodologies or methods of the Group Companies or the Business or their respective internal accounting controls, (B)&nbsp;any fraud that involves any director,
manager or officer of any Group Company or (C)&nbsp;any claim or allegation regarding any of the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;4.4 </U></B><B><U>Absence of Certain Changes</U></B>. (a) (i)&nbsp;Since the date of the Latest
Business Balance Sheet through the date of this Agreement, the Business has been conducted in all material respects in the ordinary course of business and (ii)&nbsp;since December&nbsp;31, 2024 through the date of this Agreement, there has not been
any Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Since the date of the Latest Business Balance Sheet through the date of this Agreement, no Group Company
or, to the extent related to the Business, any member of the Seller Group has taken, or agreed in writing to take, any actions that, if taken during the <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period without Purchaser&#146;s consent,
would constitute a breach of any of the covenants set forth in clauses<U>&nbsp;(iv)</U>, <U>(viii)</U>, <U>(ix)</U>, <U>(x)</U>, <U>(xi)</U>, <U>(xvi)</U>, <U>(xvii)</U>, <U>(xviii)</U> , <U>(xxiii)</U> or <U>(xxiv)</U>&nbsp;of
<U>Section</U><U></U><U>&nbsp;6.1(b)</U> (insofar as clause<U>&nbsp;(xxiv)</U> relates to the foregoing clauses of <U>Section</U><U></U><U>&nbsp;6.1(b)</U>) (disregarding any such provisions relating to Purchaser consultation or notification). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;4.5 </U></B><B><U>Legal Proceedings</U></B>.
There are no pending Legal Proceedings and no Person has threatened in writing to commence any Legal Proceedings (except, in each case, for Legal Proceedings that would not, individually or in the aggregate, reasonably be expected to be material to
the Group Companies, taken as a whole) against any Group Company, any Company Associate (in his or her capacity as such) or any assets owned or used by any Group Company or otherwise relating to the Business. As of the date of this Agreement, there
are no pending Legal Proceedings and no Person has threatened in writing to commence any Legal Proceedings that would reasonably be expected to prevent, materially impair or materially delay the consummation by Seller of the Transactions. Since
June&nbsp;1, 2022 to the date of this Agreement, no Legal Proceeding was brought or, to the Knowledge of Seller, threatened against any Group Company or otherwise relating to the Business that resulted in any liability that was material to the Group
Companies, taken as a whole. No Group Company or, to the extent related to the Business, any member of the Seller Group is subject to any outstanding Order that would reasonably be expected to be, individually or in the aggregate, material to the
Group Companies, taken as a whole, or the Business. To the Knowledge of Seller, there is no material investigation of any Group Company or the Business by any Governmental Authority that is pending or threatened. To the Knowledge of Seller, as of
the date hereof, no Business Employee is subject to any unsatisfied Order that prohibits such Business Employee from engaging in or continuing any conduct, activity or practice relating to the Business or to any material assets owned or used by any
Group Company or the Business, except as would not be material to the Group Companies, taken as a whole. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;4.6 </U></B><B><U>Compliance With Laws; Permits</U></B>. (a)&nbsp;The Group Companies and, to
the extent related to the Business, the members of the Seller Group are and, at all times since June&nbsp;1, 2022, have been, in compliance in all material respects with all applicable Laws, including Health Care Laws. Since June&nbsp;1, 2022, no
Group Company or member of the Seller Group has received written notice of any claim, complaint, suit, proceeding, hearing, enforcement, audit, investigation, arbitration, or other adverse action, in each case with respect to the Group Companies or
the Business, from any Person, including any Governmental Authority or customer, alleging product liability, material <FONT STYLE="white-space:nowrap">non-compliance</FONT> or material violation of any applicable Laws, including Health Care Laws,
and, to the Knowledge of Seller, no such adverse action is pending or threatened against any Group Company or the Business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) There is
not, and since June&nbsp;1, 2022 has not been, any Order binding upon any Group Company or otherwise relating to the Business that (i)&nbsp;has, or would reasonably be expected to have, the effect of prohibiting or impairing any material business
practice of any Group Company or the Business, any acquisition of material property by any Group Company or the Business or the conduct of any Group Company or the Business or (ii)&nbsp;would not reasonably be expected to reasonably be expected to
prevent, materially impair or materially delay the consummation by Seller of the Transactions. No Group Company or, to the extent related to the Business, any member of the Seller Group is a party to any corporate integrity agreements, monitoring
agreements, consent decrees, deferred prosecution agreements, settlement orders, or similar agreements with or imposed by any Governmental Authority. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) At all times since June&nbsp;1, 2022 the Group Companies have held, and have operated
the Business in material compliance with, all material Governmental Authorizations that are necessary for the conduct of the Business (collectively, &#147;<U>Business Permits</U>&#148;). <U>Section</U><U></U><U>&nbsp;4.6(c)</U> of the Disclosure
Letter sets forth a list, as of the date hereof, of all Business Permits, and Seller has provided to Purchaser true and complete copies of such Business Permits. The Group Companies hold all right, title and interest in and to all Business Permits
free and clear of any Lien other than Permitted Liens. All fees and charges with respect to such Business Permits, as of the date hereof, have been paid in full and all filing, reporting and maintenance obligations have been completely and timely
satisfied in all material respects. The Group Companies are in material compliance with the terms of all Business Permits. As of the date hereof, no Legal Proceeding is pending or, to the Knowledge of Seller, threatened that seeks to revoke, limit,
suspend, or materially modify any Business Permit. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) All Business Permits are valid and are in full force and effect. Since June&nbsp;1,
2022, no Group Companies or member of the Seller Group has received any written notice from any Governmental Authority regarding any violation of, conflict with or failure to comply with any Business Permit in any material respect. As of the date
hereof, no material suspension, request for stay of the grant thereof (or any appeal thereof), termination or cancellation of any of Business Permit is pending or, to the Knowledge of Seller, threatened by the Governmental Authority issuing such
Business Permit. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Except as would not be material to the Group Companies, taken as a whole, (i)&nbsp;no Business Product has been, or
has been requested by a Governmental Authority or other Person to be, recalled, withdrawn, removed, suspended, seized, the subject of a corrective action or discontinued (whether voluntarily or otherwise) (collectively, &#147;<U>Recall</U>&#148;),
(ii)&nbsp;no Group Company or member of the Seller Group, or, to the Knowledge of Seller, any Governmental Authority or other Person, has sought, is seeking or has or is currently threatening or contemplating any Recall of any Business Product,
(iii)&nbsp;the Business Products have been manufactured, packaged, labeled, tested, stored, shipped, handled, warehoused and distributed in material compliance with all applicable Laws, including Health Care Laws, and are not, and have not been,
prohibited from introduction into interstate commerce under applicable Laws, including Health Care Laws and (iv)&nbsp;all Business Products marketed by the Group Companies or the Seller Group are, and have been, labeled, promoted and advertised in
material compliance with applicable Laws, including Health Care Laws. Except as would not be material to the Group Companies, taken as a whole, since June&nbsp;1, 2022, with respect to any Business Product, no Group Company or member of the Seller
Group has, either voluntarily or involuntarily, issued or caused to be issued any notice or communication related to an alleged lack of safety, efficacy or material noncompliance with any applicable Health Care Law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Except as would not be material to the Group Companies, taken as a whole, as of the date hereof, no Group Company or, to the extent related
to the Business, any member of the Seller Group, or any of their respective officers, directors, employees, independent contractors or, to the Knowledge of Seller, agents, have been or are currently: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) subject to mandatory or permissive debarment or suspension pursuant to 21 U.S.C. &#167;&nbsp;335a; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) excluded under 42 U.S.C.
<FONT STYLE="white-space:nowrap">&#167;&nbsp;1320a-7</FONT> or any similar law, rule or regulation of any Governmental Authority; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) excluded, debarred, suspended or deemed ineligible to participate in federal procurement and <FONT
STYLE="white-space:nowrap">non-procurement</FONT> programs, including those produced by the U.S. General Services Administration; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) charged, named in a complaint, convicted, or otherwise found liable in any Legal Proceeding that falls within the ambit of
21 U.S.C. &#167;&nbsp;331, 21 U.S.C. &#167;&nbsp;333, 21 U.S.C. &#167;&nbsp;334, 21 U.S.C. &#167;&nbsp;335a, 21 U.S.C. &#167;&nbsp;335b, 42 U.S.C. <FONT STYLE="white-space:nowrap">&#167;&nbsp;1320a-7,</FONT> 31 U.S.C. &#167;&#167;&nbsp;3729-3733, 42
U.S.C. <FONT STYLE="white-space:nowrap">&#167;&nbsp;1320a-7a,</FONT> or any other applicable Law or, to the Knowledge of Seller, threatened with prosecution by a Governmental Authority, including the Centers for Medicare&nbsp;&amp; Medicaid
Services, the U.S. Department of Health and Human Services, any state attorney general or the U.S. Department of Justice, for any violation of any applicable Law; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) disqualified or deemed ineligible pursuant to 21 C.F.R. Parts 312, 511 or 812, or otherwise restricted, in whole or in
part, or subject to an assurance; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) engaged in a pending Legal Proceeding, or otherwise received any written notice
from any Governmental Authority or any Person threatening, investigating, or pursuing any action contemplated by <U>clauses</U><U></U><U>&nbsp;(i)-(v)</U> of this <U>Section</U><U></U><U>&nbsp;4.6(f)</U> or, to the Knowledge of Seller, committed any
violation of any applicable Law, including Health Care Laws, that could reasonably be expected to serve as the basis for any such exclusion, suspension, debarment or other ineligibility. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) No Group Company or any member of the Seller Group has been restrained in any material respect by a Governmental Authority or other Person
in its ability to conduct or have conducted the manufacturing, operation, storage, import, export, distribution, warehousing, packaging, labeling, handling, shipping or nonclinical, clinical or other testing of Business Products. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) All studies and tests conducted by or on behalf of, or sponsored by, any Group Company, or that are otherwise related to the Business or
the Business Products (including in which any Group Company or any member of the Seller Group has participated), were and, if still pending, are being conducted in compliance in all material respects with all applicable Laws, including Health Care
Laws. To the Knowledge of Seller, the study reports, protocols and statistical analysis plans for all such studies and tests accurately, completely and fairly reflect the results from such studies and tests. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) To the Knowledge of Seller, no Business Product that is or has been developed, manufactured, tested, packaged, labeled, distributed,
imported, exported or marketed or sold by or on behalf of any Group Company or member of the Seller Group is subject to the FDCA or any similar Law in any foreign jurisdiction. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) To the Knowledge of Seller, there are no material Legal Proceedings or governmental, regulatory or administrative investigations, audits,
inquiries or actions against or affecting any Group Company or the Business relating to or arising under any applicable Health Care Law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) Each Group Company and, to the extent related to the Business, each member of the Seller
Group has in effect all required material Governmental Authorizations under applicable Health Care Laws necessary for it to own, lease and operate its properties and other assets and to carry on the Business as currently conducted. There has
occurred no material default under, or material violation of, any such Governmental Authorizations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;4.7 </U></B><B><U>Certain Business Practices</U></B>. (a)&nbsp;At all times during the past
five years, no (i)&nbsp;Group Company, (ii)&nbsp;director, officer, employee or, to the Knowledge of Seller, agent or Representative of any Group Company or the Business or (iii)&nbsp;to the extent related to the Business, member of the Seller Group
has committed a material violation of the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act 2010 or any other applicable anti-bribery or anticorruption Laws in any jurisdiction applicable to any Group Company (collectively, the
&#147;<U>Anticorruption Laws</U>&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) At all times during the past five years, no (i)&nbsp;Group Company, (ii)&nbsp;any director,
officer, employee or, to the Knowledge of Seller, agent or Representative of any Group Company or the Business or (iii)&nbsp;to the extent related to the Business, member of the Seller Group has been a Person with whom dealings are prohibited under
the economic or financial sanctions, restrictive measures or trade embargos imposed, administered or enforced from time to time by any Sanctions Authority (&#147;<U>Sanctions</U>&#148;), to the extent applicable, whether as a result of the specific
designation of that Person, its ownership or control, the jurisdiction in which it is located, organized or a resident, or otherwise. At all times during the past five years, (i)&nbsp;each Group Company, (ii)&nbsp;each director, officer, employee
or, to the Knowledge of Seller, agent or Representative of each Group Company or the Business or (iii)&nbsp;to the extent related to the Business, each member of the Seller Group has complied in all material respects with all applicable Laws
pertaining to Sanctions. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Each Group Company and, to the extent related to the Business, each member of the Seller Group is operating
and, at all times during the past five years, has been operated in all material respects in compliance with applicable financial recordkeeping and reporting requirements, including those of the Currency and Foreign Transactions Reporting Act of
1970, the applicable anti-money laundering statutes of all jurisdictions where the Business is conducted, the rules and regulations thereunder and any related or similar anti-money laundering rules, regulations or guidelines issued, administered or
enforced by any Governmental Authority (collectively, the &#147;<U>Anti-Money Laundering Laws</U>&#148;). No Legal Proceeding by or before any Governmental Authority involving a Group Company or the Business with respect to the Anti-Money Laundering
Laws is pending or, to the Knowledge of Seller, threatened. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) No Group Company or, to the extent related to the Business, any member of
the Seller Group has exported, <FONT STYLE="white-space:nowrap">re-exported</FONT> or retransferred any article, item, component, software, technology, service or technical data or taken any other act in material violation of any applicable Export
Control Laws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Seller has established, maintained and implemented, with regard to the Group Companies
and the Business, policies, procedures and controls reasonably designed to promote compliance with the Anticorruption Laws, Sanctions and Export Control Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;4.8 </U></B><B><U>Tax Matters</U></B>. (a)&nbsp;All material Tax Returns required to be filed
with respect to any Group Company have been timely filed (taking into account any extension of time within which to file that has been granted) and all such Tax Returns are true, correct and complete in all material respects. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) All income and other material Taxes with respect to any Group Company or the Business have been timely paid (taking into account any
extension of time within which to file that has been granted) or are being contested in good faith. In the case of income or other material Taxes not yet due, such Taxes (other than Consolidated Income Taxes) have been accrued or reserved to the
extent required by GAAP on the applicable Company Financial Statements. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Except with respect to Consolidated Income Taxes or any
Consolidated Tax Return, no material deficiency with respect to any Taxes has been proposed, asserted or assessed in writing with respect to any Group Company that has not been fully paid and settled. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) There are no Liens for material Taxes (other than Permitted Liens) upon any of the assets of the Group Companies. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) No written claim has ever been made prior to the date hereof by any Governmental Authority in any jurisdiction where a Group Company does
not currently file a Tax Return or pay Taxes that such Group Company is subject to Tax by that jurisdiction. None of the Group Companies has ever had a &#147;permanent establishment&#148; (as defined in the applicable Tax treaty or convention) or
other taxable presence in any jurisdiction other than its country of incorporation. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Except with respect to Consolidated Income Taxes
or any Consolidated Tax Return, no audit or other administrative or court proceedings are pending with any Governmental Authority with respect to material Taxes of any Group Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Except with respect to Consolidated Income Taxes or any Consolidated Tax Return, there is no outstanding waiver extending the statute of
limitations with respect to the collection or assessment of a material amount of Taxes due from or with respect to any Group Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)
All material Taxes required to be withheld by any Group Company have been timely withheld, and to the extent required, such withheld Taxes have been timely paid to the appropriate Governmental Authority. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) No Group Company (i)&nbsp;is or has been a member of an affiliated group of corporations filing a Consolidated Tax Return or (ii)&nbsp;has
any liability with respect to Taxes of another Person under applicable Law (including under Treasury Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;1.1502-6</FONT> (or any comparable provision of state, local or foreign Law) as a result
of filing Tax Returns on a consolidated, combined or unitary basis with such Person), in each case, other than (x)&nbsp;pursuant to or as a result of its inclusion as a member of any such group that includes Seller or (y)&nbsp;customary withholding
Taxes. No Group Company is a party to, bound by, or has any obligation under, any Tax sharing agreement or Tax indemnity obligation (other than pursuant to an agreement the principal purpose of which is not the sharing or indemnification of Taxes).
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) None of the Group Companies has participated in or been a party to a transaction that
constitutes a &#147;listed transaction&#148; within the meaning of Treasury Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;1.6011-4(b).</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) Except with respect to Consolidated Income Taxes or any Consolidated Tax Return, no power of attorney with respect to material Taxes has
been granted with respect to the Group Companies that will remain in effect following the Closing. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) Except with respect to Consolidated
Income Taxes or any Consolidated Tax Return, none of the Group Companies have entered into a closing agreement or other agreement with respect to material Taxes with any Governmental Authority. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) All material transactions between a Group Company, on the one hand, and Seller or any of its Affiliates, on the other hand (including for
this purpose, another Group Company), have been conducted on arm&#146;s length terms in all material respects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;4.9 </U></B><B><U>Employee Benefits Matters</U></B>.
(a)<U>&nbsp;Section</U><U></U><U>&nbsp;4.9(a)</U> of the Disclosure Letter sets forth a true and complete list of all material Company Plans in effect on the date of this Agreement and separately identifies each Company Plan that is an Assumed Plan;
<I>provided</I> that <U>Section</U><U></U><U>&nbsp;4.9(a)</U> of the Disclosure Letter shall not be required to list (i)&nbsp;any individual offer letter, employment contract or consultancy agreement with a natural person that is in all material
respects consistent with a standard form made available to Purchaser prior to the date of this Agreement and listed on <U>Section</U><U></U><U>&nbsp;4.9(a)</U> of the Disclosure Letter, (ii)&nbsp;any individual equity award agreement that is in all
material respects consistent with a standard form made available prior to the date of this Agreement and listed on <U>Section</U><U></U><U>&nbsp;4.9(a)</U> of the Disclosure Letter or (iii)&nbsp;any Company Plans required to be maintained pursuant
to applicable Laws and that do not provide compensation or benefits in excess of those required by applicable Laws. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) As applicable with
respect to each Company Plan required to be listed on <U>Section</U><U></U><U>&nbsp;4.9(a)</U> of the Disclosure Letter, Seller has made available to Purchaser true and complete copies of (i)&nbsp;each Company Plan, including all amendments thereto,
and in the case of an unwritten Company Plan, a written description thereof, (ii)&nbsp;all current trust documents, investment management contracts, custodial agreements, administrative services agreements and insurance and annuity contracts
relating thereto, (iii)&nbsp;the current summary plan description and a summary of material modifications thereto, (iv)&nbsp;the three most recently filed annual reports with any Governmental Authority (<I>e.g.</I>, Form&nbsp;5500 and all schedules
thereto), (v)&nbsp;the most recent determination, opinion or advisory letter from the IRS with respect to each Company Plan intended to qualify under Section&nbsp;401(a) of the Code, (vi)&nbsp;the most recent summary annual report, three most recent
nondiscrimination testing reports, actuarial reports, financial statements and trustee reports, (vii)&nbsp;all <FONT STYLE="white-space:nowrap">non-routine</FONT> correspondence received from or provided to the DOL, the Pension Benefit Guaranty
Corporation, the IRS or any other Governmental Authority since June&nbsp;1, 2022 and (viii)&nbsp;all notices and filings concerning IRS, DOL or other Governmental Authority audits or investigations since June&nbsp;1, 2022, including with respect to
&#147;prohibited transactions&#148; within the meaning of Section&nbsp;406 of ERISA or Section&nbsp;4975 of the Code. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Each Company Plan has been established, maintained, funded, operated and administered in
compliance in all material respects with its terms and any related documents or agreements and the applicable provisions of ERISA, the Code and all other applicable Laws. The Group Companies have complied in all material respects with all applicable
provisions of ERISA, the Code and all other applicable Laws, as they relate to each Company Plan they have established, maintained, funded, operated and administered. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Company Plans which are &#147;employee pension benefit plans&#148; within the meaning of Section&nbsp;3(2) of ERISA and which are
intended to meet the qualification requirements of Section&nbsp;401(a) of the Code have received determination or opinion letters from the IRS on which they may currently rely to the effect that such Company Plans are qualified under
Section&nbsp;401(a) of the Code and the related trusts are exempt from federal income Taxes under Section&nbsp;501(a) of the Code, respectively, or are covered by advisory or opinion letters with respect to a volume submitter or prototype plan, and,
to the Knowledge of Seller, nothing has occurred that would reasonably be expected to adversely affect the qualification of such Company Plan or the <FONT STYLE="white-space:nowrap">tax-exempt</FONT> status of the related trust. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) No Group Company or any ERISA Affiliate sponsors, maintains, contributes to or is required to contribute to, or has ever sponsored,
maintained, contributed to or been required to contribute to, or has or had any actual or contingent liability with respect to, (i)&nbsp;any &#147;employee pension benefit plan&#148; (within the meaning of Section&nbsp;3(2) of ERISA) that is subject
to Title IV or Section&nbsp;302 of ERISA or Section&nbsp;412 of the Code, (ii)&nbsp;any &#147;multiemployer plan&#148; (within the meaning of Section&nbsp;3(37) or 4001(a)(3) of ERISA), (iii)&nbsp;any &#147;multiple employer plan&#148; (within the
meaning of Section&nbsp;413 of the Code), (iv)&nbsp;any &#147;multiple employer welfare arrangement&#148; (within the meaning of Section&nbsp;3(40) of ERISA) or (v)&nbsp;any &#147;voluntary employees beneficiary association&#148; (within the meaning
of Section&nbsp;501(c)(9) of the Code). The obligations of all Assumed Plans that provide health, welfare or similar insurance are fully insured by bona fide third-party insurers. No Assumed Plan is maintained through a human resources or benefit
outsourcing entity, professional employer organization or other similar provider. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) As of the date of this Agreement, there are no
pending or, to the Knowledge of Seller, threatened audits or investigations by any Governmental Authority involving any Assumed Plan, and no pending or, to the Knowledge of Seller, threatened claims (except for individual claims for benefits payable
in the ordinary course of operating the Company Plans), suits or proceedings involving any Assumed Plan, any fiduciary thereof or service provider thereto. Since June&nbsp;1, 2022, all material contributions and premium payments required to have
been timely made under any of the Company Plans or by applicable Law (without regard to any waivers granted under Section&nbsp;412 of the Code) have been timely made, no Group Company has any liability for any such unpaid contributions with respect
to any Company Plan, all benefits accrued under any unfunded Company Plan have been paid, accrued or otherwise adequately reserved in accordance with GAAP, and all reports, returns and similar documents required to be filed with any Governmental
Authority or distributed to any plan participant have been timely filed or distributed. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Neither Seller nor its Affiliates (including the Group Companies), or, to the Knowledge
of Seller, any fiduciary, trustee or administrator of any Company Plan, has engaged in, or in connection with the Transactions will engage in, any transaction with respect to any Assumed Plan which would subject any such Assumed Plan or any Group
Company to a material Tax, penalty or liability for a &#147;prohibited transaction&#148; under Section&nbsp;406 of ERISA or Section&nbsp;4975 of the Code. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) No Company Plan provides death, medical, dental, vision, life insurance or other welfare benefits beyond termination of service or
retirement to any Business Employee or for which any Group Company would be liable, other than coverage mandated by Part&nbsp;6 of Subtitle B of Title I of ERISA, Section&nbsp;4980B of the Code or any other applicable Law at the participant or
beneficiary&#146;s sole expense and, with respect to any Business Employee, neither Seller nor its Affiliates (including the Group Companies) has any obligation to provide such insurance or benefits (whether under a Company Plan or otherwise) and
has not made a written or oral representation promising to provide such insurance or benefits. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) For each Assumed Plan that is a group
health plan under Section&nbsp;733(a)(1) of ERISA, Seller and its Affiliates (including any Group Company) has complied in all material respects with the Patient Protection and Affordable Care Act, including the Health Care and Education
Reconciliation Act of 2010, as amended and including any guidance issued thereunder (&#147;<U>PPACA</U>&#148;) and the Consolidated Omnibus Budget Reconciliation Act. With respect to each Company Associate, neither Seller nor any of its Affiliates
(including any Group Company) has failed to comply in all material respects with Sections&nbsp;601 to 609 of ERISA and Section&nbsp;4980B of the Code and has, for any relevant period, offered the requisite number of &#147;full-time employees&#148;
group health coverage that is &#147;affordable&#148; and of &#147;minimum value&#148; (as such terms are defined by the employer shared responsibility provisions of PPACA). Neither Seller nor any of its Affiliates (including any Group Company) has
incurred (whether or not assessed), or is reasonably expected to incur or to be subject to, any Tax, penalty or other liability that may be imposed under PPACA or Sections&nbsp;4980B, 4980D, 4980H, 6721 or 6722 of the Code or with respect to any
requirement to timely file PPACA information returns with the IRS or provide statements to participants under Section&nbsp;6055 or 6056 of the Code or state law requirements as applicable, or pursuant to Sections&nbsp;4976 through 4980 of the Code
or Title I of ERISA with respect to any Assumed Plan. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) Except as set forth on <U>Section</U><U></U><U>&nbsp;4.9(j)</U> of the
Disclosure Letter, neither the execution of this Agreement nor the consummation of the Transactions will either alone or in connection with any other event(s) (i)&nbsp;result in any payment (whether of severance pay or otherwise) becoming due to or
forgiveness of Indebtedness for any Company Associate, (ii)&nbsp;increase any amount of compensation or benefits otherwise payable to any Company Associate, (iii)&nbsp;result in the acceleration of the time of payment, funding or vesting of any
benefits under any Company Plan, (iv)&nbsp;require any contribution or payment to fund any obligation under any Assumed Plan or (v)&nbsp;limit the right to merge, amend or terminate any Assumed Plan (or result in adverse consequences for so doing).
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) Neither the execution of this Agreement nor the consummation of the Transactions (either alone or when combined with the occurrence of
any other event, including a termination of employment) will result in any person who is a Disqualified Individual receiving (i)&nbsp;any payment or benefit that would reasonably be expected to be characterized as a &#147;parachute payment&#148;
(within the meaning of Section&nbsp;280G of the Code), determined without regard to the application of Section&nbsp;280G(b)(5) of the Code or (ii)&nbsp;any amount for which the deduction would be disallowed by any Group Company under
Section&nbsp;162(m) of the Code. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) Each Assumed Plan providing for deferred compensation that constitutes a
&#147;nonqualified deferred compensation plan&#148; (as defined in Section&nbsp;409A(d)(1) of the Code and the regulations promulgated thereunder) is and has been established, administered and maintained in material compliance in both form and
operation with the requirements of Section&nbsp;409A of the Code and the regulations promulgated thereunder. No Group Company has any liability for nonreporting or underreporting of income subject to Section&nbsp;409A of the Code with respect to any
Company Associate. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) No Company Associate has any &#147;gross up&#148; agreements with Seller or any of its Affiliates (including any
Group Company) or other assurance of reimbursement for any Taxes imposed under Section&nbsp;409A or 4999 of the Code. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) There are, and
since June&nbsp;1, 2022, there have been, no actual, threatened or pending negotiations, strikes, labor disputes, work stoppages, requests for representation, pickets, work slow-downs due to labor disagreements or any proceedings or arbitrations
that involve the labor or employment relations of any Group Company or any Business Employees. No Group Company is a party to, is bound by or has a duty to bargain under any collective bargaining agreement or other Contract with a labor union or
labor organization representing any Company Associate, and there is no labor union or labor organization representing or, to the Knowledge of Seller, purporting to represent or seeking to represent any Business Employee, including through the filing
of a petition for a representation election. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) Seller and its Affiliates (including each Group Company) is, and since June&nbsp;1, 2022
has been, in material compliance with all applicable Laws respecting labor, employment, employment practices, and terms and conditions of employment with respect to Company Associates, including worker classification, discrimination, wrongful
termination, harassment and retaliation, equal employment opportunities, fair employment practices, meal and rest periods, immigration (including <FONT STYLE="white-space:nowrap">I-9</FONT> usage), reasonable accommodation, disability rights or
benefits, child labor, working conditions, privacy, employee safety and health, wages (including overtime wages), unemployment and workers&#146; compensation, leaves of absence and time off and hours of work. With respect to Company Associates,
Seller and its Affiliates (including each Group Company), since June&nbsp;1, 2022 (i)&nbsp;have withheld and reported all amounts required by Law or by agreement to be withheld and reported with respect to wages, salaries and other payments,
benefits, or compensation to such Company Associates, (ii)&nbsp;are not liable for any arrears of wages (including overtime wages), premiums, commissions, paid time off, <FONT STYLE="white-space:nowrap">on-call</FONT> payments, bonus, benefits,
severance pay or any Taxes or any penalty or damages for failure to comply with any of the foregoing, and (iii)&nbsp;are not liable for any payment to any trust or other fund governed by or maintained by or on behalf of any Governmental Authority,
with respect to unemployment compensation benefits, disability, social security or other benefits or obligations for such Company Associates (other than routine payments to be made in the ordinary course of business). As of the date of this
Agreement, there are no actions, suits, claims, charges, demands, lawsuits, investigations, audits or administrative matters pending or, to the Knowledge of Seller, threatened or reasonably anticipated against Seller or any of its Affiliates
(including any Group Company) or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any Company Associate (in his or her capacity as such) relating to any Company Associate, applicant for employment as a Company Associate, employment agreement of a Company Associate or Assumed
Plan (other than routine claims for benefits). All U.S.-based Business Employees are employed <FONT STYLE="white-space:nowrap">&#147;at-will&#148;</FONT> and their employment can be terminated without advance notice or payment of severance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p) Except as would not be reasonably likely to result in a material liability, with respect to each Company Associate on or after
June&nbsp;1, 2022, Seller and its Affiliates (including the Group Companies) have accurately classified each such individual as an employee, independent contractor, or otherwise under all applicable Laws and, for each such individual classified as
an employee, Seller and its Affiliates (including the Group Companies) have accurately classified him or her as overtime eligible or overtime ineligible under all applicable Laws. No Group Company has any material liability with respect to any
misclassification of (i)&nbsp;any Person as an independent contractor rather than as an employee, (ii)&nbsp;any employee leased from another employer or (iii)&nbsp;any employee currently or formerly classified as exempt from overtime wages. No
Business Employees are employed on a work visa or work permit. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(q) No Assumed Plan is or has been maintained outside the jurisdiction of
the United States, or covers or covered any Company Associates permanently residing or working outside the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(r) Since
June&nbsp;1, 2022, no Group Company has, with respect to any Company Associates, (i)&nbsp;caused a plant closing, as defined in the Worker Adjustment and Retraining Notification Act (the &#147;<U>WARN Act</U>&#148;), affecting any single site of
employment or one or more operating units within any site of employment or (ii)&nbsp;engaged in a mass layoff, as defined in the WARN Act or (iii)&nbsp;been affected by any transactions or engaged in layoffs or employment terminations that are
sufficient in number to trigger application of any similar foreign, state or local Law. No Business Employee has been notified of an upcoming employment loss, as defined in the WARN Act, within the <FONT STYLE="white-space:nowrap">90-day</FONT>
period ending on the date hereof. Since June&nbsp;1, 2022, neither Seller nor any of its Affiliates (including each Group Company) has implemented any material workplace changes affecting Company Associates, such as layoffs, furloughs, permanent
office closures, or reductions in compensation, benefits or hours. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(s) No Legal Proceedings are, as of the date hereof, open and pending
(or since June&nbsp;1, 2022 have been settled or otherwise closed) against any Group Company or any member of the Seller Group with respect to the employment of, or failure to employ, any individual in connection with the Business, including any
Legal Proceeding brought with or by the Equal Employment Opportunity Commission, the Office of Federal Contract Compliance Programs or other any other Governmental Authority regulating the employment or compensation of individuals (or, with respect
to discrimination, unlawful harassment, retaliation, or similar wrongdoing, pursuant to internal complaint procedures), and no Company Associate has made, since June&nbsp;1, 2022, a written complaint or, to the Knowledge of Seller, an oral complaint
of discrimination, unlawful harassment, retaliation or other similar wrongdoing. Since June&nbsp;1, 2022, no Group Company or any member of the Seller Group has received any requests for, or conducted, an internal investigation of any Company
Associate with respect to any claims of discrimination, unlawful harassment, retaliation or other similar wrongdoing. No Group Company or any member of the Seller Group is a party to any settlement agreement entered into since June&nbsp;1, 2022 that
resolves allegations of discrimination, unlawful harassment, retaliation or other similar wrongdoing by any Company Associate. Since June&nbsp;1, 2022, Seller and its Affiliates (including any Group Company) have promptly, thoroughly and impartially
investigated all allegations by or against any Company Associate regarding allegations of discrimination, unlawful harassment, retaliation or other similar wrongdoing in accordance with applicable Law and, with respect to each such allegation with
potential merit, Seller and its Affiliates (including any Group Company) have taken prompt corrective action reasonably calculated to prevent further discrimination, harassment, retaliation or other similar wrongdoing, and Seller and its Affiliates
(including any Group Company), taken as a whole, are not reasonably expected to incur any material liability with respect to any such allegation by a Company Associate. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(t) <U>Section</U><U></U><U>&nbsp;4.9(t)</U> of the Disclosure Letter (the &#147;<U>Business
Employee Schedule</U>&#148;) lists all Persons who are Business Employees as of the date hereof, including any employee who is on a leave of absence of any nature, paid or unpaid, authorized or unauthorized, and sets forth for each such individual
the following: (i)&nbsp;name (or if not permitted under applicable Data Protection Regulations, employee ID), (ii)&nbsp;title or position (including whether full or part time), (iii)&nbsp;hire date, (iv)&nbsp;annual base salary or hourly rate of
pay, (v)&nbsp;aggregate commission, bonus or other incentive-based compensation paid for prior year, (vi)&nbsp;commission, target bonus or other incentive-based compensation opportunity for current year, (vii)&nbsp;leave status, if applicable,
including reason for leave and expected date of return (if known), (viii)&nbsp;classification as either exempt or <FONT STYLE="white-space:nowrap">non-exempt</FONT> under the Fair Labor Standards Act and state and local wage and hour laws,
(ix)&nbsp;city, state, and country of service and (x)&nbsp;city, state, and country of residence. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(u)
<U>Section</U><U></U><U>&nbsp;4.9(u)</U> of the Disclosure Letter (the &#147;<U>Business Consultant Schedule</U>&#148;) sets forth each Person currently retained by Seller or any of its Affiliates (including each Group Company) as a consultant or
independent contractor (in each case, who is a natural person) solely or primarily for the Business and further sets forth the following information with respect to each: (i)&nbsp;name, (ii)&nbsp;services, (iii)&nbsp;date of engagement,
(iv)&nbsp;the entity or entities to which the Person provides services and (v)&nbsp;fees paid or payable to the Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;4.10 </U></B><B><U>Environmental Matters</U></B>. Except as would not be material to the Group
Companies, taken as a whole, each Group Company and, to the extent related to the Business, each member of the Seller Group is and has been since June&nbsp;1, 2022 in compliance with all applicable Environmental Laws. Each Group Company and, to the
extent related to the Business, each member of the Seller Group has and maintains, in full force and effect, and has complied in all material respects with, all Governmental Authorizations required under applicable Environmental Laws for the
operation of the Business or use of the Company Leased Real Property. No Group Company or member of the Seller Group has received any written notice or other written communication, whether from a Governmental Authority or other Person, since
June&nbsp;1, 2022 or that is otherwise unresolved and alleges that any Group Company or the Business (a)&nbsp;is not in compliance with or has liability pursuant to any Environmental Law, (b)&nbsp;has been identified as a potentially responsible
party under any Environmental Law or (c)&nbsp;has generated, stored, treated, transported, disposed of or arranged for any other Person to transport or dispose of Hazardous Materials that have been found at any site at which a Governmental Authority
or other Person has conducted or has been ordered to conduct a remedial investigation, removal or other response actions pursuant to Environmental Law, in each of <U>clauses</U><U></U><U>&nbsp;(a)-(c)</U>&nbsp;to the extent such notice or
communication would reasonably be expected to result in any material Legal Proceeding </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
against, or material liability or cleanup obligation on the part of, any Group Company. To the Knowledge of Seller, (A)&nbsp;there are no underground storage tanks or other underground storage
receptacles for Hazardous Materials for which a Group Company is responsible present on any Company Leased Real Property and (B)&nbsp;except as reflected in the Business Financial Statements, no capital or other expenses (including with respect to
any use or storage of refrigerants) are required for any Group Company or its facilities to achieve or maintain compliance in all material respects with Environmental Law. There has not been any Release of or exposure to any Hazardous Materials,
including at, on or under the Company Leased Real Property and any real property used by any Group Company for the disposal of waste, that would reasonably be expected to result in any material Legal Proceeding against, or material cleanup
obligation on the part of, any Group Company. No Group Company or member of the Seller Group has retained or assumed, either contractually or by operation of Law, any material liabilities or material obligations that would reasonably be expected to
form the basis of any material Legal Proceeding relating to any Environmental Law against any Group Company or the Business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;4.11 </U></B><B><U>Intellectual Property</U></B>.
(a)<U>&nbsp;Section</U><U></U><U>&nbsp;4.11(a)</U> of the Disclosure Letter sets forth a true, complete and accurate list, as of the date hereof, of all Company Registered IP, indicating for each, as applicable, (i)&nbsp;the current legal and record
owner(s), (ii)&nbsp;the jurisdictions in which such item is issued or registered or in which any application for issuance or registration has been filed, (iii)&nbsp;the respective issuance or registration and application numbers of the item,
(iv)&nbsp;the dates of application and issuance or registration of the item and (v)&nbsp;the current status of the item (<I>e.g.</I>, registered or pending). The applicable Group Company indicated in <U>Section</U><U></U><U>&nbsp;4.11(a)</U> of the
Disclosure Letter owns (or in the case of Internet domain names, is the registrant of) all of its Company Registered IP free and clear of all Liens, except for Permitted Liens. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except as would not be material to the Group Companies, taken as a whole, (i)&nbsp;one or more Group Companies are the sole and exclusive
owner of all right, title and interest in and to all Company Owned IP and (ii)&nbsp;one or more Group Companies have the right to use, pursuant to valid and enforceable agreements, all Company IP other than Company Owned IP (&#147;<U>Company <FONT
STYLE="white-space:nowrap">In-Licensed</FONT> IP</U>&#148;), in the case of each of <U>subsections</U><U></U><U>&nbsp;(i)</U>&nbsp;and (ii)&nbsp;of this <U>Section</U><U></U><U>&nbsp;4.11(b)</U>, free and clear of all Liens other than Permitted
Liens. One or more Group Companies are the sole and exclusive owner of all right, title and interest in and to all &#147;Licensed Intellectual Property&#148; (as such term is defined in the License Agreement), free and clear of all Liens other than
Permitted Liens. All material Company Owned IP is subsisting and, to the Knowledge of Seller, valid and enforceable. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Except as would
not be material to the Group Companies, taken as a whole, since June&nbsp;1, 2022, (i)&nbsp;to the Knowledge of Seller, the conduct of the Business has not infringed, misappropriated, diluted or otherwise violated any Person&#146;s Intellectual
Property, (ii)&nbsp;there has been no claim of infringement, misappropriation, dilution or other violation of any Person&#146;s Intellectual Property filed, pending or threatened in writing against any Group Company or the Seller Group, in each case
with respect to the Business, (iii)&nbsp;to the Knowledge of Seller, no Person has infringed, misappropriated, diluted or otherwise violated any Company Owned IP and (iv)&nbsp;there has been no claim of infringement, misappropriation, dilution or
other violation of any Company Owned IP filed, pending or threatened in writing by Seller or any of its Affiliates (including any Group Company) against any Person. Since June&nbsp;1, 2022, there has been no claim, opposition, post-grant review,
reexamination proceeding, extension of time to oppose, interference </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or any other proceeding or dispute filed, pending or threatened in writing by any Person challenging the scope, validity, enforceability or ownership of any Company Registered IP. No Company
Owned IP or, to the Knowledge of Seller, any Company <FONT STYLE="white-space:nowrap">In-Licensed</FONT> IP is subject to any pending or outstanding Order that would restrict the filing, enforcement, licensing, use, registration, transfer, disposal
of or other exploitation by any Group Company of any such Company Owned IP or Company <FONT STYLE="white-space:nowrap">In-Licensed</FONT> IP. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Since June&nbsp;1, 2022, the Group Companies have taken commercially reasonable measures intended to ensure the protection of all of the
material Company Owned IP (including, with regard to the material Company Registered IP, and in their reasonable business judgment, making and maintaining in full force and effect all necessary filings, registrations and issuances, including paying
all fees related thereto). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) No current or former Company Associate has filed or threatened in writing any claim of ownership or right,
in whole or in part, to any material Company Owned IP or has asserted in a Legal Proceeding any such claim of ownership or right. Each current and former Company Associate who, either alone or with others, conceives of, creates, develops, invents,
reduces to practice or has conceived of, created, developed, invented or reduced to practice any material Intellectual Property for or on behalf of any Group Company or the Business has entered into a written Contract with a Group Company, the
current form of which has been made available to Purchaser, providing for the present assignment to a Group Company of such Intellectual Property (without the present assignment to a Group Company of such Intellectual Property being contingent on
further payment being owed to any such Company Associate and without any restrictions or obligations on the ownership thereof by such Group Company or on the use thereof by any other Group Company or the Business), to the extent that such Group
Company does not own such Intellectual Property by operation of Law. All current and former Company Associates who, either alone or with others, conceive of, create, develop, invent, reduce to practice or has conceived of, created, developed,
invented or reduced to practice any material Intellectual Property for or on behalf of any Group Company or the Business has executed and delivered to a Group Company a written Contract in substantially the form provided to Purchaser. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Each Person that is or has been permitted to access any material Trade Secrets or other material confidential or proprietary information
controlled by or in the possession of a Group Company has signed a valid, enforceable written Contract at least commensurate with industry standards requiring such Person to maintain the confidentiality of such Trade Secrets or other confidential or
proprietary information, and, to the Knowledge of Seller, there has not been any breach by any Person of any such written Contract. The Group Companies have taken commercially reasonable measures intended to maintain the confidentiality of all
material Trade Secrets and other material confidential or proprietary information of the Group Companies. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) A Group Company has sole
ownership of, is in actual possession of and has exclusive control over the source code for all proprietary Software included in the Company Owned IP. Except as would not be material to the Group Companies, taken as a whole, no proprietary Software
included in the Company Owned IP, the source code for which Seller and its Affiliates intended to be kept confidential, incorporates Open Source Code in a manner that (i)&nbsp;requires the licensing or distribution of such Software or disclosure of
any source code of such Software, (ii)&nbsp;prohibits or limits the receipt of consideration in connection with licensing, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
sublicensing or distributing such Software or any source code of such Software or (iii)&nbsp;requires (or conditions the use or distribution of such Software or any source code of such Software
on) the granting of a license under any Company Owned IP. No Group Company or member of the Seller Group has delivered, licensed or made available (or is subject to an obligation to deliver, license or make available) any source code of any
proprietary Software included in the Company Owned IP to any escrow agent. No Group Company or, to the extent related to the Business, member of the Seller Group has received any notice or written request from any third Person (x)&nbsp;to distribute
or license any Software or disclose the source code of any Software included in the Company Owned IP, in each case, pursuant to a requirement or obligation under any Open Source Code license that applies to a Group Company or, to the extent related
to the Business, member of the Seller Group or (y)&nbsp;alleging noncompliance with any Open Source Code license. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) No funding,
facilities or personnel of any Governmental Authority or any university, college, research institute or other educational or academic institution has been used, in whole or in part, to create any Company Owned IP. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) No Group Company is now, or has ever been, a member of, or a contributor to, any industry standards body or any similar organization (each,
an &#147;<U>Industry Body</U>&#148;) that requires or obligates it to grant or offer to any other Person any license or right to any Company Owned IP. To the Knowledge of Seller, no patent or patent application included in the Company Owned IP is or
has ever been declared, disclosed, proposed or otherwise identified as a standard-essential patent by or to any Industry Body. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;4.12 </U></B><B><U>Privacy and Data Security</U></B>. <B></B>(a) The Group Companies and, to
the extent related to the Business, the members of the Seller Group have complied, and continue to comply, in all material respects with applicable Data Protection Regulations, including compliance in all material respects with applicable Data
Protection Regulations regarding (i)&nbsp;binding principles relating to Processing Personal Data, (ii)&nbsp;requirements to Process Personal Data lawfully, (iii)&nbsp;contractual requirements applicable to the engagement of data processors
Processing Personal Data on behalf of the Business, (iv)&nbsp;requirements to provide adequate security measures to protect Personal Data, (v)&nbsp;regulatory notification obligations to the extent required by applicable Data Protection Regulations,
(vi)&nbsp;conduct of appropriate data privacy impact assessments to the extent required by applicable Data Protection Regulations and (vii)&nbsp;requirements related to lawful cross-border data transfers of Personal Data. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Group Companies and, to the extent related to the Business, the members of the Seller Group have, as applicable, implemented, and
regularly assessed the implementation of, commercially reasonable physical, technical and organizational measures designed to ensure that Personal Data is protected against unauthorized loss, theft or Processing. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Except as would not reasonably be expected to cause any material loss, harm, or liability to the Group Companies, taken as a whole,
(i)&nbsp;no Group Company or, to the extent related to the Business, member of the Seller Group transfers Personal Data outside of the country of origin of the Personal Data unless such Group Company or Seller Group member, as applicable, has
complied with any applicable Data Protection Regulations regarding data transfers, including the consent of individuals where required by applicable Data Protection Regulations, (ii)&nbsp;where any transfers of Personal Data outside the European
Economic Area or the United </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Kingdom formerly relied upon the <FONT STYLE="white-space:nowrap">E.U.-U.S.</FONT> or <FONT STYLE="white-space:nowrap">Swiss-U.S.</FONT> Privacy Shield framework, the Group Companies and, to the
extent related to the Business, the members of the Seller Group have, as applicable, ensured that the Personal Data transfers are lawful in all material respects through an alternative mechanism or derogation in accordance with the GDPR,
(iii)&nbsp;where required by applicable Data Protection Regulations, the Group Companies and, to the extent related to the Business, the members of the Seller Group have, as applicable, conducted a risk assessment regarding the transfer of Personal
Data pursuant to standard contractual clauses or binding corporate rules&nbsp;or other requirements and concluded that such transfers are compliant with applicable Data Protection Regulations and (iv)&nbsp;no Group Company or, to the extent related
to the Business, member of the Seller Group has suspended or terminated a transfer of Personal Data or notified a supervisory authority due to any concerns regarding a transfer of Personal Data pursuant to standard contractual clauses or binding
corporate rules&nbsp;and, to the Knowledge of Seller, there are no circumstances which reasonably justify such a notification. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Except
as would not be material to the Group Companies, taken as a whole, the Group Companies have purchased a sufficient number of license seats, and scope of rights, for all Software licensed by a Group Company from a third Person and have complied with
the terms of the corresponding Contract. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) (i)&nbsp;Each Group Company and member of the Seller Group has, as applicable, implemented
and maintained commercially reasonable measures and policies intended to protect the integrity, continuous operation and security of the Company IT Systems owned or controlled by such Group Company or member of the Seller Group and the data stored
thereon, including from Harmful Code, (ii)&nbsp;the Company IT Systems operate and perform in all material respects as required to carry on the Business as currently conducted, (iii)&nbsp;to the Knowledge of Seller, the Company IT Systems are free
from bugs and Harmful Code that would reasonably be expected to cause material disruption in the operation of the Business as currently conducted and (iv)&nbsp;each Group Company and, to the extent related to the Business, the Seller Group has
implemented commercially reasonable backup and disaster recovery technology and procedures and has acted in material compliance therewith. Since June&nbsp;1, 2022, to the Knowledge of Seller, the Company IT Systems have not malfunctioned or failed,
or been subject to any Security Incident that has caused (A)&nbsp;disruption of or interruption in the ability to carry on the Business as currently conducted; (B)&nbsp;loss, destruction, damage or harm to the Group Companies, taken as a whole or
(C)&nbsp;liability of any kind to the Group Companies, taken as a whole. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Except as would not reasonably be expected to cause any
material loss, harm, or liability to the Group Companies, taken as a whole, since June&nbsp;1, 2022, to the Knowledge of Seller, there has not been, (i)&nbsp;a Security Incident compromising Personal Data or any Trade Secrets or other confidential
or proprietary information used in the Business (collectively, &#147;<U>Company Sensitive Data</U>&#148;) or (ii)&nbsp;any action or any circumstance requiring the Group Companies or the Seller Group to notify a Governmental Authority or any Person
as a result of a Security Incident or a violation of any Data Protection Regulations in connection with the Business, or requiring any individual to comply with applicable notification requirements of the Data Protection Regulations in connection
therewith. Since June&nbsp;1, 2022, neither the Group Companies nor the Seller Group have notified a Governmental Authority or any Person of a Security Incident or a violation of any Data Protection Regulations in connection with the Business. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Since June&nbsp;1, 2022, neither the Group Companies nor the members of the Seller Group
have received (i)(A)&nbsp;a written claim, complaint, allegation or other written notice of&nbsp;any actual or alleged or threatened Security Incident compromising or revealing a material weakness in the security of Company Sensitive Data or Company
IT Systems or (B)&nbsp;written notice of any Legal Proceeding (whether directly or indirectly) from or on behalf of any Person regarding the Personal Data Processing activities of the Group Companies or, to the extent related to the Business, the
Seller Group, or (ii)&nbsp;a written notice from any supervisory authority or Governmental Authority of any investigation, inquiry, request for information or request for cooperation regarding the Personal Data Processing activities of the Group
Companies or, to the extent related to the Business, the Seller Group. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) None of the Group Companies (i)&nbsp;is a &#147;covered
person&#148; or (ii)&nbsp;Processes data or operates in a &#147;country of concern&#148; (in each case as such terms are defined in 28 C.F.R. Part&nbsp;202), and no member of the Seller Group has knowingly engaged in prohibited transactions in
violation of 28 C.F.R. Part&nbsp;202. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;4.13 </U></B><B><U>Customers and Suppliers</U></B>.
(a)<U>&nbsp;Section</U><U></U><U>&nbsp;4.13(a)</U> of the Disclosure Letter sets forth a true and complete list of the 10 largest customers of the Business based on the revenue accrued by Seller and its Affiliates, taken as a whole, in connection
with the Business for each of the fiscal year ended December&nbsp;31, 2024 and the five-month period ended May&nbsp;31, 2025 (the &#147;<U>Company Material Customers</U>&#148;). As of the date of this Agreement, no Group Company or member of the
Seller Group has received written notice from any Company Material Customer that such Company Material Customer intends to, or has exercised any right to, terminate or modify in any material respect the amounts, frequency or terms of the business
such Company Material Customer conducts with Seller or any of its Affiliates with respect to the Business. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)
<U>Section</U><U></U><U>&nbsp;4.13(b)</U> of the Disclosure Letter sets forth a true and complete list of the 10 largest suppliers of the Business based on the expenses accrued by Seller and its Affiliates, taken as a whole, in connection with the
Business for each of the fiscal year ended December&nbsp;31, 2024 and the five-month period ended May&nbsp;31, 2025 (the &#147;<U>Company Material Suppliers</U>&#148;). As of the date of this Agreement, no Group Company or member of the Seller Group
has received written notice from any Company Material Supplier that such Company Material Supplier intends to, or has exercised any right to, terminate or modify in any material respect the amounts, frequency or terms of the business such Company
Material Supplier conducts with Seller or any of its Affiliates with respect to the Business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;4.14 </U></B><B><U>Real Estate</U></B>.<B> </B>(a)&nbsp;No Group Company owns, or has, to the
Knowledge of Seller, ever owned, any real property. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Section</U><U></U><U>&nbsp;4.14(b)</U> of the Disclosure Letter sets forth a
true and complete list, as of the date hereof, of all real property leased, licensed, subleased or otherwise used by any Group Company as lessee, sublessee, licensee or occupant (the &#147;<U>Company Leased Real Property</U>&#148;), together with a
description of each underlying lease, sublease, license and occupancy agreement (each, including all amendments, extensions, renewals, guaranties and other agreements with respect thereto, a &#147;<U>Company Real Estate Lease</U>&#148;). Seller has
made available to Purchaser true and complete copies of all Company Real Estate Leases. Except as set forth in the applicable Company Real Estate Lease, a Group Company has exclusive possession of each such Company Leased Real
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Property and such Company Leased Real Property is not subject to any current grant by any Group Company of any use or occupancy rights to tenants, subtenants or licensees with respect to such
Company Leased Real Property or any portion thereof. No Group Company has assigned, transferred, subleased or pledged (directly or indirectly) any interest in any of the Company Real Estate Leases. A Group Company has a valid leasehold or
subleasehold interest in (or a valid right to use and occupy) each Company Leased Real Property, free and clear of all Liens other than Permitted Liens. Each Company Real Estate Lease is valid and binding on a Group Company and is in full force and
effect and, to the Knowledge of Seller, valid and binding on, and enforceable against, the other parties thereto, and no Group Company, or to the Knowledge of Seller, any party thereto, is in material breach or default under any Company Real Estate
Lease, beyond any applicable grace periods, and, to the Knowledge of Seller, no event has occurred or circumstances exists that, with notice or the passage of time, or both, could result in a material breach or default thereunder. The Company Leased
Real Properties comprise all of the real property used in the operation of the Business as currently conducted (other than any properties at which Overhead and Shared Services are conducted) and is sufficient in all material respects to operate the
Business as currently conducted (other than any properties at which Operations and Shared Services are conducted). Except as would not be material to the Group Companies, taken as a whole, all structures and buildings on the Company Leased Real
Properties are in good operating condition and repair for the requirements of the Business as currently conducted, ordinary wear and tear excepted. To the Knowledge of Seller, neither the whole nor any part of any Company Leased Real Property is
subject to any pending suit for condemnation, proceeding in eminent domain or other taking by any Governmental Authority, and no such condemnation, proceeding in eminent domain or other taking is threatened or contemplated. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;4.15 </U></B><B><U>Contracts</U></B><B>. </B>(a)<U>&nbsp;Section</U><U></U><U>&nbsp;4.15(a)</U>
of the Disclosure Letter sets forth, as of the date hereof, a true and complete list of the following Contracts to which any Group Company is a party or by which any Group Company or any of their respective assets are bound (other than (x)&nbsp;any
purchase order, work order or quality agreement that, for each of the foregoing, does not modify any material term or condition of, or contain any material term or condition that is not contemplated by or contained in, a Contract disclosed in
<U>Section</U><U></U><U>&nbsp;4.15(a)</U> of the Disclosure Letter or (y)&nbsp;any Company Plan): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) each Contract
pursuant to which the Group Companies, taken as a whole, may be entitled to receive or obligated to pay more than $500,000 in any fiscal year; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) [reserved]; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) each Contract that is material to the Business or operation of the Group Companies, taken as a whole, containing
(A)&nbsp;any provision limiting the freedom of any Group Company to engage in any line of business or compete with any Person (other than any employee, customer or consultant <FONT STYLE="white-space:nowrap">non-solicitation</FONT> covenants entered
into in the ordinary course of business), (B)&nbsp;any &#147;most-favored nations&#148; pricing provisions or marketing or distribution rights related to any products or territory, (C)&nbsp;any exclusivity provision or (D)&nbsp;any agreement to
purchase a minimum quantity of goods or services; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) each Contract that is material to the Business or operation of the
Group Companies, taken as a whole, that grants to the counterparty any rights of first refusal, first negotiation, first offer or similar right, and each Contract that limits or purports to limit the ability of any Group Company to own, operate,
sell, transfer, or otherwise dispose of its material assets; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) each Contract that governs the formation, creation,
governance, economics or control of any joint venture, legal partnership or other similar arrangement, other than with respect to any Contract solely between or among Group Companies; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) each Contract relating to capital expenditures and requiring payments after the date of this Agreement in excess of
$150,000 pursuant to its express terms and not cancelable without penalty; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vii) each Contract relating to the disposition
or acquisition of assets for consideration in excess of $150,000, or assets that are otherwise material to the Business or the Group Companies, taken as a whole, or of any ownership interest in any entity (whether by merger, sale of stock, sale of
assets or otherwise); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(viii) each Contract pursuant to which any Group Company has indemnification obligations, or
purchase price adjustment, earnout or other contingent payment obligations, in each case in connection with any merger or other business combination or any acquisition or disposition of a business or Person; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ix) each Contract relating to any pending business acquisition by any Group Company; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x) each Contract providing for the creation of any mortgages, loans or notes of any Group Company, each indenture, credit
agreement, security agreement or other agreement or instrument providing for the creation of Indebtedness for borrowed money of any Group Company, any guaranty provided by any Group Company of any obligation for borrowed money or other guaranty
provided by any Group Company and each Contract creating any material Liens, other than Contracts creating Liens of the type, nature and scope contemplated by <U>clauses</U><U></U><U>&nbsp;(ii)</U>, <U>(iii)</U>, <U>(iv)</U>, <U>(v)</U> or
<U>(vii)</U>&nbsp;of the definition of Permitted Liens; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xi) each Contract under which a Group Company, directly or
indirectly, has made any advance, loan, extension of credit or capital contribution to, or other investment in, any Person (other than a Group Company), in any such case which, individually, is in excess of $150,000, other than (A)&nbsp;trade credit
advanced in the ordinary course of business or (B)&nbsp;to directors, managers, officers or employees for business and travel expenses in the ordinary course of business; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xii) each Company Real Estate Lease; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xiii) each Contract with any Governmental Authority or any university, college, research institute or other educational or
academic institution that provides for research and development activities involving the creation of any material Intellectual Property rights; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xiv) (A)&nbsp;each license of Company
<FONT STYLE="white-space:nowrap">In-Licensed</FONT> IP (other than any <FONT STYLE="white-space:nowrap">non-exclusive</FONT> licenses incidental to the primary purpose of commercial agreements, <FONT STYLE="white-space:nowrap">non-disclosure</FONT>
agreements entered into in the ordinary course of business, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Off-the-shelf</FONT></FONT> Software and licenses to Open Source Code) and (B)&nbsp;each settlement, <FONT
STYLE="white-space:nowrap">co-existence</FONT> or other Contract that grants any third Person a license or right to use, or restricts any Group Company from filing, enforcing, licensing, using, registering, transferring, disposing of or otherwise
exploiting, any Company Owned IP (other than any <FONT STYLE="white-space:nowrap">non-exclusive</FONT> licenses incidental to the primary purpose of commercial agreements and <FONT STYLE="white-space:nowrap">non-disclosure</FONT> agreements entered
into in the ordinary course of business); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xv) each Contract pursuant to which any material research or development
activities are conducted by any Group Company for a third party or by a third party for any Group Company; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xvi) each
Contract that is material to the Business or operations of Group Companies, taken as a whole, under which any Group Company has continuing milestone, royalty or similar contingent payment obligations, including upon the achievement of regulatory or
commercial milestones or obligation to pay any royalty, dividend or similar payment based on the revenues or profits of any Group Company, in each case, excluding indemnification and performance guarantee obligations provided for in the ordinary
course of business; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xvii) each Contract that is not terminable at will with fewer than 60&nbsp;days&#146; prior notice
(with no penalty or payment) by any Group Company and which expressly provides for payment or receipt by any Group Company after the date of this Agreement of more than $500,000 in the aggregate; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xviii) each collective bargaining agreement or other similar Contract with any labor organization, union, group or association
covering any Business Employee; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xix) each Contract (A)&nbsp;for the employment of any Business Employee providing such
Business Employee with target annual compensation or fees in excess of $350,000, (B)&nbsp;providing for the payment of any Cash or other compensation or benefits in connection with or upon the consummation of the Transactions to any Business
Employee or otherwise payable by any Group Company, (C)&nbsp;restricting any Group Company&#146;s ability to terminate the employment or services of any Business Employee at any time for any lawful reason or for no reason without penalty or
(D)&nbsp;providing for severance or similar termination payments, retention or change in control payments, or for the acceleration of vesting or grant of any incentive equity or similar compensation to any Business Employee or otherwise payable by
any Group Company; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xx) each Contract with a Company Material Customer; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxi) each Contract with a Company Material Supplier; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxii) each &#147;single-source&#148; supply Contract, pursuant to which material goods or services are supplied to any Group
Company from an exclusive source that cannot be replaced by one or more other sources on substantially similar terms and in a reasonably timely manner; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxiii) each Contract that is a settlement, conciliation or similar
agreement with any Governmental Authority that imposes any material unpaid monetary or other material ongoing obligation upon any Group Company; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxiv) each Contract with (A)&nbsp;Seller or any Affiliate of Seller (other than any Group Company) or (B)&nbsp;any officer or
director of Seller or its Affiliates (including the Group Companies) or any Affiliate thereof (other than a Group Company); or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxv) each commitment or agreement to enter into any of the foregoing. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Section</U><U></U><U>&nbsp;4.15(b)</U> of the Disclosure Letter sets forth, as of the date hereof, a true and complete list of any
Contracts to which any member of the Seller Group is a party that are exclusively related to the Business. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Seller has made available
to Purchaser true and complete copies of all Contracts that are referred to in <U>Section</U><U></U><U>&nbsp;4.15(a)</U> or <U>Section</U><U></U><U>&nbsp;4.15(b)</U> (such Contracts, together with any Contract entered into after the date hereof that
would have been required to be listed in <U>Section</U><U></U><U>&nbsp;4.15(a)</U> or <U>Section</U><U></U><U>&nbsp;4.15(b)</U> of the Disclosure Letter if such Contract had been entered into prior to the date hereof, the &#147;<U>Material
Contracts</U>&#148;), including all material amendments thereto. There are no Material Contracts that are not in written form. Neither Seller nor its Affiliates (including each Group Company to the extent such Group Company is a party thereto), as
applicable, nor, to the Knowledge of Seller, any other party to a Material Contract, has (i)&nbsp;failed to perform in any material respect any obligations required to be performed by it under any such Material Contract or (ii)&nbsp;breached,
violated or defaulted under, or received notice that it breached, violated or defaulted under, any of the terms or conditions of, or Laws applicable to, any such Material Contract in such manner as would permit any party thereto, with notice, lapse
of time or both, to accelerate, modify, cancel or terminate such Material Contract or to seek damages or pursue other legal remedies which would reasonably be expected to be material to the Group Companies, taken as a whole. As to Seller and its
Affiliates (including each Group Company to the extent such Group Company is a party thereto), as applicable, and, to the Knowledge of Seller, any other party to any Material Contract, each such Material Contract is valid, binding, enforceable and
in full force and effect, subject to the Bankruptcy and Equity Exception. Between the date of the Latest Business Balance Sheet and the date hereof, no counterparty to a Material Contract has notified Seller or any of its Affiliates in writing (or,
to the Knowledge of Seller, otherwise) that it intends to terminate or not renew a Material Contract, and neither Seller nor any of its Affiliates has provided any notice that it intends to terminate or not renew a Material Contract. As of the date
of this Agreement, there are no material disputes pending or, to the Knowledge of Seller, threatened with respect to any Material Contract or any counterparty thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;4.16 </U></B><B><U>Insurance</U></B>. <U>Section</U><U></U><U>&nbsp;4.16</U> of the Disclosure
Letter lists each material insurance policy maintained by the Group Companies or, to the extent related to the Business, the Seller Group (the &#147;<U>Insurance Policies</U>&#148;) as of the date hereof, and Seller has made available to Purchaser
true and complete copies of all Insurance Policies. Each Insurance Policy is in full force and effect, and Seller and its Affiliates, as applicable, are in compliance in all material respects </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
with the terms thereof. Other than customary end of policy notifications from insurance carriers, since June&nbsp;1, 2022, no Group Company or member of the Seller Group (a)&nbsp;is in material
default with respect to its obligations under any Insurance Policy or (b)&nbsp;has received any written notice or other written communication regarding any actual or possible (i)&nbsp;cancellation or invalidation of any Insurance Policy,
(ii)&nbsp;refusal or denial of any coverage or rejection of any material claim under any Insurance Policy or (iii)&nbsp;unwillingness or inability of any party to perform its obligations under any Insurance Policy in any material respect (other than
reservation rights). With respect to each Insurance Policy, the Group Companies or members of the Seller Group, as applicable, have provided timely written notice to the appropriate insurance carrier(s) of each Legal Proceeding that is currently
pending against any Group Company or member of the Seller Group for which such Group Company or member of the Seller Group has insurance coverage under an Insurance Policy, and no such carrier has issued a denial of coverage with respect to any such
Legal Proceeding or informed any Group Company or member of the Seller Group of its intent to do so. The Insurance Policies are sufficient for compliance in all material respects under all Business Permits and Material Contracts to which any Group
Company is a party or by which any Group Company, the Business or their respective properties or assets are bound. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;4.17 </U></B><B><U>Affiliate Transactions</U></B>. No officer, director, manager or Affiliate
of a member of the Seller Group or of a Group Company (other than another Group Company) or, to the Knowledge of Seller, any individual in such officer&#146;s, director&#146;s or manager&#146;s immediate family is a party to any Contract with any
Group Company or related to the Business (other than arising under or in connection with employment-related Contracts, Company Plans and confidentiality Contracts or other Contracts incident to such Person&#146;s employment with a Group Company) or
has any ownership of any material property used in or necessary for the conduct of the Business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;4.18 </U></B><B><U>Takeover Statutes</U></B>. Assuming the accuracy of the representations of
Purchaser in <U>Section</U><U></U><U>&nbsp;5.5</U>, no anti-takeover or similar statute or regulation (such as Section&nbsp;203 of the DGCL) applies or will apply to this Agreement or the Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;4.19 </U></B><B><U>Assets and Liabilities of the Group Companies</U></B>. At the Closing,
taking into account and giving effect to all the Ancillary Agreements (including the services to be provided pursuant to the Transition Services Agreement) and other than with respect to Overhead and Shared Services, (a)&nbsp;the assets and
properties owned, leased, licensed or otherwise used by the Group Companies will constitute all of the assets and properties necessary for, used or held for use in connection with the conduct of the Business immediately following the Closing in
substantially the same manner as the Business is conducted immediately prior to the date hereof and the Closing, including, for the avoidance of doubt, all Single SOMAmers; <I><U>provided</U></I> that the foregoing shall not be construed as a
representation or warranty regarding any infringement, misappropriation or violation of any Intellectual Property, and (b)&nbsp;no right or interest in any material property or asset that is necessary for, used or held for use in connection with the
operation of the Business as it currently conducted, or conducted immediately prior to Closing will at the Closing be owned or held by a member of the Seller Group. At the Closing, except as would not, individually or in the aggregate, be material
to the Group Companies, taken as a whole, the liabilities of the Group Companies shall not include any liabilities that (i)&nbsp;arise out of or relate to any Seller Business or (ii)&nbsp;constitute Excluded Employee Liabilities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Representations and Warranties of Purchaser </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Purchaser represents and warrants to Seller that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;5.1 </U></B><B><U>Organization, Standing and Organizational Power of Purchaser</U></B>.
Purchaser is a corporation duly organized, validly existing and in good standing under the Laws of Delaware. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;5.2 </U></B><B><U>Authority; Noncontravention</U></B>. <B></B>(a) Purchaser has all necessary
corporate power and authority to execute and deliver this Agreement and all other agreements and documents contemplated hereby to which it is a party, to perform its obligations hereunder and thereunder and to consummate the Transactions. The
execution and delivery of and performance by Purchaser under this Agreement, and the consummation by Purchaser of the Transactions, have been duly authorized and approved by all requisite corporate action by Purchaser (including the board of
directors of Purchaser), and no other corporate action on the part of Purchaser and no action on the part of Purchaser&#146;s stockholders is necessary to authorize the execution and delivery of and performance by Purchaser under this Agreement and
the consummation by Purchaser of the Transactions. This Agreement has been duly executed and delivered by Purchaser and, assuming due authorization, execution and delivery hereof by Seller, constitutes a legal, valid and binding obligation of
Purchaser, enforceable against Purchaser in accordance with its terms, subject to the Bankruptcy and Equity Exception. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)Neither the
execution and delivery of this Agreement by Purchaser, nor the consummation by Purchaser of the Transactions, nor compliance by Purchaser with any of the terms or provisions hereof, shall (i)&nbsp;conflict with or violate any provision of the
certificate of incorporation and bylaws of Purchaser, in each case as amended to the date of this Agreement, (ii)&nbsp;assuming that each of the consents, authorizations and approvals referred to in <U>Section</U><U></U><U>&nbsp;5.3</U> are received
(and any condition precedent to any such consent, authorization or approval has been satisfied) and each of the filings referred to in <U>Section</U><U></U><U>&nbsp;5.3</U> are made and any applicable waiting periods referred to therein have
expired, violate any Law or Order applicable to Purchaser or any of its Subsidiaries or (iii)&nbsp;result in any breach of, or constitute a default (with or without notice or lapse of time, or both) under, or give rise to any right of termination,
amendment, acceleration or cancellation of, or result in any material or increased, additional, accelerated or guaranteed rights or entitlements of any Person under, any Contract to which Purchaser or any of its Subsidiaries is a party, except, in
the case of <U>clauses</U><U></U><U>&nbsp;(ii)</U> or <U>(iii)</U>&nbsp;above, as would not, individually or in the aggregate, reasonably be expected to have a Purchaser Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;5.3 </U></B><B><U>Governmental Approvals</U></B>. Except for filings required under, and
compliance with other applicable requirements of, the HSR Act, the Regulatory Laws, the Securities Act, the Exchange Act, state securities or blue sky laws and the rules of NASDAQ, no material consents or approvals of, or material filings,
declarations or registrations with, any Governmental Authority are necessary for the execution and delivery of this Agreement by Purchaser and the consummation by Purchaser of the Transactions, other than as would not, individually or in the
aggregate, reasonably be expected to have a Purchaser Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;5.4 </U></B><B><U>Brokers and Other
Advisors</U></B>. Except for Goldman Sachs&nbsp;&amp; Co. LLC, the fees and commission of which shall be borne wholly by Purchaser, no broker, investment banker, financial advisor, intermediary, finder or other Person is entitled to any
broker&#146;s, finder&#146;s or financial advisor&#146;s fee or other similar fee or commission, or the reimbursement of expenses, directly or indirectly, in connection with the Transactions based upon arrangements made by or on behalf of Purchaser
or any of its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;5.5 </U></B><B><U>No Interested Stockholder</U></B>. Neither
Purchaser nor any of its &#147;affiliates&#148; or &#147;associates&#148; is, or has been within the last three years, an &#147;interested stockholder&#148; (in each case as such terms are defined in Section&nbsp;203 of the DGCL) of Seller. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;5.6 </U></B><B><U>Sufficient Funds</U></B>. At the Closing, Purchaser will have available to it
sufficient funds to consummate the Transactions, including payment of the Closing Aggregate Consideration. Purchaser expressly acknowledges and agrees that Purchaser&#146;s ability to obtain financing is not a condition to its obligations under this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;5.7 </U></B><B><U>Legal Proceedings</U></B>. There are no Legal Proceedings
pending or, to the Knowledge of Purchaser, threatened in writing against Purchaser, at law or in equity, other than any Legal Proceedings that, if determined adversely to Purchaser, would not, individually or in the aggregate, reasonably be expected
to have a Purchaser Material Adverse Effect. Purchaser is not subject to any outstanding Orders, other than any Orders that would not, individually or in the aggregate, reasonably be expected to have a Purchaser Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;5.8 </U></B><B><U>Investment Representation</U></B>. Purchaser is acquiring the Shares for its
own account with the present intention of holding such securities for investment purposes and not with a view to, or for sale in connection with, any distribution of such securities in violation of any federal or state securities Laws. Purchaser is
an &#147;accredited investor&#148; as defined in Regulation&nbsp;D promulgated by the SEC under the Securities Act. Purchaser acknowledges that the Shares have not been registered under the Securities Act, or any state or foreign securities Laws and
that the Shares may not be sold, transferred, offered for sale, pledged, hypothecated or otherwise disposed of unless such transfer, sale, assignment, pledge, hypothecation or other disposition is registered under any applicable state or foreign
securities Laws or sold pursuant to an exemption from registration under the Securities Act, and any applicable state or foreign securities Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;5.9 </U></B><B><U>Acknowledgement by Purchaser; No Reliance</U></B>. Purchaser acknowledges and
agrees that: (i)&nbsp;it has conducted to its satisfaction its own independent investigation and verification of the financial condition, results of operations, assets, liabilities, properties and projected operations of the Business and the Group
Companies, (ii)&nbsp;the express representations and warranties of Seller set forth in <U>Article</U><U></U><U>&nbsp;III</U> and <U>Article</U><U></U><U>&nbsp;IV</U> of this Agreement, the certificate delivered pursuant to
<U>Section</U><U></U><U>&nbsp;7.2(d)</U> and as may be set forth in the Ancillary Agreements constitute the sole and exclusive representations and warranties of Seller in connection with the Transactions, (iii)&nbsp;except for such express
representations and warranties, neither Seller nor any other Person makes, or has made, any other express or implied representation or warranty with respect to Seller, the Group Companies, the Business or the Transactions and all other
representations and warranties of any kind or nature, expressed or implied (including any relating to the future or historical financial condition, results of operations, assets or liabilities of the Group Companies or the Business), are
specifically disclaimed by Seller and (iv)&nbsp;such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
disclaimer is agreed by Purchaser and Purchaser agrees that it and its Affiliates are not relying on any representations and warranties in connection with the Transactions except the express
representations and warranties of Seller set forth in <U>Article</U><U></U><U>&nbsp;III</U> and <U>Article</U><U></U><U>&nbsp;IV</U> of this Agreement, the certificate delivered pursuant to <U>Section</U><U></U><U>&nbsp;7.2(d)</U> or as may be set
forth in the Ancillary Agreements. In connection with Purchaser&#146;s investigation of the Group Companies and the Business, Purchaser has received certain projections and certain business plan information of or relating to the Group Companies and
the Business. Purchaser acknowledges and agrees that there are uncertainties inherent in attempting to make such projections and other forecasts and plans, that Purchaser is familiar with such uncertainties, that Purchaser, for purposes of agreeing
to purchase from Seller all of the issued and outstanding Shares, is taking full responsibility for making its own evaluation of the adequacy and accuracy of all projections and other forecasts and plans so furnished to it, including the
reasonableness of the assumptions underlying such projections and forecasts, and that no representations or warranties of any kind, express or implied, are made by Seller with respect thereto. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VI </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Covenants
</U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;6.1 </U></B><B><U>Conduct of Business</U></B>. (a)&nbsp;Except (i)&nbsp;for matters
set forth in <U>Section</U><U></U><U>&nbsp;6.1(a)</U> of the Disclosure Letter, (ii)&nbsp;as expressly permitted by or required in accordance this Agreement, (iii)&nbsp;for actions necessary to comply with the representations and warranties set
forth in <U>Section</U><U></U><U>&nbsp;4.19</U>, (iv)&nbsp;as required by applicable Law or (v)&nbsp;as may be consented to in writing by Purchaser (which consent shall not be unreasonably withheld, delayed or conditioned), from the date of this
Agreement to the Closing, or, if earlier, the termination of this Agreement in accordance with its terms (such time, the &#147;<U><FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period</U>&#148;), Seller shall, and shall cause each of its
Affiliates (including the Group Companies) to, (x)&nbsp;use reasonable best efforts to conduct the Business in all material respects in the ordinary course of business and (y)&nbsp;use reasonable best efforts to (1)&nbsp;preserve intact the
respective business organizations of the Group Companies, (2)&nbsp;maintain the assets of the Business (including Intellectual Property and material Company IT Systems), (3)&nbsp;preserve the Business&#146; relationships with manufacturers,
suppliers, vendors, distributors, Governmental Authorities with jurisdiction over the Businesses&#146; operations, customers, licensors, licensees and other Persons with whom the Business has material business dealings and (4)&nbsp;maintain the
confidentiality of all material Trade Secrets and other material confidential or proprietary information included in the Company Owned IP (except Trade Secrets required by applicable Law to be included in patent applications filed in the ordinary
course of business); <I>provided</I> that no action with respect to matters specifically addressed by any provision of <U>Section</U><U></U><U>&nbsp;6.1(b)</U> shall be deemed a breach of this <U>Section</U><U></U><U>&nbsp;6.1(a)</U>, which matters
shall be exclusively governed by the relevant provisions of <U>Section</U><U></U><U>&nbsp;6.1(b)</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Without limiting the generality
of <U>Section</U><U></U><U>&nbsp;6.1(a)</U>, except (i)&nbsp;for matters set forth in <U>Section</U><U></U><U>&nbsp;6.1(b)</U> of the Disclosure Letter, (ii)&nbsp;as expressly permitted by or required in accordance this Agreement, (iii)&nbsp;for
actions necessary to comply with the representations and warranties set forth in <U>Section</U><U></U><U>&nbsp;4.19</U>, (iv)&nbsp;as required by applicable Law or (v)&nbsp;as may be consented to in writing by Purchaser (which consent shall not be
unreasonably withheld, delayed or conditioned), during the <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period, the Group Companies and, to the extent related to the Business, Seller and the other members of the Seller Group shall not: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) in the case of any Group Company, issue, sell or grant any shares of
capital stock or other equity interests, or any securities or rights convertible into, exchangeable or exercisable for, or evidencing the right to subscribe for any of its capital stock or other equity interests, or any rights, warrants or options
to purchase any of its capital stock or other equity interests, or any securities or rights convertible into, exchangeable or exercisable for, or evidencing the right to subscribe for, any of its capital stock or other equity interests, any
&#147;phantom&#148; units or rights, stock appreciation rights, performance stock units or other rights that are linked in any way to the price or value of any such capital stock or other equity interests; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) in the case of any Group Company, redeem, purchase or otherwise acquire any of its outstanding capital stock or other
equity interests, or any rights, warrants or options to acquire any of its capital stock or other equity interests; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)
in the case of any Group Company, (A)&nbsp;declare, authorize, set aside for payment or pay any dividend on, or make any other distribution in respect of, any of its capital stock or other equity interests, other than dividends or distributions by
any Company Subsidiary or Sengenics Malaysia to any Group Company and other than dividends or distributions in cash, (B)&nbsp;declare or authorize any dividend or other distribution with a record date prior to the Closing and payment date after the
Closing or (C)&nbsp;adjust, split, combine, subdivide or reclassify any of its capital stock or other equity interests; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) sell, assign, lease, sublease, license to any Person, transfer or otherwise dispose of or encumber or voluntarily subject
to any Lien (other than a Permitted Lien) any of its properties (including any Company Leased Real Property) or assets that are, individually or in the aggregate, material to the Business, except (A)&nbsp;dispositions of obsolete, surplus or worn
out assets that are no longer used or useful in the conduct of the Business, (B)&nbsp;transfers among Group Companies or (C)&nbsp;Company IP, which shall be governed by <U>clause</U><U></U><U>&nbsp;(v)</U> below; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) sell, transfer, assign, encumber with any Lien (other than a Permitted Lien), convey, lease, license, sublicense, cancel,
let lapse, abandon or otherwise dispose of any Company Owned IP, except (A)&nbsp;the lapse or abandonment of immaterial Company Registered IP in the ordinary course of business, (B)&nbsp;at the end of an item of Company Registered IP&#146;s maximum
statutory term or (C)&nbsp;for <FONT STYLE="white-space:nowrap">non-exclusive</FONT> licenses granted to a Group Company&#146;s customers, service providers and suppliers in the ordinary course of business; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) for the fiscal year ended December&nbsp;31, 2025, make any material capital expenditures outside the ordinary course of
business and inconsistent with the capital expenditure budget set forth in <U>Section</U><U></U><U>&nbsp;6.1(b)(vi)</U> of the Disclosure Letter, and for the fiscal year ended December&nbsp;31, 2026, make any capital expenditures that, in the
aggregate, exceed the aggregate amount of expenditures provided for in the capital expenditure budget set forth in <U>Section</U><U></U><U>&nbsp;6.1(b)(vi)</U> of the Disclosure Letter by more than 10% during any fiscal quarter; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vii) deliver, license or make available any source code of any material
proprietary Software included in the Company Owned IP to any (A)&nbsp;escrow agent or (B)&nbsp;other Person who is not under an obligation of confidentiality to a Group Company with respect to such source code; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(viii) make any acquisition (including by merger or consolidation) of (A)&nbsp;the capital stock of any other Person or
(B)&nbsp;a material portion of the assets or properties of any other Person (or any business or division of any other Person); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ix) make any loans, advances or capital contributions to, or investments in, any other Person, other than to a Group Company,
except for extensions of trade credit or advances to employees, each in the ordinary course of business; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x) make any loan
to or enter into any other material transaction with any of its directors, managers, officers or other Affiliates (other than transactions solely among the Group Companies), except (A)&nbsp;as permitted in the exceptions set forth in
<U>Section</U><U></U><U>&nbsp;6.1(b)(xii)</U> or (B)&nbsp;pursuant to Contracts in force as of the date of this Agreement and set forth in <U>Section</U><U></U><U>&nbsp;6.1(b)(x)</U> of the Disclosure Letter, a true and complete copy of which has
been made available to Purchaser; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xi) incur, assume or guarantee any Indebtedness for borrowed money, except, in each
case, for (A)&nbsp;borrowings under lines of credit (including business credit cards), credit agreements, financing agreements or other similar arrangements in existence as of the date of this Agreement in the ordinary course of business or
(B)&nbsp;pursuant to arrangements solely among Group Companies; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xii) enter into any material new line of business
(excluding, for the avoidance of doubt, any line of business that is reasonably related to, and a reasonably foreseeable extension of, any line of business existing as of the date of this Agreement) or terminate any material line of business
existing as of the date of this Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xiii) (A)&nbsp;grant to any Business Employee any increase in compensation,
bonus, bonus opportunity or other benefits (including fringe benefits), other than for Business Employees with annual base compensation less than $200,000, annual increases in connection with the Company&#146;s annual compensation review cycle or
other merit or promotion-based increases, in all cases, as conducted in the ordinary course and consistent with past practice, and provided that such increases do not exceed 5% of the aggregate of all such Business Employees&#146; annual target cash
compensation in effect as of the date of this Agreement, (B)&nbsp;grant or increase any equity or equity-based award, long-term incentive award, change in control, retention, transaction, severance, termination or similar compensation or benefit
with respect to any Business Employee, (C)&nbsp;adopt, establish, enter into, amend, modify or terminate any Company Plan or any collective bargaining, works council or other labor Contract, (D)&nbsp;take any action to accelerate the time of vesting
or payment of any compensation or benefit under, or change any actuarial or other assumptions used to calculate the funding obligations with respect to, any Company Plan, or fund or otherwise secure the payment of any compensation or benefit for a
Business Employee or (E)&nbsp;forgive any loans or cash advances, or issue any loans to any Business </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Employees, except, in each case, (I)&nbsp;pursuant to the terms of Company Plans as in effect on the date of this Agreement or entered into after the date of this Agreement and permitted
hereunder, true and complete copies of which shall have been made available to Purchaser, (II)&nbsp;pursuant to Contracts in effect as of the date hereof or entered into after the date hereof and permitted hereunder, true and complete copies of
which shall have been made available to Purchaser or (III)&nbsp;in connection with any action that applies uniformly to Business Employees and a material number of other similarly situated employees of the Seller Group; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xiv) take any action, including hiring, firing or transferring, that affects whether or not an individual is a Business
Employee, other than (A)&nbsp;hiring (I)&nbsp;to fill a vacancy resulting from the departure of a Business Employee or (II)&nbsp;in the ordinary course where such hiring relates to an employee with annual base compensation less than $200,000, in
each case provided that such offers are on terms consistent with past practice, subject to reasonable market adjustments, and (B)&nbsp;terminating the employment of any Business Employee for cause (as determined in good faith in a manner consistent
with past practice); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xv) amend or terminate any of the Group Company Charter Documents; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xvi) make any material change in any method of financial accounting or financial accounting practice in effect date as of the
Latest Business Balance Sheet, except&nbsp;as required by GAAP; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xvii) adopt a plan or agreement of complete or partial
liquidation or dissolution, restructuring, recapitalization or other reorganization of any Group Company; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xviii) except
with respect to Consolidated Income Taxes or any Consolidated Tax Return, (A)&nbsp;make any material Tax election outside the ordinary course of business with respect to the Business, (B)&nbsp;settle or compromise any audit or proceeding relating to
Income Taxes or a material amount of other Taxes, (C)&nbsp;request or consent to any extension or waiver of any limitation period with respect to any claim or assessment for Income Taxes or a material amount of other Taxes (other than pursuant to an
extension of time to file any Tax Return granted in the ordinary course of business), (D)&nbsp;file any amended Tax Return reflecting Income Taxes or a material amount of other Taxes with respect to the Business, (E)&nbsp;change any Tax accounting
method with respect to the Business or (F)&nbsp;enter into any Tax allocation, sharing, indemnification or other similar agreement or arrangement relating to a material amount of Taxes with respect to the Business (other than an agreement the
principal purpose of which is not the allocation, sharing or indemnification of Taxes); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xix) (A)&nbsp;terminate (other
than automatic terminations), expressly release any material rights under or materially amend any Material Contract or a material purchase order, work order or quality agreement with respect thereto in a manner adverse to the Group Companies or the
Business in any material respect or (B)&nbsp;enter into, renew or extend the term of (other than automatic renewals or extensions) any Contract that would be or is considered a Material Contract under any of <U>clause</U><U></U><U>&nbsp;(iii)</U>,
<U>(iv)</U>, <U>(xii)</U> (subject to <U>Section</U><U></U><U>&nbsp;6.22</U>) or <U>(xviii)</U>&nbsp;of <U>Section</U><U></U><U>&nbsp;4.15(a)</U> (it being understood that the renewal or extension of any Contract in the ordinary course of business
that contains terms described in those clauses </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
shall be permitted if the Contract being renewed or extended contains such terms and the renewal Contract contains the same such terms or comparable terms that are no less favorable to the Group
Companies or the Business) if in effect on the date of this Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xx) settle or compromise any proceeding or claim
against a Group Company or relating to the Business other than proceedings and claims that are settled or compromised solely upon payment of Cash (and so long as such settlement or compromise does not result in any
<FONT STYLE="white-space:nowrap">non-monetary</FONT> liability or other continuing obligation or undertaking of any Group Company or the Business post-Closing (other than <I>de minimis</I> liabilities or obligations incidental to such settlement or
compromise, including confidentiality obligations)); <I>provided</I> that (A)&nbsp;Seller notifies Purchaser reasonably in advance of such settlement and gives Purchaser an opportunity to review any proposed settlement agreement and (B)&nbsp;such
settlements do not exceed $200,000 individually or $1,000,000 in the aggregate; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxi) exercise any options under any
collaboration agreement relating to <FONT STYLE="white-space:nowrap">&#147;co-funding&#148;,</FONT> <FONT STYLE="white-space:nowrap">&#147;co-commercialization&#148;</FONT> or similar
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">cost-and-profit</FONT></FONT> participation rights (whether an exercise to &#147;opt in&#148; or &#147;opt out&#148; of such rights) with respect to any Business Product to which such
collaboration agreement relates; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxii) fail to use reasonable best efforts to avoid entering into any Material Contract
(other than automatic renewals or extensions) if the performance of this Agreement and the consummation of the <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Transactions and the Transactions will conflict with, or result in any material breach
or violation of, or default (with or without notice or the lapse of time, or both) under such Material Contract; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxiii)
take the actions set forth on <U>Section 6.1(b)(xxiii)</U> of the Disclosure Letter; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxiv) agree in writing to take
any of the foregoing actions. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Whenever this Agreement requires a Group Company or any other Affiliate of Seller to take any action,
such requirement shall be deemed to include an undertaking on the part of Seller to cause such Group Company or other Affiliate, as applicable, to take such action. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;6.2 </U></B><B><U>Invoices</U></B>. Seller shall use reasonable best efforts to obtain from
each payee of Specified Transaction Expenses or Shared Expenses incurred by Seller and deliver to Purchaser, at least three Business Days prior to the Closing, a written invoice for the full amount of the Specified Transaction Expenses or Shared
Expenses incurred by Seller, as applicable, owed to such payee (&#147;<U>Invoices</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;6.3 </U></B><B><U>Exclusivity</U></B>. Seller agrees that after the date hereof until the
earlier of the Closing or the termination of this Agreement in accordance with its terms, it shall not, and it shall cause its Affiliates and Representatives not to, directly or indirectly: (i)&nbsp;solicit, initiate, facilitate or encourage the
submission of any Acquisition Proposal; (ii)&nbsp;participate in any discussions or negotiations regarding, or furnish to any Person any information with respect to, or take any other action knowingly to facilitate or encourage any inquiries or the
making of any proposal that constitutes, or could reasonably be expected to lead to, any Acquisition Proposal; or (iii)&nbsp;enter into any agreement with respect to any Acquisition Proposal. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;6.4 </U></B><B><U>Reasonable Best
Efforts</U></B>. (a)&nbsp;Subject to the terms and conditions of this Agreement, each of Purchaser and Seller shall, and shall cause their respective Affiliates to, use its and their reasonable best efforts to (i)&nbsp;cause the Transactions to be
consummated prior to the Outside Date, (ii)&nbsp;make promptly any required submissions and filings under applicable Regulatory Laws with respect to the Transactions, (iii)&nbsp;promptly furnish information required in connection with such
submissions and filings under such Regulatory Laws, (iv)&nbsp;keep the other Party reasonably informed with respect to the status of any such submissions and filings (including with respect to (A)&nbsp;the receipt of any <FONT
STYLE="white-space:nowrap">non-action,</FONT> action, clearance, consent, approval or waiver, (B)&nbsp;the expiration of any waiting period, (C)&nbsp;the commencement or proposed or threatened commencement of any investigation, litigation or
administrative or judicial action or proceeding under Regulatory Laws and (D)&nbsp;the nature and status of any objections raised or proposed or threatened to be raised under Regulatory Laws) and (v)&nbsp;obtain all actions or <FONT
STYLE="white-space:nowrap">non-actions,</FONT> approvals, consents, waivers, registrations, permits, authorizations and other confirmations from any Governmental Authority necessary, proper or advisable to consummate the Transactions as soon as
practicable in connection with Regulatory Laws. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In furtherance and not in limitation of the foregoing: Purchaser and Seller agree to
(i)&nbsp;make, or cause to be made, their respective required filings under the HSR Act and the foreign Regulatory Laws listed in <U>Section</U><U></U><U>&nbsp;6.4</U> of the Disclosure Letter, in each case, as promptly as reasonably practicable
after the date of this Agreement, (ii)&nbsp;supply as soon as practicable any additional information and documentary material that may be requested pursuant to the Regulatory Laws and (iii)&nbsp;use its reasonable best efforts to take, or cause to
be taken, all other actions consistent with this <U>Section</U><U></U><U>&nbsp;6.4</U> necessary to cause the expiration or termination of the applicable waiting periods under the Regulatory Laws (including any extensions thereof) as soon as
practicable. All filing fees under the HSR Act and any other Regulatory Laws or other applicable Laws in connection with the Transactions shall constitute Shared Expenses. For the avoidance of doubt, and notwithstanding anything herein to the
contrary, Purchaser shall, following consultation with and considering in good faith the views of Seller, direct and control all aspects of the Parties&#146; efforts to obtain, and determine the strategy with respect to obtaining, any clearances,
consents, approvals and waivers under Regulatory Laws required by any Governmental Authority for the consummation of the Transactions. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)
Each Party shall, in connection with the Regulatory Laws and the required filings thereunder: (i)&nbsp;promptly notify the other Party of, and if in writing, furnish the other with copies of (or, in the case of oral communications, advise the other
of the contents of) any material communication to such Person from a Governmental Authority and permit the other to review and discuss in advance (and to consider in good faith any comments made by the other in relation to) any proposed written
communication to a Governmental Authority, (ii)&nbsp;keep the other reasonably informed of any developments, meetings or discussions with any Governmental Authority in respect of any filings, investigation, or inquiry concerning the Transactions and
(iii)&nbsp;not independently participate in any material meeting or discussions with a Governmental Authority in respect of any filings, investigation or inquiry concerning the Transactions without giving the other Party prior notice of such meeting
or discussions and, unless prohibited by such Governmental </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Authority, the opportunity to attend or participate; <I>provided</I> that, in each case, each of Purchaser and Seller may designate any <FONT STYLE="white-space:nowrap">non-public</FONT>
information provided to any Governmental Authority as restricted to only the outside lawyers and consultants of the other Party, and any such information shall not be shared with employees, officers, managers or directors or their equivalents of the
other Party without approval of the Party providing the <FONT STYLE="white-space:nowrap">non-public</FONT> information. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)
Notwithstanding the foregoing, in no event shall Purchaser or any of its Affiliates be required to commit to or effect, or Seller or any of its Affiliates be permitted (without the prior written consent of Purchaser) to commit to or effect, by
consent decree, hold separate orders, trust, or otherwise, (i)&nbsp;the sale, license, holding separate or other disposition of assets or businesses of Purchaser or any of its Affiliates or any Group Company or (ii)&nbsp;any restriction or
limitation on any business, operations, assets, properties or contractual freedoms of Purchaser, any of its Affiliates or any Group Company, or any other behavioral remedy, requested by a Governmental Authority in order to achieve clearance under
any Regulatory Law, including terminating, relinquishing, modifying or waiving existing, or creating new, relationships, ventures, contractual rights, obligations or other arrangements of Purchaser or any of its Affiliates or any Group Company (each
of the actions described in the foregoing <U>clauses</U><U></U><U>&nbsp;(i)</U>&nbsp;and <U>(ii)</U>, a &#147;<U>Remedy Action</U>&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Seller and Purchaser shall each, with the reasonable cooperation of the other, use reasonable best efforts to obtain consents, approvals or
waivers, as applicable, with respect to the consummation of the Transactions in respect of the Contracts set forth in <U>Section</U><U></U><U>&nbsp;6.4(e)</U> of the Disclosure Letter; <I>provided</I> that the failure of a Party to obtain any such
consent, approval or waiver shall not, in and of itself, constitute a breach of this <U>Section</U><U></U><U>&nbsp;6.4(e)</U> or give rise to the failure of any condition to Closing set forth in <U>Article</U><U></U><U>&nbsp;VII</U> or any
termination right set forth in <U>Article</U><U></U><U>&nbsp;VIII</U>. For purposes of this <U>Section</U><U></U><U>&nbsp;6.4(e)</U>, &#147;reasonable best efforts&#148; in connection with seeking or obtaining such consents, approvals or waivers
shall not, among other things, be deemed to require (i)&nbsp;Seller, Purchaser or any of their respective Affiliates to undertake extraordinary measures, including the waiver of any condition to Closing in its favor, (ii)&nbsp;the initiation,
prosecution or defense of or participation in any Legal Proceedings, (iii)&nbsp;the expenditure of payment of funds in excess of normal and usual administrative and processing fees, if any, or (iv)&nbsp;the giving of any other consideration or any
adjustment to the Closing Aggregate Consideration with respect to seeking or obtaining any such consents, approvals or waivers. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)
Neither Purchaser nor any of its Affiliates shall after the date of this Agreement acquire or agree to acquire any rights, business, Person or division thereof (by way of license, merger, consolidation, share exchange, investment or other business
combination, asset, stock or equity purchase or otherwise) or enter into or agree to enter into any joint venture, collaboration or other similar arrangement in the proteomics business that, in each case, (i)&nbsp;would be reportable under the HSR
Act and (ii)&nbsp;would reasonably be expected to prevent, materially delay or materially impair the Parties&#146; ability to cause the waiting period (and any extension thereof) applicable to the consummation of the Transactions under the HSR Act
to expire or be terminated or to obtain the consent, authorization or approval of any Governmental Authority under applicable Regulatory Laws that constitute a condition to Closing under <U>Section</U><U></U><U>&nbsp;7.1(a)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;6.5 </U></B><B><U>Public
Announcements</U></B>. The initial press release with respect to the execution of this Agreement shall be reasonably agreed upon by Purchaser and Seller. Following such initial press release, Purchaser and Seller shall consult with each other before
issuing, and give each other the opportunity to review and comment upon, any press release or other public statements with respect to the Transactions and shall not issue any such press release or make any such public statement prior to such
consultation, except as such Party may reasonably conclude may be required by applicable Law, court process or by obligations pursuant to any listing agreement with or the listing rules of any national securities exchange or national securities
quotation system (and then only after as much advance notice and consultation as is reasonably feasible); <I>provided</I>, <I>however</I>, that the foregoing shall not preclude any press releases and other communications or disclosures
(a)&nbsp;necessary to implement the provisions of this Agreement or, following the Closing, in connection with court filings made in any litigation related to the Parties or this Agreement or (b)&nbsp;that in the good faith judgment of the
applicable Party are consistent with prior press releases issued or other public communications or disclosures made in compliance with this <U>Section</U><U></U><U>&nbsp;6.5</U> and, in any event, do not contain any information relating to the
Transactions that has not been previously announced or made public in compliance with this <U>Section</U><U></U><U>&nbsp;6.5</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;6.6 </U></B><B><U>Access to Information; Contact with Employees, Customers and Suppliers;
Confidentiality</U></B>. (a) Subject to applicable Laws relating to the exchange of information, from the date hereof until the earlier of the Closing or the date on which this Agreement is terminated in accordance with its terms, Seller shall, and
shall cause each Group Company to, afford to Purchaser and its Representatives (including any Insurers and underwriters in respect of the Representation and Warranty Insurance Policy) reasonable access during normal business hours to the properties,
books, Contracts and records of the Group Companies and, to the extent related to the Business, the members of the Seller Group, and Seller shall, and shall cause each Group Company to, furnish promptly to Purchaser such information concerning the
Business and the Group Companies&#146; properties as Purchaser may reasonably request; <I>provided</I> that Purchaser and its Representatives shall conduct any such activities in such a manner as not to interfere unreasonably with the business or
operations of Seller or its Subsidiaries; <I>provided</I>, <I>further</I>, that Seller and the Group Companies shall not be obligated to provide such access or information (i)&nbsp;if Seller determines, in its reasonable judgment after consultation
with counsel, that doing so would violate applicable Law or jeopardize the protection of the attorney-client privilege, work product doctrine or similar protection or (ii)&nbsp;that constitute <FONT STYLE="white-space:nowrap">non-financial</FONT>
Trade Secrets (<I>provided</I> that, in each case, the Parties shall reasonably cooperate in seeking an alternative means whereby Purchaser is provided access to such information or the contents or a reasonable redacted summary thereof). Until the
Closing, the information provided shall be subject to the terms of the Confidentiality Agreement and, as applicable, the Clean Team Agreement and, without limiting the generality of the foregoing, Purchaser shall not, and Purchaser shall cause its
Representatives not to, use such information for any purpose unrelated to the Transactions (including for the purpose of coordinating integration activities and transition planning with the Business Employees). No information or knowledge obtained
in any investigation by Purchaser or other information received by Purchaser pursuant to this <U>Section</U><U></U><U>&nbsp;6.6</U> shall operate as a waiver or be deemed to modify or otherwise affect any representation, warranty or agreement
contained herein or in any certificate, document or other instrument delivered in connection herewith, the conditions to the obligations of the Parties to consummate the Closing in <U>Article</U><U></U><U>&nbsp;VII</U> or otherwise prejudice in any
way the rights and remedies of Purchaser or any other Indemnified Persons hereunder, including pursuant to <U>Article</U><U></U><U>&nbsp;IX</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Prior to the Closing, Purchaser and its Representatives may only contact and communicate
with the employees, customers, service providers and suppliers of Seller and its Subsidiaries in connection with the Transactions after prior consultation with and approval by Seller, such approval not to be unreasonably withheld, conditioned or
delayed. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) To the extent permitted under the terms thereof, Seller shall, and shall cause its Affiliates to, assign to Purchaser or the
Group Companies, as applicable, at the Closing all of their rights under such agreements to confidential treatment and <FONT STYLE="white-space:nowrap">non-use</FONT> of information related to the Business or the Group Companies or with respect to
solicitation and hiring of Business Employees; <I>provided</I> that in the event Seller is unable to assign any such rights under any such agreements, from and after the Closing, at the request of Purchaser, Seller shall use reasonable best efforts
to enforce such rights on behalf of Purchaser and the Group Companies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;6.7
</U></B><B><U>Access to Books and Records</U></B>. From and after the Closing, for a period of seven years, each Party (in such capacity, the &#147;<U>Granting Party</U>&#148;) shall, and shall cause its Affiliates to, grant the other Party (in such
capacity, the &#147;<U>Accessing Party</U>&#148;) and its Affiliates and authorized Representatives access, during normal business hours, upon reasonable notice and at the Accessing Party&#146;s sole expense, to (i)&nbsp;the books and records (for
the purpose of examining and copying) of the Group Companies to the extent related to the Business with respect to periods or occurrences prior to or on the Closing Date and (ii)&nbsp;employees of the Granting Party and its Subsidiaries for purposes
of better understanding such books and records, in each case only (A)&nbsp;to the extent necessary for the Accessing Party to comply with applicable Law, for tax or accounting purposes, to respond to a request, investigation, inquiry or examination
from any regulatory authority or to comply with or perform obligations under this Agreement or any Ancillary Agreement or (B)&nbsp;in connection with a dispute, action, suit, proceeding or litigation brought by a third party against the Accessing
Party or its Affiliates; <I>provided</I> that the Accessing Party and its Affiliates and authorized Representatives shall conduct any such activities in a manner that does not unreasonably interfere with the business or operations of the Granting
Party or its Affiliates; <I>provided</I>, <I>further</I>, that in connection with litigation to which Seller or any of its Affiliates, on the one hand, and Purchaser or any of its Affiliates, on the other hand, are adverse parties, the Granting
Party shall not be required to provide access to any such books, records or employees pursuant to this <U>Section</U><U></U><U>&nbsp;6.7</U>. Unless otherwise consented to in writing by any Accessing Party, no Granting Party shall, nor shall it
permit its Affiliates to, for a period of seven years following the Closing Date, destroy, alter or otherwise dispose of any of the books and records of the Group Companies for any period prior to the Closing Date without first giving reasonable
prior written notice to the Accessing Party and offering to surrender to the Accessing Party such books and records or any portion thereof that are intended to be destroyed, altered or disposed of. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;6.8 </U></B><B><U>Indemnification and Insurance</U></B>. (a)&nbsp;From and after the Closing,
Purchaser shall cause the Group Companies, to (i)&nbsp;indemnify, defend and hold harmless each individual who is a current or former manager, director and officer of any Group Company (each, a &#147;<U>D&amp;O Indemnitee</U>&#148; and,
collectively, the &#147;<U>D&amp;O Indemnitees</U>&#148;) against all claims, liabilities, losses, damages, judgments, fines, penalties, costs (including amounts paid in settlement or compromise) and expenses (including fees and expenses of legal
counsel) in connection with any actual or threatened claim, suit, action, proceeding or investigation (whether civil, criminal, administrative or investigative) (each, a &#147;<U>D&amp;O Claim</U>&#148;), whenever asserted, arising out of, relating
to or in connection with any action or omission taken or omitted in their capacity as manager, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
director or officer of a Group Company or any other Person whom such D&amp;O Indemnitee serves at the request of any Group Company occurring or alleged to have occurred before or at the Closing
(including any D&amp;O Claim relating in whole or in part to this Agreement or the Transactions), to the fullest extent permitted under applicable Law and (ii)&nbsp;maintain, honor and fulfill all obligations of the Group Companies to the D&amp;O
Indemnitees in respect of limitation of liability, exculpation, indemnification and advancement of expenses as provided in (A)&nbsp;the Group Company Charter Documents, in each case as in effect on the date hereof and (B)&nbsp;any indemnification
agreements with a D&amp;O Indemnitee, in each case as in effect on the date hereof (correct and complete copies of which shall have been made available to Purchaser), which shall in each case survive the Transactions and continue in full force and
effect to the extent permitted by applicable Law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) From and after the Closing, Purchaser shall, and shall cause the Group Companies to,
pay and advance to each D&amp;O Indemnitee any expenses (including fees and expenses of legal counsel) in connection with any D&amp;O Claim relating to any acts or omissions covered under this <U>Section</U><U></U><U>&nbsp;6.8</U> or the enforcement
of a D&amp;O Indemnitee&#146;s rights under this <U>Section</U><U></U><U>&nbsp;6.8</U> as and when incurred to the fullest extent permitted under applicable Law; <I>provided</I> that the Person to whom expenses are advanced provides an undertaking
to repay such expenses if it is ultimately determined that such Person is not entitled to be indemnified or reimbursed pursuant to this <U>Section</U><U></U><U>&nbsp;6.8</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) During the period commencing at the Closing and ending on the sixth anniversary of the Closing Date, each Group Company shall (and
Purchaser shall cause each Group Company to), subject to applicable Law, cause such Group Company&#146;s Group Company Charter Documents to contain provisions with respect to indemnification, exculpation and the advancement of expenses with regard
to acts or omissions by D&amp;O Indemnitees occurring at or prior to the Closing that are at least as favorable as the indemnification, exculpation and advancement of expenses provisions set forth in the Group Company Charter Documents of such Group
Company as of the date of this Agreement. During such <FONT STYLE="white-space:nowrap">six-year</FONT> period, such provisions may not be repealed, amended or otherwise modified in any manner adverse to the D&amp;O Indemnitees except as required by
applicable Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) On or prior to the Closing Date, Seller shall use reasonable best efforts to cause the Company to obtain and pay for
a <FONT STYLE="white-space:nowrap">non-cancelable</FONT> <FONT STYLE="white-space:nowrap">run-off</FONT> or tail directors and officers insurance policy for a period of six years from and after the Closing Date to provide insurance coverage for
events, acts or omissions occurring on or prior to the Closing Date for all of the D&amp;O Indemnitees (the &#147;<U>D&amp;O Insurance</U>&#148;) on terms with respect to coverage, deductibles and amounts no less favorable than those of such policy
in effect on the date hereof, at a price not to exceed 300% of the aggregate annual premium most recently paid by Seller for the Group Companies (the &#147;<U>Maximum Amount</U>&#148;); provided that if Purchaser can procure a policy on superior
terms or on equivalent terms, but at a lower price, as compared to any such policy that may be procured by Seller, then Purchaser may obtain such policy in lieu of Seller. If Seller is unable to obtain the insurance required by this
<U>Section</U><U></U><U>&nbsp;6.8(d)</U> because its cost exceeds the Maximum Amount, Seller shall use reasonable best efforts to obtain as much comparable insurance as possible for the years within such
<FONT STYLE="white-space:nowrap">six-year</FONT> period for a premium equal to the Maximum Amount (after reasonably cooperating with, and consulting with, Purchaser). Purchaser shall maintain any such D&amp;O Insurance in full force and effect for
the full term thereof. The costs of any such D&amp;O Insurance shall be considered a &#147;Shared Expense&#148; for purposes of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The provisions of this <U>Section</U><U></U><U>&nbsp;6.8</U> are (i)&nbsp;intended to be
for the benefit of, and shall be enforceable by, each D&amp;O Indemnitee, his or her heirs and his or her Representatives and (ii)&nbsp;in addition to, and not in substitution for or limitation of, any other rights to indemnification or contribution
that any such Person may have by contract or otherwise. The obligations of Purchaser under this <U>Section</U><U></U><U>&nbsp;6.8</U> shall not be terminated or modified in such a manner as to adversely affect the rights of any D&amp;O Indemnitee to
whom this <U>Section</U><U></U><U>&nbsp;6.8</U> applies unless (A)&nbsp;such termination or modification is required by applicable Law or (B)&nbsp;the affected D&amp;O Indemnitee, his or her heirs and his or her Representatives shall have consented
in writing to such termination or modification (it being expressly agreed that the D&amp;O Indemnitees, heirs and Representatives to whom this <U>Section</U><U></U><U>&nbsp;6.8</U> applies shall be third party beneficiaries of this
<U>Section</U><U></U><U>&nbsp;6.8</U>). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) In the event that Purchaser, a Group Company or any of their respective successors or assigns
(i)&nbsp;consolidates with or merges into any other Person and is not the continuing or surviving corporation or entity of such consolidation or merger or (ii)&nbsp;transfers or conveys all or substantially all of its properties and assets to any
Person, then, and in each such case, proper provision shall be made so that the successors and assigns of Purchaser and the applicable Group Company shall assume all of the obligations thereof set forth in this <U>Section</U><U></U><U>&nbsp;6.8</U>.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Nothing in this Agreement is intended to, shall be construed to or shall release, waive or impair any rights to members&#146;,
managers&#146;, directors&#146; and officers&#146; insurance claims under any policy that is or has been in existence with respect to any Group Company or its managers, directors or officers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;6.9 </U></B><B><U>No Control of Other Party</U></B><B><U>&#146;</U></B><B><U>s
Business</U></B>. Nothing contained in this Agreement is intended to give Purchaser, directly or indirectly, the right to control or direct Seller&#146;s or any of its Affiliates&#146; (including, prior to the Closing, the Group Companies&#146;)
businesses or operations. Seller shall exercise, consistent with the terms and conditions of this Agreement, complete control and supervision over its and its Affiliates&#146; (including, prior to the Closing, the Group Companies&#146;) businesses
and operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;6.10 </U></B><B><U>Employee Matters</U></B>. (a)&nbsp;Following the date
of this Agreement, Seller shall (i)&nbsp;deliver to Purchaser an updated version of the Business Employee Schedule (with names listed to the extent permitted under applicable Data Protection Regulations) and the Business Consultant Schedule, each on
a monthly basis to the extent there are changes and (ii)&nbsp;deliver to Purchaser not later than 10 Business Days prior to the Closing Date a final updated version of the Business Employee Schedule (with names listed to the extent permitted under
applicable Data Protection Regulations) and the Business Consultant Schedule, in each case, that is true and complete as of 12 Business Days prior to the Closing. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Purchaser shall, or shall cause each Group Company or Purchaser&#146;s other Affiliates to, for a period of at least 12 months following
the Closing Date (or any such shorter period of employment), provide to each Continuing Employee (i)&nbsp;at least the same base salary or wage rate that was provided to such Continuing Employee immediately prior to the Closing, (ii)&nbsp;target
annual or short-term cash incentive opportunities that are no less favorable than those opportunities (excluding retention, <FONT STYLE="white-space:nowrap">one-time</FONT> or special bonuses and change in control payments) provided to such
Continuing Employee immediately prior to the Closing, (iii)&nbsp;severance benefits </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
that are no less favorable than those set forth on <U>Section</U><U></U><U>&nbsp;6.10(b)</U> of the Disclosure Letter, and (iv)&nbsp;other employee benefits that are either, at Purchaser&#146;s
election, (A)&nbsp;substantially comparable in the aggregate to those benefits provided to such Continuing Employee immediately prior to the Closing (excluding for such purposes, defined benefit pension, retiree or post-employment health or welfare,
nonqualified deferred compensation, retention, <FONT STYLE="white-space:nowrap">one-time</FONT> or special bonuses and change in control payments) or (B)&nbsp;no less favorable than the other employee benefits provided by Purchaser to its similarly
situated employees during such period, except as otherwise required by applicable Law; <I>provided</I> that nothing in this <U>Section</U><U></U><U>&nbsp;6.10(b)</U> shall require Purchaser or any of its Affiliates to continue to employ any
Continuing Employee. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) For eligibility and vesting purposes (other than vesting of future equity awards) and for purposes of determining
severance amounts and future vacation accruals under the compensation and employee benefit plans, policies or arrangements of Purchaser and its Affiliates (including, after the Closing, any Group Company), each Continuing Employee shall receive
credit for his or her service with Seller and its Affiliates (including any Group Company) prior to the Closing Date as if such service were with Purchaser or its Affiliates to the same extent that such Continuing Employee was entitled, before the
Closing, to credit for his or her service under any similar or comparable Company Plans (except to the extent this credit would result in a duplication of benefits in respect of the same period of service). In addition, for any medical, dental,
health or other welfare benefit plan, program or arrangement maintained by Purchaser or its Affiliates (each, a &#147;<U>Successor Plan</U>&#148;) other than the plan or plans in which Continuing Employees participated immediately prior to the
Closing (each, a &#147;<U>Prior Plan</U>&#148;), Purchaser shall, or shall cause each Group Company or Purchaser&#146;s other Affiliates to, use reasonable best efforts to (i)&nbsp;cause each Continuing Employee to be eligible to participate
immediately, without any waiting time, in any and all Successor Plans, (ii)&nbsp;cause the Successor Plans to not include any restrictions, limitations or exclusionary provisions with respect to <FONT STYLE="white-space:nowrap">pre-existing</FONT>
conditions, exclusions or any <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">actively-at-work</FONT></FONT> requirements relating to such Continuing Employee and his or her dependents (except to the extent that such exclusions or
requirements were applicable to Continuing Employees (including their respective dependents and beneficiaries, if any) under any similar Prior Plan at the time of commencement of participation in such Successor Plan) and (iii)&nbsp;cause any
eligible expenses incurred by any Continuing Employee and his or her covered dependents during the portion of the plan year of the Prior Plan ending on the date of such Continuing Employee&#146;s commencement of participation in the Successor Plan
to be taken into account under the Successor Plan for purposes of satisfying all deductible, coinsurance and maximum <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> requirements applicable to such
Continuing Employee and his or her covered dependents for the applicable plan year as if these amounts had been paid in accordance with the Successor Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Prior to the Closing, Seller and its Affiliates shall have taken such actions as may be necessary to fully vest all account balances of
Continuing Employees (and their beneficiaries) who participated in all Company Plans providing for deferral of compensation pursuant to Section&nbsp;401(k) of the Code (each, a &#147;<U>Company 401(k)</U><U></U><U>&nbsp;Plan</U>&#148;).
Notwithstanding any other provision of this Agreement, effective as of the Closing, Purchaser shall (i)&nbsp;permit each Continuing Employee who was a participant in or eligible to participate in a Company 401(k)&nbsp;Plan prior to the Closing to
participate in a <FONT STYLE="white-space:nowrap">tax-qualified</FONT> defined contribution retirement plan established or designated by Purchaser (the &#147;<U>Purchaser 401(k)</U><U></U><U>&nbsp;Plan</U>&#148;) and (ii)&nbsp;take such reasonable
actions as may be required to permit each Continuing Employee to make rollover contributions of &#147;eligible </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
rollover distributions&#148; (within the meaning of Section&nbsp;401(a)(31) of the Code, including promissory notes evidencing outstanding participant loans) in the form of Cash and <FONT
STYLE="white-space:nowrap">in-kind</FONT> in the case of participant loans to the Purchaser 401(k)&nbsp;Plan in an amount equal to the eligible rollover distribution portion of the account balance distributed to such Continuing Employee from any
Company 401(k)&nbsp;Plan; <I>provided</I> that such rollover shall be conditioned on Purchaser&#146;s reasonable determination that such rollovers are in compliance with ERISA, the Code and the terms of the Purchaser 401(k)&nbsp;Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Notwithstanding any other provision of this Agreement, effective as of the Closing, Purchaser shall, or shall cause its Affiliates to, have
in effect as of the Closing flexible spending reimbursement accounts for medical and dependent care under a cafeteria plan qualifying under Section&nbsp;125 of the Code (the &#147;<U>Purchaser Cafeteria Plan</U>&#148;) that provides benefits to
eligible Continuing Employees. Purchaser agrees to cause the Purchaser Cafeteria Plan to accept a <FONT STYLE="white-space:nowrap">spin-off</FONT> of the flexible spending reimbursement accounts of the Continuing Employees from the cafeteria plan in
which Continuing Employees participate immediately prior to the Closing (the &#147;<U>Seller Cafeteria Plan</U>&#148;) and to honor and continue through the end of the calendar year in which the Closing Date occurs the elections made by each
Continuing Employee under the Seller Cafeteria Plan in respect of the flexible spending reimbursement accounts that are in effect immediately prior to the Closing. Purchaser shall credit or debit, as applicable, effective as of the Closing Date, the
applicable account of each Continuing Employee under Purchaser&#146;s Cafeteria Plan with an amount equal to the balance of such Continuing Employee&#146;s account under the Seller Cafeteria Plan as of immediately prior to the Closing Date. As soon
as practicable following the Closing Date, Seller shall cause to be transferred from the Seller Cafeteria Plan to the Purchaser Cafeteria Plan the excess, if any, of the aggregate accumulated contributions to the flexible spending reimbursement
accounts made prior to the Closing during the year in which the Closing Date occurs by Continuing Employees over the aggregate reimbursement payouts made prior to the Closing for such year from such accounts to the Continuing Employees. If the
aggregate reimbursement payouts from the flexible spending reimbursement accounts made prior to the Closing during the year in which the Closing Date occurs made to Continuing Employees exceed the aggregate accumulated contributions to such accounts
prior to the Closing for such year by the Continuing Employees, Purchaser shall cause such excess to be transferred to Seller as soon as practicable following the Closing Date. From and after the Closing, Purchaser shall assume and be solely
responsible for all claims by Continuing Employees under the Seller Cafeteria Plan whether incurred prior to, on or after the Closing Date, that have not been paid in full as of the Closing. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Seller shall, or shall cause one of its Affiliates (excluding any Group Company) to, make a cash payment to each Continuing Employee in
respect of his or her unused vacation and paid <FONT STYLE="white-space:nowrap">time-off</FONT> accrued as of immediately prior to the Closing, such that no obligations with respect to such accrued but unused vacation or paid <FONT
STYLE="white-space:nowrap">time-off</FONT> shall exist as of immediately following the Closing. Notwithstanding the foregoing, if payment of unused vacation and paid <FONT STYLE="white-space:nowrap">time-off</FONT> accrued as of immediately prior to
the Closing is not permissible under applicable Laws, such payment shall not be made by Seller or its Affiliates to the applicable Continuing Employee and, after the Closing, to the extent required by Applicable Laws, Purchaser shall, or shall cause
each Group Company or Purchaser&#146;s other Affiliates to, (i)&nbsp;recognize and provide all earned but unused vacation and paid <FONT STYLE="white-space:nowrap">time-off</FONT> accrued as of immediately prior to Closing that has not been so paid
out and (ii)&nbsp;allow each applicable Continuing Employee to use such earned but unused vacation and paid <FONT STYLE="white-space:nowrap">time-off</FONT> at such times as would have been allowed under Purchaser&#146;s vacation and paid <FONT
STYLE="white-space:nowrap">time-off</FONT> policies in effect on or following the Closing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) If any Continuing Employee requires a visa, work permit, employment pass or other
approval for his or her employment to transfer to or continue with Purchaser or its Affiliates following the Closing and such approval cannot be transferred to Purchaser and its Affiliates, Purchaser shall ensure that any necessary applications are
promptly made and use its reasonable best efforts to secure the necessary visa, permit, pass or other approval effective as of the Closing, and Seller shall provide such assistance as reasonably requested by Purchaser in connection therewith. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Prior to the Closing Date, Seller and its Affiliates shall take all steps as are reasonably required to (i)&nbsp;transfer each Business
Employee (other than an Offer Employee) who is employed by the Seller Group to a Group Company and (ii)&nbsp;transfer the employment of each individual who is employed by a Group Company who is not a Business Employee (including each Excluded Group
Company Employee) to the Seller Group; <I>provided</I>, <I>however</I>, that any Business Employee who is receiving long-term disability benefits as of immediately prior to the Closing under a Company Plan that is not an Assumed Plan (each such
Business Employee, an &#147;<U>Inactive Business Employee</U>&#148;) shall remain an employee of Seller or its Affiliates (other than the Group Companies) following the Closing. With respect to each Inactive Business Employee, Purchaser shall, or
shall cause one of its Affiliates to, make an offer of employment to such Inactive Business Employee on terms consistent with those provided to Continuing Employees pursuant to <U>Section</U><U></U><U>&nbsp;6.10(b)</U>, with employment to be
effective as of the date on which such Inactive Business Employee (i)&nbsp;presents himself or herself to Purchaser for active employment, (ii)&nbsp;is qualified to resume active employment with or without reasonable accommodation and
(iii)&nbsp;accepts such offer of employment from Purchaser or any of its Affiliates; <I>provided</I> that such Inactive Business Employee presents himself or herself for active employment within six&nbsp;months following the Closing Date or within
such longer time period as required under applicable Law. Each Inactive Business Employee who becomes an employee of Purchaser or its Affiliates pursuant to this <U>Section</U><U></U><U>&nbsp;6.10(h)</U> shall be considered a Continuing Employee for
purposes of this <U>Section</U><U></U><U>&nbsp;6.10</U> and all references to the &#147;Closing&#148; or &#147;Closing Date&#148; (other than in <U>Section</U><U></U><U>&nbsp;6.10(b)</U> and this <U>Section</U><U></U><U>&nbsp;6.10(h)</U>) shall be
deemed to refer to the date on which such Inactive Business Employees commences employment with Purchaser or its Affiliates as the context so requires. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) At least 5 Business Days prior to the Closing Date, Purchaser shall, or shall cause one of its Affiliates to, make an offer of employment
to each Business Employee residing in a jurisdiction set forth on <U>Section</U><U></U><U>&nbsp;6.10(i)</U> of the Disclosure Letter (each, an &#147;<U>Offer Employee</U>&#148;). Any offers of employment made to an Offer Employee shall be on terms
consistent with those provided to other Continuing Employees pursuant to <U>Section</U><U></U><U>&nbsp;6.10(b)</U>, with employment to be effective as of the Closing Date. Notwithstanding the foregoing, any such Offer Employee who is an Inactive
Business Employee shall be offered employment pursuant to the terms and conditions set forth in <U>Section</U><U></U><U>&nbsp;6.10(h)</U> and not this <U>Section</U><U></U><U>&nbsp;6.10(i)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) Seller and Purchaser intend that the Transactions shall not constitute a severance or
termination of employment of any Business Employee prior to or upon the Closing for purposes of any Company Plan that provides for severance or termination benefits or under applicable Law and that the Continuing Employees shall have continuous and
uninterrupted employment immediately before and immediately after the Closing, and Seller and Purchaser shall comply with any requirement under applicable Law to ensure the same. Purchaser shall be solely responsible for, and shall indemnify and
hold harmless Seller from, all liabilities that may result in respect of claims for statutory, contractual or common law severance or other separation benefits or mandated payment obligations under applicable Law, together with the employer-paid
portion of any employment or payroll Taxes (including social security or similar contributions) related thereto, arising out of, relating to or in connection with Purchaser&#146;s failure to offer (or cause to be offered) employment to any Offer
Employee on terms consistent with <U>Section</U><U></U><U>&nbsp;6.10(b)</U> and <U>Section</U><U></U><U>&nbsp;6.10(i)</U> and in accordance with applicable Law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) Prior to the Closing Date, Seller shall, and shall cause its Affiliates to, transfer the sponsorship of (i)&nbsp;each Company Plan set
forth on <U>Section</U><U></U><U>&nbsp;6.10(k)(i)</U> of the Disclosure Letter to a member of the Seller Group; <I>provided</I> that with respect to any such Company Plan that is a defined contribution plan and intended to be qualified under
Section&nbsp;401(a) of the Code, such Company Plan shall be transferred to an Affiliate of Seller that is considered a single employer under Section&nbsp;414 of the Code with the relevant participating Group Company at the time of the transfer, but
will not be so considered immediately following the Closing, and (ii)&nbsp;each Company Plan set forth on <U>Section</U><U></U><U>&nbsp;6.10(k)(ii)</U> of the Disclosure Letter to a Group Company, which will constitute an Assumed Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) Effective as of the Closing, Seller shall, or shall cause its Affiliates (other than the Group Companies) to, assume or retain, as
applicable, and pay, perform, fulfill and discharge, in due course in full, (i)&nbsp;all liabilities under all Company Plans (other than those that are Assumed Plans), whenever incurred, (ii)&nbsp;all liabilities arising out of, relating to or
resulting from the employment or service or termination of employment or service of any employee, officer, director or manager of or consultant to Seller or any of its Affiliates, and their dependents and beneficiaries (and any alternate payees in
respect thereof), who are not (A)&nbsp;Continuing Employees or (B)&nbsp;former employees or other individual service providers of a Group Company (other than an Excluded Group Company Employee or any other former employees or other individual
service providers of a Group Company who, as of their final date of employment or engagement with Seller and its Affiliates, were not primarily engaged in the operation of the Business), whenever incurred, (iii)&nbsp;all liabilities in respect of
any Inactive Business Employee engaged by the Seller Group arising during the period of such engagement and prior to the period that such Inactive Business Employee commences employment with Purchaser and its Affiliates, (iv)&nbsp;all liabilities
arising out of, relating to or resulting from the transfer of Business Employees from any member of the Seller Group to the Group Companies and (v)&nbsp;any liabilities of the Group Companies as a result of being treated as an ERISA Affiliate with
any Person at any time during the <FONT STYLE="white-space:nowrap">six-year</FONT> period prior to the Closing Date (the liabilities described in the foregoing <U>clauses</U><U></U><U>&nbsp;(i)</U> through <U>(v)</U>, collectively, the
&#147;<U>Excluded Employee Liabilities</U>&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) Effective as of the Closing, Purchaser shall, or shall cause its Affiliates to,
assume or retain, as applicable, and pay, perform, fulfill and discharge, in due course in full, (i)&nbsp;all liabilities under all Assumed Plans, whenever incurred and (ii)&nbsp;all liabilities arising out of, relating to or resulting from the
employment or service or termination of employment or service of any Continuing Employee or former employee or other individual service provider of a Group Company (other than an Excluded Group Company Employee or any other former employees or other
individual service providers of a Group Company who, as of their final date of employment engagement with Seller and its Affiliates, were not primarily engaged in the operation of the Business), whenever incurred (except, in the case of this
<U>clause</U><U></U><U>&nbsp;(ii)</U> only, for liabilities expressly retained by Seller under Company Plans that are not Assumed Plans). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) Prior to the Closing, any employee notices or communication materials from Purchaser or
its Affiliates to the Business Employees, including notices or communication materials with respect to employment, compensation or benefits matters addressed in this Agreement, or related, directly or indirectly, to the Transactions, shall be
subject to Seller having a reasonable opportunity to review and comment. Purchaser shall consider Seller&#146;s comments in good faith before transmitting the employee notices or communication materials. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) Nothing contained in this <U>Section</U><U></U><U>&nbsp;6.10</U>, express or implied: (i)&nbsp;shall be construed to establish, amend or
modify any benefit or compensation plan, program, agreement or arrangement, (ii)&nbsp;shall subject to compliance with the other provisions of this <U>Section</U><U></U><U>&nbsp;6.10</U> alter or limit Purchaser&#146;s or any of its Affiliates&#146;
ability to amend, modify or terminate any particular benefit plan, program, agreement or arrangement after the Closing, (iii)&nbsp;is intended to confer upon any current or former employee any right to employment or continued employment for any
period of time, or any right to a particular term or condition of employment, (iv)&nbsp;shall limit the ability of Purchaser or its Affiliates to terminate the employment of any employee at any time and for any or no reason or (v)&nbsp;is intended
to confer upon any individual other than a party to this Agreement (including employees, retirees, or dependents or beneficiaries of employees or retirees) any right as a third party beneficiary of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;6.11 </U></B><B><U>Key Business Employees</U></B>. Except as otherwise set forth in
<U>Section</U><U></U><U>&nbsp;6.11</U> of the Disclosure Letter, as soon as practicable following the date hereof (but in any event no later than five Business Days following the date hereof), Seller shall implement one or more programs (each, a
&#147;<U>Key Business Employee Retention Program</U>&#148;) to incentivize certain key Business Employees to remain employed by Seller or its Affiliates throughout the <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period, consistent with the
terms set forth in <U>Section</U><U></U><U>&nbsp;6.11</U> of the Disclosure Letter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;6.12
</U></B><B><U>Confidentiality</U></B>. From and after the Closing, Seller shall, and shall cause its Affiliates to, keep confidential and not disclose to any other Person, or use for their own benefit or the benefit of any other Person, any
confidential and <FONT STYLE="white-space:nowrap">non-public</FONT> information regarding Purchaser, any of its Subsidiaries (including the Group Companies) or the Business which Seller or its Affiliates (a)&nbsp;possess as a result of Seller&#146;s
historical relationship with the Group Companies (including as a stockholder or other equityholder of any Group Company) or (b)&nbsp;obtain pursuant to Seller&#146;s access and information rights under this Agreement. The obligations under this
<U>Section</U><U></U><U>&nbsp;6.12</U> shall not apply to information which (i)&nbsp;is or becomes generally available to the public without breach of Seller&#146;s or its Affiliates&#146; obligations under this
<U>Section</U><U></U><U>&nbsp;6.12</U>, (ii)&nbsp;in the case of information covered by <U>clause</U><U></U><U>&nbsp;(b)</U> above, (A)&nbsp;was in the possession of Seller prior to its disclosure by Purchaser (excluding information covered by
<U>clause</U><U></U><U>&nbsp;(a)</U>); <I>provided</I> that such information is not and was not subject to or prohibited from being disclosed pursuant to another confidentiality obligation, (B)&nbsp;becomes known to Seller through a third party who
Seller reasonably believes, after reasonable inquiry, is not under any obligation of confidentiality to Purchaser or (C)&nbsp;is independently developed by or for Seller without use of any information provided by on or behalf of Purchaser and not in
violation of this <U>Section</U><U></U><U>&nbsp;6.12</U> or (iii)&nbsp;is required to be disclosed by applicable Law; <I>provided</I> that, in the case of <U>clause</U><U></U><U>&nbsp;(iii)</U>, Seller shall notify Purchaser as early as
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
practicable prior to disclosure to allow Purchaser to take appropriate measures to preserve the confidentiality of such information; <I>provided</I>, <I>further</I>, that the use limitations in
this <U>Section</U><U></U><U>&nbsp;6.12</U> shall not apply in connection with the Transactions and other matters contemplated by the Ancillary Agreements and the Collaboration Agreement which have their own confidentiality obligations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;6.13 </U></B><B><U><FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Transactions</U></B>.<B>
</B>(a)&nbsp;At or prior to the Closing, subject to <U>Section</U><U></U><U>&nbsp;6.13(b)</U>, Seller shall take, or cause to be taken, the actions set forth in <U>Section</U><U></U><U>&nbsp;6.13(a)</U> of the Disclosure Letter. The transactions
described in this <U>Section</U><U></U><U>&nbsp;6.13(a)</U> are referred to in this Agreement as the &#147;<U><FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Transactions</U>&#148;. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) If any third party consent is required to effect the <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Transactions with respect to any
Contract, and such consent is not obtained prior to Closing, then until such consent has been obtained, the Parties shall use reasonable best efforts to enter into reasonable alternative arrangements which shall result in Purchaser receiving
substantially all of the benefits and bearing substantially all of the costs, liabilities and burdens with respect to any such Contract until such consent is obtained. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U><U></U><U>&nbsp;6.14 </U><U>Post-Closing Payments; Mail Handling.</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">After the Closing, each of Purchaser and its Affiliates (including the Group Companies), on the one hand, and the Seller Group, on the other
hand, shall hold and promptly transfer and deliver to the other Party, from time to time as and when received by them, any cash, checks with appropriate endorsements, mail, packages or other property that they may receive which properly belong to
the other Party, and shall account to the other Party for all receipts in respect of any such property. The Parties acknowledge and agree there is no right of offset regarding any such payments and a Party may not withhold funds received from third
parties for the account of the other Party in the event there is a dispute regarding any other issue under any this Agreement or any of the Ancillary Agreements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;6.15 </U></B><B><U><FONT STYLE="white-space:nowrap">Non-Solicit</FONT> and <FONT
STYLE="white-space:nowrap">No-Hire</FONT> of Employees; <FONT STYLE="white-space:nowrap">Non-Competition</FONT></U></B>. (a)&nbsp;As a necessary measure to ensure that Purchaser realizes the goodwill and associated benefits of the Transactions, for
a period of two years following the Closing Date, Seller shall not, and shall cause its controlled Affiliates not to, directly or indirectly (i)&nbsp;solicit for employment or consulting service any individual who was a Business Employee as of the
Closing Date (a &#147;<U>Purchaser Restricted Person</U>&#148;), or (ii)&nbsp;hire, whether as a manager, director, officer, employee, contractor, consultant or other individual service provider, any Purchaser Restricted Person; <I>provided</I> that
the restrictions contained in this <U>Section</U><U></U><U>&nbsp;6.15(a)</U> shall not apply to (A)&nbsp;the placement of general advertisements (whether in paper or digital media), conducting any other form of general solicitation or the use of
general search firm services that are not targeted towards any Purchaser Restricted Persons and the hiring of any such Purchaser Restricted Persons who respond to such general advertisements, general solicitation or general searches or (B)&nbsp;with
respect to any Purchaser Restricted Person from and after the date that is six months after such Purchaser Restricted Person&#146;s employment with the Business ceases (provided that if such Purchaser Restricted Person&#146;s employment is
terminated by Purchaser or its applicable Affiliate without cause, such <FONT STYLE="white-space:nowrap">six-month</FONT> cooling off period shall not apply). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) As a necessary measure to ensure that Seller realizes the goodwill and associated
benefits of the Transactions, from the date of this Agreement through the Closing Date, Purchaser shall not, and shall cause its controlled Affiliates not to, directly or indirectly (i)&nbsp;solicit for employment or consulting service any employee
of the Seller Group about whom Purchaser received information in connection with its evaluation of the Transactions or with whom Purchaser had substantial contact during its evaluation of the Transactions (a &#147;<U>Seller Restricted
Person</U>&#148;) or (ii)&nbsp;hire, whether as a manager, director, officer, employee, contractor, consultant or other individual service provider, any Seller Restricted Person; <I>provided</I> that the restrictions contained in this
<U>Section</U><U></U><U>&nbsp;6.15(b)</U> shall not apply to (A)&nbsp;the placement of general advertisements (whether in paper or digital media), conducting any other form of general solicitation or the use of general search firm services that are
not targeted towards any Seller Restricted Persons and the hiring of any such Seller Restricted Persons who respond to such general advertisements, general solicitation or general searches or (B)&nbsp;with respect to any Seller Restricted Person
from and after the date that is six months after such Seller Restricted Person&#146;s employment with the Seller Group ceases (provided that if such Seller Restricted Person&#146;s employment is terminated by Seller or its applicable Affiliate
without cause, such <FONT STYLE="white-space:nowrap">six-month</FONT> cooling off period shall not apply). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) As a necessary measure to
ensure that Purchaser realizes the goodwill and associated benefits of the Transactions, for a period of three years<SUP STYLE="font-size:75%; vertical-align:top"> </SUP>following the Closing Date, Seller shall not, and shall cause its controlled
Affiliates not to, directly or indirectly, invest in, acquire, own, manage, operate or otherwise engage in any Competing Business other than in connection with exercising its rights under Section&nbsp;2.1 of the License Agreement with respect to
&#147;Licensed Products&#148; in the &#147;Field&#148; (as such terms are defined in the License Agreement); <I>provided</I> that nothing herein shall prevent or restrict: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Seller or any of its Affiliates from acquiring or owning, directly or indirectly, as a passive, <FONT
STYLE="white-space:nowrap">non-controlling</FONT> investor 10% or less of the outstanding securities of any Person; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)
Seller or any of its Affiliates from acquiring or owning, directly or indirectly, 5% or less of any class of capital stock of any Person if such stock is publicly traded and listed on any national exchange; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) Seller or any of its Affiliates from acquiring any Persons or businesses (each, an &#147;<U>Acquired Business</U>&#148;)
(or an ownership stake therein) that include a Competing Business (the portion that includes such a Competing Business, an &#147;<U>Acquired Competing Business</U>&#148;) and carrying on the Acquired Competing Business if such Acquired Competing
Business comprises less than&nbsp;25% of the revenues of the Acquired Business (measured as of the completed calendar year preceding the year in which the acquisition of the Acquired Business is completed); <I>provided</I>, <I>however</I>, that
Seller shall use reasonable best efforts to execute a definitive agreement for the divestiture of the Acquired Competing Business on commercially reasonable terms as soon as reasonably practicable following, and in any event within twelve months of,
the acquisition of the Acquired Business; or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) the combination with or acquisition of any equity interests of Seller
or any of its Affiliates or the acquisition of assets, operations or a business from Seller or one or more of its Affiliates in an <FONT STYLE="white-space:nowrap">arm&#146;s-length</FONT> transaction by a Person engaged, directly or indirectly, in
a Competing Business or the activities of any such Person or its Affiliates (other than Seller or its controlled Affiliates). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Seller
agrees and acknowledges, on behalf of itself and its Affiliates, that (i)&nbsp;Purchaser is relying to its detriment on the covenants set forth in this <U>Section</U><U></U><U>&nbsp;6.15</U> in connection with entering into this Agreement and
consummating the Transactions, (ii)&nbsp;the enforcement of any covenants set forth in this <U>Section</U><U></U><U>&nbsp;6.15</U> against Seller or its Affiliates would not impose any undue burden upon Seller or its Affiliates and (iii)&nbsp;none
of the covenants set forth in this <U>Section</U><U></U><U>&nbsp;6.15</U> are unreasonable as to duration or scope. The Parties agree that irreparable damage would occur and that the Parties would not have any adequate remedy at law if any of the
provisions of this <U>Section</U><U></U><U>&nbsp;6.15</U> were not performed in accordance with their specific terms or were otherwise breached. The Parties therefore agree that each Party shall be entitled to one or more injunctions to prevent
breaches of this <U>Section</U><U></U><U>&nbsp;6.15</U> and to enforce specifically the terms and provisions of this <U>Section</U><U></U><U>&nbsp;6.15</U> without proof of actual damages, this being in addition to any other remedy to which either
Party is entitled at law or in equity. Each Party further agrees that (A)&nbsp;no Party or any other Person shall be required to obtain, furnish or post any bond or similar instrument in connection with or as a condition to obtaining any remedy
referred to in this <U>Section</U><U></U><U>&nbsp;6.15(d)</U>, and each Party irrevocably waives any right it may have to require the obtaining, furnishing or posting of any such bond or similar instrument, and (B)&nbsp;it will not oppose the
granting of such remedy. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Parties agree that if any court of competent jurisdiction in a final nonappealable Order determines that
a specified time period, a specified geographical area, a specified business limitation or any other relevant feature of this <U>Section</U><U></U><U>&nbsp;6.15</U> is unreasonable, arbitrary or against public policy, then a lesser time period,
geographical area, business limitation or other relevant feature which is determined by such court to be reasonable, not arbitrary and not against public policy shall be enforced against the applicable Party to the maximum extent permitted under
applicable Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;6.16 </U></B><B><U>Intercompany Accounts; Intercompany
Arrangements</U></B>. (a)&nbsp;At or prior to the Closing, all intercompany accounts between any member of the Seller Group, on the one hand, and any Group Company, on the other hand, shall be settled or otherwise eliminated, and to the extent any
payment is made to settle or eliminate any such account, such payment shall be made solely in Cash, and no party shall have any further liability with respect thereto. For the avoidance of doubt, intercompany accounts solely between and among any of
the Group Companies shall not be affected by this <U>Section</U><U></U><U>&nbsp;6.16(a)</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Effective at the Closing, other than any
intercompany accounts governed by <U>Section</U><U></U><U>&nbsp;6.16(a)</U>, the Ancillary Agreements and items set forth in <U>Section</U><U></U><U>&nbsp;6.16(b)</U> of the Disclosure Letter, all arrangements, understandings or Contracts, including
all obligations to provide goods, services or other benefits, by any member of the Seller Group, on the one hand, and any Group Company, on the other hand, shall be terminated without any party having any continuing obligations or liability to the
other, except for this Agreement and the Ancillary Agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;6.17 </U></B><B><U>Wrong
Pockets</U></B>. (a)&nbsp;If, at any time within 12&nbsp;months following the Closing, but subject to the Transition Services Agreement, any right, property or asset not predominantly related to or predominantly used in the Business is found to have
been transferred to Purchaser in error, either directly or indirectly, Purchaser shall, or shall cause its Affiliates (including the Group Companies) to, transfer, at no cost to Purchaser or its Affiliates, such right, property or asset (and any
related liability) as soon as practicable to Seller or its designated Affiliates as directed in writing by Seller. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) If, at any time within 12&nbsp;months following the Closing, but subject to the
Transition Services Agreement and excluding any assets in respect of Overhead and Shared Services, any right, property or asset predominantly related to or predominantly used in the Business is found to have been retained by Seller or any of its
Affiliates in error, either directly or indirectly, Seller shall, or shall cause its applicable Affiliate to, transfer, at no cost to Purchaser or its Affiliates, such right, property or asset (and any related liability) as soon as practicable to
Purchaser or its designated Affiliates as directed in writing by Purchaser. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) For all purposes of this
<U>Section</U><U></U><U>&nbsp;6.17</U>, the term &#147;predominantly&#148; shall mean 90% or more. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;6.18 </U></B><B><U>Representation and Warranty Insurance</U></B>.<B> </B>(a)&nbsp;As of the
date of this Agreement, Purchaser has entered into a binder agreement (the &#147;Binder Agreement&#148;) with one or more representation and warranty insurers (each, an &#147;Insurer&#148;) (or an agent to the Binder Agreement) that conditionally
binds a buyer-side representation and warranty insurance policy (the &#147;Representation and Warranty Insurance Policy&#148;). Seller acknowledges that a true and correct draft of the Binder Agreement was provided to Seller on or prior to the date
of this Agreement. Prior to Closing, Seller shall, and shall cause its Affiliates to, use reasonable best efforts to cooperate with Purchaser and its Affiliates with respect to the Representation and Warranty Insurance Policy, including by providing
all information reasonably requested by or on behalf of any Insurer. From and after the Closing, Seller shall, and shall cause its Affiliates to, use reasonable best efforts to cooperate with Purchaser in connection with any claim made by Purchaser
under the Representation and Warranty Insurance Policy. As promptly as practicable, but in any event not later than two Business Days following the Closing Date, Seller shall deliver, or shall cause to be delivered to Purchaser an electronic copy of
the Data Room, as of the Closing Date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) All fees, costs and expenses of the insurance broker(s), underwriter(s) or Insurer(s) actually
incurred by Purchaser in connection with obtaining the Representation and Warranty Insurance Policy, including all premiums, underwriting costs, brokerage commissions and other fees and expenses of the Representation and Warranty Insurance Policy
shall constitute Shared Expenses. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Purchaser and its Affiliates shall ensure that the Representation and Warranty Insurance Policy
shall not include any rights of subrogation, contribution or similar rights against Seller, its Affiliates or any of their respective Representatives, based upon, arising out of or related to this Agreement, or the negotiation, execution or
performance of this Agreement, other than in the case of Fraud. Purchaser acknowledges and agrees that neither it nor any of its Affiliates shall enter into any representation and warranty insurance policy that is inconsistent with the foregoing
requirements. Purchaser and its Affiliates shall not, and shall not permit any other Person to, terminate, amend, alter or waive any provisions of the Representation and Warranty Insurance Policy with respect to such waiver of subrogation,
contribution or similar rights set forth therein in a manner that is adverse to Seller without the prior written consent of Seller. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;6.19 </U></B><B><U>Ancillary
Agreements</U></B>. On the Closing Date, each of Purchaser and Seller shall execute and deliver (i)&nbsp;the royalty agreement in the form attached as <U>Exhibit</U><U></U><U>&nbsp;B</U> (the &#147;<U>Royalty Agreement</U>&#148;), (ii)&nbsp;the
transition services agreement in the form attached as <U>Exhibit</U><U></U><U>&nbsp;C</U> (the &#147;<U>Transition Services Agreement</U>&#148;), (iii)&nbsp;the license agreement in the form attached as <U>Exhibit</U><U></U><U>&nbsp;D</U> (the
&#147;<U>License Agreement</U>&#148;) and (iv)&nbsp;the royalty agreement in the form attached as <U>Exhibit</U><U></U><U>&nbsp;E</U> (the &#147;<U>Single SOMAmer Royalty Agreement</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;6.20 </U></B><B><U>Use of Seller Marks</U></B>. Neither Purchaser nor any of its Affiliates
(including, following the Closing, the Group Companies) shall acquire any rights in, or use, or have the right to use, any Seller Marks except as expressly provided in this <U>Section</U><U></U><U>&nbsp;6.20</U> and subject to the terms and
conditions hereof. The Group Companies may temporarily continue to use the Seller Marks following the Closing, solely to the extent and in the same manner as used by the Group Companies in the Business immediately prior to the Closing, so long as
Purchaser shall, and shall cause each of its Affiliates (including the Group Companies) to, (i)&nbsp;immediately after the Closing, cease to hold itself and its Affiliates out as having any affiliation with Seller or any of its Affiliates and
(ii)&nbsp;use reasonable best efforts to minimize and eliminate use of the Seller Marks by the Business from and after the Closing; <I>provided</I> that as soon as practicable after the Closing Date (and in any event within 6 months thereafter),
Purchaser shall, and shall cause each of its Affiliates (including the Group Companies) to (A)&nbsp;cease and discontinue use of all Seller Marks and (B)&nbsp;complete the removal of the Seller Marks from all products, signage, vehicles, properties,
technical information and promotional or other marketing materials and other assets; <I>provided</I>, <I>further</I>, that products of the Business in finished goods inventory (to the extent the same bear any of the Seller Marks on the Closing Date)
may be disposed of without remarking in the ordinary course of business until the date that is 6 months following the Closing Date or until the supply is exhausted, whichever is the first to occur. Any and all goodwill that arises from use of the
Seller Marks by shall inure solely to the benefit of Seller and its Affiliates, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;6.21 </U></B><B><U>Further Assurances</U></B>. Following the Closing, each Party shall, at the
request of the other Party, execute, or cause its Affiliates to execute, such further documents, and perform, or cause its Affiliates to perform, such further acts, as may be reasonably necessary or appropriate to give full effect to the assignment,
conveyance, transfer or allocation of rights, benefits, obligations and liabilities contemplated by this Agreement, the Ancillary Agreements and the transactions contemplated hereby and thereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;6.22 </U></B><B><U>Specified Actions and Obligations</U></B>. Seller and Purchaser, as
applicable, shall take the actions and comply with the obligations set forth in <U>Section</U><U></U><U>&nbsp;6.22</U> of the Disclosure Letter. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VII </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Conditions
Precedent </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;7.1 </U></B><B><U>Conditions to Each
Party</U></B><B><U>&#146;</U></B><B><U>s Obligation</U></B>. The respective obligations of each Party to consummate the Transactions shall be subject to the satisfaction (or waiver, if permissible under applicable Law) on or prior to the Closing
Date of the following conditions: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Regulatory Approval</U>. (i)&nbsp;Any waiting period (and any extension thereof)
applicable to the consummation of the Transactions under the HSR Act shall have expired or been terminated and (ii)&nbsp;each consent, authorization and approval from a Governmental Authority required to be obtained in connection with the
consummation of the Transactions as set forth in <U>Section</U><U></U><U>&nbsp;7.1(a)</U> of the Disclosure Letter shall have been obtained (or, if applicable, the applicable waiting periods shall have expired or been earlier terminated). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>No Injunctions or Restraints</U>. No Law or Order enacted, promulgated, issued, entered, amended or enforced by any Governmental
Authority after the date of this Agreement (collectively, &#147;<U>Restraints</U>&#148;) shall be in effect enjoining, restraining, preventing or prohibiting consummation of the Transactions or making the consummation of the Transactions illegal.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;7.2 </U></B><B><U>Conditions to Obligation of Purchaser</U></B>. The obligation of
Purchaser to consummate the Transactions is further subject to the satisfaction (or waiver by Purchaser) on or prior to the Closing Date of the following conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Representations and Warranties</U>. (i)&nbsp;The representations and warranties of Seller set forth in
<U>Article</U><U></U><U>&nbsp;III</U> and <U>Article</U><U></U><U>&nbsp;IV</U> of this Agreement (excluding the representations set forth in the following <U>clauses</U><U></U><U>&nbsp;(ii)</U> or <U>(iii)</U>), disregarding all qualifications and
exceptions contained therein relating to materiality or Material Adverse Effect, shall be true and correct as of the Closing with the same effect as though made on and as of the Closing (except to the extent that such representation and warranty
expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct as of such earlier date), except where the failures to be true and correct would not, individually or in the aggregate, reasonably be
expected to have a Material Adverse Effect, (ii)&nbsp;the Seller Fundamental Representations (other than the representations and warranties of Seller set forth in <U>Section</U><U></U><U>&nbsp;3.4</U> and <U>Section</U><U></U><U>&nbsp;4.2</U>) shall
be true and correct in all material respects as of the Closing with the same effect as though made on and as of the Closing (except to the extent that any such Seller Fundamental Representation expressly speaks as of an earlier date, in which case
such Seller Fundamental Representation shall be true and correct as of such earlier date) and (iii)&nbsp;the representations and warranties of Seller set forth in <U>Section</U><U></U><U>&nbsp;3.4</U> and <U>Section</U><U></U><U>&nbsp;4.4(a)(ii)</U>
shall be true and correct in all respects as of the Closing with the same effect as though made on and as of the Closing ((x)&nbsp;in the case of <U>Section</U><U></U><U>&nbsp;4.4(a)(ii)</U>, solely with respect to the period covered therein and
(y)&nbsp;in the case of <U>Section</U><U></U><U>&nbsp;3.4</U>, except to the extent that such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct as of such
earlier date). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Performance of Obligations of Seller</U>. Seller and the Group Companies shall have performed in all material
respects all obligations required to be performed by them under this Agreement at or prior to the Closing. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Absence of Material
Adverse Effect</U>. Since the date of this Agreement, there shall not have occurred a Material Adverse Effect that is continuing as of the Closing Date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Officer</U><U>&#146;</U><U>s Certificate</U>. Seller shall have delivered to Purchaser a certificate of Seller, dated as of the Closing
Date and signed by a duly authorized officer of Seller, representing that the conditions specified in <U>Section</U><U></U><U>&nbsp;7.2(a)</U>, <U>Section</U><U></U><U>&nbsp;7.2(b)</U> and <U>Section</U><U></U><U>&nbsp;7.2(c)</U> have been
satisfied. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Remedy Actions</U>. No Restraint shall be in effect imposing a Remedy Action. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Legal Proceedings</U>. There shall not be pending any Legal Proceeding brought by or on behalf of a Governmental Authority under any
Regulatory Law that would reasonably be expected to result in any Restraint having the effect of enjoining, restraining, preventing or prohibiting consummation of the Transactions, making the consummation of the Transactions illegal or imposing a
Remedy Action. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;7.3 </U></B><B><U>Conditions to Obligation of Seller</U></B>. The
obligation of Seller to consummate the Transactions is further subject to the satisfaction (or waiver by Seller) on or prior to the Closing Date of the following conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Representations and Warranties</U>. The representations and warranties of Purchaser set forth in <U>Article</U><U></U><U>&nbsp;V</U>,
disregarding all qualifications and exceptions contained therein relating to materiality or Purchaser Material Adverse Effect, shall be true and correct as of the Closing with the same effect as though made on and as of the Closing (except to the
extent that such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct as of such earlier date), except where the failure to be true and correct would not,
individually or in the aggregate, reasonably be expected to have a Purchaser Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Performance of Obligations of
Purchaser</U>. Purchaser shall have performed in all material respects all obligations required to be performed by it under this Agreement at or prior to the Closing. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Officer</U><U>&#146;</U><U>s Certificate</U>. Purchaser shall have delivered to Seller a certificate of Purchaser, dated as of the
Closing Date and signed by a duly authorized officer of Purchaser, representing that the conditions specified in <U>Section</U><U></U><U>&nbsp;7.3(a)</U> and <U>Section</U><U></U><U>&nbsp;7.3(b)</U> have been satisfied. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;7.4 </U></B><B><U>Frustration of Closing Conditions</U></B>. Neither Seller nor Purchaser may
rely on the failure of any condition set forth in <U>Section</U><U></U><U>&nbsp;7.1</U>, <U>Section</U><U></U><U>&nbsp;7.2</U> or <U>Section</U><U></U><U>&nbsp;7.3</U>, as the case may be, to be satisfied if such failure was caused by such
Party&#146;s failure to use its reasonable best efforts to consummate the Transactions or due to the failure of such Party to perform any of its other obligations under this Agreement. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VIII </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Termination </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;8.1 </U></B><B><U>Termination</U></B>. This Agreement may be terminated and the Transactions
abandoned at any time prior to the Closing: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) by the mutual written consent of Seller and Purchaser; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) by either of Seller or Purchaser if: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) the Closing shall not have been consummated on or before 11:59 p.m. New York City time on March 23, 2026 (such date and
time, the &#147;<U>Initial Outside Date</U>&#148;, and as may be extended pursuant to this <U>Section</U><U></U><U>&nbsp;8.1(b)(i)</U>, the &#147;<U>Outside Date</U>&#148;); <I>provided</I> that if, as of the Initial Outside Date, the conditions set
forth in <U>Section</U><U></U><U>&nbsp;7.1(a)</U> or <U>Section</U><U></U><U>&nbsp;7.1(b)</U> (in each case, solely to the extent such Restraint arises under the HSR Act or any other Regulatory Law), <U>Section</U><U></U><U>&nbsp;7.2(e)</U> or
<U>Section</U><U></U><U>&nbsp;7.2(f)</U> have not been satisfied (but all other conditions set forth in <U>Section</U><U></U><U>&nbsp;7.1</U> and <U>Section</U><U></U><U>&nbsp;7.2</U> have been satisfied, other than those conditions that by their
nature are to be satisfied at the Closing, each of which is capable of being satisfied at the Closing), then such date shall be automatically extended to 11:59&nbsp;p.m. New York City time on June 22, 2026 (such date and time, the &#147;<U>First
Extended Outside Date</U>&#148;); <I>provided</I>, <I>further</I>, that if, as of the First Extended Outside Date, the conditions set forth in <U>Section</U><U></U><U>&nbsp;7.1(a)</U> or <U>Section</U><U></U><U>&nbsp;7.1(b)</U> (in each case, solely
to the extent such Restraint arises under the HSR Act or any other Regulatory Law), <U>Section</U><U></U><U>&nbsp;7.2(e)</U> or <U>Section</U><U></U><U>&nbsp;7.2(f)</U> have not been satisfied (but all other conditions set forth in
<U>Section</U><U></U><U>&nbsp;7.1</U> and <U>Section</U><U></U><U>&nbsp;7.2</U> have been satisfied, other than those conditions that by their nature are to be satisfied at the Closing, each of which is capable of being satisfied at the Closing),
then such date shall be automatically extended to 11:59 p.m. New York City time on September 22, 2026 (such date and time, the &#147;<U>Second Extended Outside Date</U>&#148;); <I>provided</I>,<I> further</I>, that if, as of the Second Extended
Outside Date, the conditions set forth in <U>Section</U><U></U><U>&nbsp;7.1(a)</U> or <U>Section</U><U></U><U>&nbsp;7.1(b)</U> (in each case, solely to the extent such Restraint arises under the HSR Act or any other Regulatory Law),<U>
Section</U><U></U><U>&nbsp;7.2(e)</U> or <U>Section</U><U></U><U>&nbsp;7.2(f)</U> have not been satisfied (but all other conditions set forth in <U>Section</U><U></U><U>&nbsp;7.1</U> and <U>Section</U><U></U><U>&nbsp;7.2</U> have been satisfied,
other than those conditions that by their nature are to be satisfied at the Closing, each of which is capable of being satisfied at the Closing), then such date shall be automatically extended to 11:59 p.m. New York City time on December 22, 2026;
<I>provided</I>, <I>further</I>, <I>however</I>, that the right to terminate this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;8.1(b)(i)</U>&nbsp;shall not be available to a Party if the failure of the Closing to have been consummated on
or before the Outside Date was primarily due to the failure of such Party to perform any of its obligations under this Agreement; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) any Restraint having the effect set forth in <U>Section</U><U></U><U>&nbsp;7.1(b)</U> shall be in effect and such
Restraint shall have become final and <FONT STYLE="white-space:nowrap">non-appealable;</FONT> <I>provided</I>, <I>however</I>, that the right to terminate this Agreement under this <U>Section</U><U></U><U>&nbsp;8.1(b)(ii)</U>&nbsp;shall not be
available to a Party if the issuance of such final, <FONT STYLE="white-space:nowrap">non-appealable</FONT> Restraint was primarily due to the failure of such Party to perform any of its obligations under this Agreement or if such Party shall have
failed to comply with its obligations under <U>Section</U><U></U><U>&nbsp;6.3</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) by Purchaser if: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Seller or any of the Group Companies shall have breached or failed to perform any of its representations, warranties,
covenants or agreements set forth in this Agreement, which breach or failure to perform (A)&nbsp;would give rise to the failure of a condition set forth in <U>Section</U><U></U><U>&nbsp;7.2(a)</U> or <U>Section</U><U></U><U>&nbsp;7.2(b)</U>,
respectively, and (B)&nbsp;cannot be cured by the Outside Date or, if capable of being cured, shall not have been cured within 30&nbsp;days following receipt of written notice from Purchaser stating Purchaser&#146;s intention to
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
terminate this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;8.1(c)(i)</U>&nbsp;and the basis for such termination; <I>provided</I> that Purchaser shall not have the right to terminate
this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;8.1(c)(i)</U>&nbsp;if it is then in breach of or has failed to perform its representations, warranties, covenants or other agreements hereunder, which breach or failure to perform would
give rise to the failure of a condition set forth in <U>Section</U><U></U><U>&nbsp;7.3(a)</U> or <U>Section</U><U></U><U>&nbsp;7.3(b)</U> and such breach or failure to perform has not been cured; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) if any Restraint having the effect set forth in <U>Section</U><U></U><U>&nbsp;7.2(e)</U> shall be in effect and such
Restraint shall have become final and <FONT STYLE="white-space:nowrap">non-appealable;</FONT> <I>provided</I>, <I>however</I>, that the right to terminate this Agreement under this <U>Section</U><U></U><U>&nbsp;8.1(c)(ii)</U>&nbsp;shall not be
available to Purchaser if the issuance of such final, <FONT STYLE="white-space:nowrap">non-appealable</FONT> Restraint was primarily due to the failure of Purchaser to perform any of its obligations under this Agreement or if Purchaser shall have
failed to comply with its obligations under <U>Section</U><U></U><U>&nbsp;6.3</U>; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) by Seller if Purchaser shall have breached or
failed to perform any of its representations, warranties, covenants or agreements set forth in this Agreement, which breach or failure to perform (i)&nbsp;would give rise to the failure of a condition set forth in
<U>Section</U><U></U><U>&nbsp;7.3(a)</U> or <U>Section</U><U></U><U>&nbsp;7.3(b)</U>, respectively, and (ii)&nbsp;cannot be cured by Purchaser by the Outside Date or, if capable of being cured, shall not have been cured within 30&nbsp;days following
receipt of written notice from Seller stating Seller&#146;s intention to terminate this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;8.1(d)</U> and the basis for such termination; <I>provided</I> that Seller shall not have the right to
terminate this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;8.1(d)</U> if it is then in breach of or has failed to perform its representations, warranties, covenants or other agreements hereunder, which breach or failure to perform would
give rise to the failure of a condition set forth in <U>Section</U><U></U><U>&nbsp;7.2(a)</U> or <U>Section</U><U></U><U>&nbsp;7.2(b)</U> and such breach or failure to perform has not been cured; <I>provided</I>, <I>further</I>, that the failure to
deliver the Closing Aggregate Consideration as required hereunder shall not be subject to cure hereunder unless otherwise agreed to in writing by Seller. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;8.2 </U></B><B><U>Effect of Termination</U></B>. <B></B>(a) In the event of the termination of
this Agreement as provided in <U>Section</U><U></U><U>&nbsp;8.1</U>, written notice thereof shall be given to the other Party, specifying the provision of this Agreement pursuant to which such termination is made and the basis therefor described in
reasonable detail (the &#147;<U>Termination Notice</U>&#148;), and this Agreement shall forthwith become null and void (other than this <U>Section</U><U></U><U>&nbsp;8.2</U> and <U>Article</U><U></U><U>&nbsp;XI</U> (other than
<U>Section</U><U></U><U>&nbsp;11.9</U> except to the extent it relates to any provisions that are stated to survive termination of this Agreement), all of which shall survive termination of this Agreement), and there shall be no liability hereunder
on the part of Purchaser or Seller, their respective Affiliates or their and their Affiliates&#146; respective current, former or future officers, managers, directors, employees, agents and other Representatives (collectively, &#147;<U>Related
Parties</U>&#148;); <I>provided</I>, <I>however</I>, that no Party shall be relieved or released from any liabilities or damages arising out of Fraud or any willful breach of this Agreement. The Confidentiality Agreement and the Clean Team Agreement
shall each survive the termination of this Agreement in accordance with their respective terms. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Reverse Termination Fee</U>. In the
event this Agreement is validly terminated by (i)&nbsp;Seller or Purchaser pursuant to <U>Section</U><U></U><U>&nbsp;8.1(b)(i)</U>&nbsp;and, at the time of such termination, one or more of the conditions set forth in
<U>Section</U><U></U><U>&nbsp;7.1(a)</U> or <U>Section</U><U></U><U>&nbsp;7.1(b)</U> (in each case, solely to the extent such Restraint arises under the HSR Act or any other Regulatory Law), <U>Section</U><U></U><U>&nbsp;7.2(e)</U> or
<U>Section</U><U></U><U>&nbsp;7.2(f)</U> were not satisfied or waived, (ii)&nbsp;by Seller or Purchaser pursuant to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<U>Section</U><U></U><U>&nbsp;8.1(b)(ii)</U>&nbsp;as a result of a Restraint arising under the HSR Act or any other Regulatory Law or (iii)&nbsp;by Purchaser pursuant to
<U>Section</U><U></U><U>&nbsp;8.1(c)(ii)</U>, and, in the case of each of <U>clauses</U><U></U><U>&nbsp;(i)</U> through <U>(iii)</U>, at the time of such termination each other condition set forth in <U>Section</U><U></U><U>&nbsp;7.1</U> or
<U>Section</U><U></U><U>&nbsp;7.2</U> has been satisfied or waived (other than those conditions that by their nature are to be satisfied at the Closing), then Purchaser shall pay to Seller within five Business Days following the <FONT
STYLE="white-space:nowrap">non-terminating</FONT> Party&#146;s receipt of the Termination Notice, by wire transfer of immediately available funds to a bank account designated in writing by Seller, an amount in cash equal to $14,500,000 (the
&#147;<U>Reverse Termination Fee</U>&#148;). For the avoidance of doubt, in no event shall Purchaser be required to pay the Reverse Termination Fee on more than one occasion. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) In the event the Reverse Termination Fee is payable to Seller pursuant to <U>Section</U><U></U><U>&nbsp;8.2(b)</U>, (x)&nbsp;payment of the
Reverse Termination Fee shall constitute the sole and exclusive remedy of Seller against Purchaser and its Related Parties for any losses suffered as a result of the failure of the Transactions to be consummated and (y)&nbsp;upon Purchaser&#146;s
payment of the full Reverse Termination Fee (and any other amounts contemplated by <U>Section</U><U></U><U>&nbsp;8.2(d))</U>, pursuant to this <U>Section</U><U></U><U>&nbsp;8.2</U> in circumstances in which the Reverse Termination Fee is payable,
none of Purchaser or its Related Parties shall have any further liability or obligation relating to or arising out of this Agreement or the Transactions; <I>provided</I> that nothing herein shall relieve Purchaser from liability for (or limit the
damages to which Seller may be entitled in the case of) Fraud or willful breach of this Agreement. Purchaser acknowledges and agrees that the provisions of this <U>Section</U><U></U><U>&nbsp;8.2</U> are reasonable and necessary to protect the
legitimate interests of Seller and constitutes a material inducement to Seller to enter into this Agreement and consummate the Transactions and that any payment of the Reverse Termination Fee does not constitute a penalty but is liquidated damages
in a reasonable amount that will compensate Seller in circumstances in which the Reverse Termination Fee is payable, which amount would otherwise be impossible to calculate with precision; <I>provided</I> that nothing herein shall relieve Purchaser
from liability for (or limit the damages to which Seller may be entitled in the case of) Fraud or willful breach of this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) If
Purchaser fails to pay in a timely manner any amount due pursuant to <U>Section</U><U></U><U>&nbsp;8.2(c)</U>, then (i)&nbsp;Purchaser shall reimburse Seller for all costs and expenses (including disbursements and fees of counsel) incurred in the
collection of such overdue amounts, including in connection with any related claims, actions or proceedings commenced and (ii)&nbsp;Purchaser shall pay to Seller the interest on the amounts payable pursuant to
<U>Section</U><U></U><U>&nbsp;8.2(c)</U>, from and including the date payment of such amounts was due to but excluding the date of actual payment at the prime rate set forth in the <I>Wall Street Journal</I> in effect on the date such payment was
required to be made. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IX </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>INDEMNIFICATION </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;9.1 </U></B><B><U>Survival</U></B>. Except for (1)&nbsp;the Seller Fundamental Representations,
each of which shall survive until the expiration of the applicable statute of limitations and (2)&nbsp;the representations and warranties of Purchaser set forth in <U>Section</U><U></U><U>&nbsp;5.9</U> and the representations and warranties of
Seller set forth in <U>Section</U><U></U><U>&nbsp;3.8</U>, each of which shall survive indefinitely, the representations and warranties of Seller and Purchaser set forth in this Agreement shall terminate effective as of the Closing and shall not
survive the Closing; <I>provided</I>, <I>however</I>, that nothing in this <U>Section</U><U></U><U>&nbsp;9.1</U> shall, and shall not be deemed or construed to, waive or release any claim or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
remedy for Fraud. The covenants and agreements of the Parties contained in this Agreement (i)&nbsp;that are required by their terms to be performed in full prior to the Closing shall survive the
Closing and continue in full force and effect until the date that is 12&nbsp;months after the Closing Date and (ii)&nbsp;that are required to be performed (in full or in part) at or after the Closing shall continue in full force and effect in
accordance with their respective terms. The obligations of Seller to indemnify the Purchaser Indemnified Persons (x)&nbsp;pursuant to <U>Section</U><U></U><U>&nbsp;9.2(a)(i)</U> or <U>Section</U><U></U><U>&nbsp;9.2(a)(ii)</U>&nbsp;shall survive
until the applicable representation, warranty, covenant or agreement terminates pursuant to the foregoing provisions of this <U>Section</U><U></U><U>&nbsp;9.1</U> and (y)&nbsp;pursuant to <U>Section</U><U></U><U>&nbsp;9.2(a)(iv)</U> and
<U>Section</U><U></U><U>&nbsp;9.2(a)(v)</U> shall survive indefinitely. The obligations of Purchaser to indemnify the Seller Indemnified Persons (A)&nbsp;pursuant to <U>Section</U><U></U><U>&nbsp;9.2(b)(i)</U>&nbsp;shall survive until the applicable
covenant or agreement terminates pursuant to the foregoing provisions of this <U>Section</U><U></U><U>&nbsp;9.1</U> and (B)&nbsp;pursuant to <U>Section</U><U></U><U>&nbsp;9.2(b)(ii)</U>&nbsp;shall survive indefinitely. Notwithstanding the foregoing,
the obligation of an Indemnifying Person to indemnify the applicable Indemnified Persons in respect of any breach of representation, warranty, covenant or agreement shall survive the time at which it would otherwise terminate pursuant to this
<U>Section</U><U></U><U>&nbsp;9.1</U>, and shall not terminate until finally resolved, if notice of the inaccuracy or breach thereof will have been given to the Indemnifying Person prior to such time in accordance with
<U>Section</U><U></U><U>&nbsp;9.3</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;9.2 </U></B><B><U>Indemnification</U></B>.
<B></B>(a) Subject to the provisions set forth in this <U>Article</U><U></U><U>&nbsp;IX</U>, from and after the Closing, Seller shall indemnify and hold harmless Purchaser and its Affiliates and their respective Representatives (the
&#147;<U>Purchaser Indemnified Persons</U>&#148;) from and against any and all losses, damages, costs, charges, expenses (including reasonable attorneys&#146;, accountants&#146; and other professionals&#146; fees, disbursements and expenses),
settlement payments, awards, judgments, fines or obligations (collectively, &#147;<U>Damages</U>&#148;) incurred or suffered by the Purchaser Indemnified Persons and arising out of or resulting from: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) any breach or inaccuracy of any Seller Fundamental Representation as of the date of this Agreement or as of the Closing
Date (with the same effect as though such Seller Fundamental Representation is made on and as of the Closing Date (except to the extent that such Seller Fundamental Representation speaks as of an earlier date, in which case as of such earlier
date)); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) any breach of any covenant or agreement of Seller or, prior to the Closing, any Group Company, contained in
this Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) any liabilities or obligations relating to or arising out of any matter set forth on
<U>Section</U><U></U><U>&nbsp;9.2(a)(iii)</U> of the Disclosure Letter; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) any liabilities or obligations to the extent
related to the Seller Business, the <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Transactions or the Excluded Employee Liabilities; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) any Taxes of Seller or any of its Affiliates (other than the Group Companies) for which any of the Group Companies is
liable under Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.1502-6</FONT> (or any comparable provision of state, local or foreign Law). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Subject to the provisions set forth in this <U>Article</U><U></U><U>&nbsp;IX</U>, from
and after the Closing, Purchaser shall indemnify and hold harmless Seller and its Affiliates and their respective Representatives (the &#147;<U>Seller Indemnified Persons</U>&#148;) from and against any and all Damages incurred or suffered by the
Seller Indemnified Persons and arising out of or resulting from: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) any breach of any covenant or agreement of Purchaser
or, following the Closing, any Group Company, contained in this Agreement; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) any liabilities or obligations to the
extent related to the conduct or operation of the Business, whether occurring prior to, at or after the Closing (<I>provided</I> that, for the avoidance of doubt, any indemnification obligation of Seller pursuant to
<U>Section</U><U></U><U>&nbsp;9.2(a)(i)</U> or any reimbursement obligation of Seller pursuant to <U>Section</U><U></U><U>&nbsp;9.7(b)</U> shall not be considered a liability or obligation within the scope of this
<U>Section</U><U></U><U>&nbsp;9.2(b)(ii)</U>). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;9.3 </U></B><B><U>Indemnification
Procedures</U></B>. (a)&nbsp;Any Purchaser Indemnified Person or Seller Indemnified Person (any of them, an &#147;<U>Indemnified Person</U>&#148;) seeking indemnification or reimbursement pursuant to this <U>Article</U><U></U><U>&nbsp;IX</U> shall
promptly provide to Seller (if such Indemnified Person is a Purchaser Indemnified Person) or to Purchaser (if such Indemnified Person is a Seller Indemnified Person) (i)&nbsp;a written notice of any claims that it may have pursuant to this
<U>Article</U><U></U><U>&nbsp;IX</U> (such notice, a &#147;<U>Claim Notice</U>&#148;, and the recipient of such Claim Notice, the &#147;<U>Indemnifying Person</U>&#148;) and (ii)&nbsp;in the event that there be asserted against any Indemnified
Person any written claim or demand by a third-party for which such Indemnified Person may be entitled to indemnification pursuant to this <U>Article</U><U></U><U>&nbsp;IX</U> (a &#147;<U>Third-Party Claim</U>&#148;), a Claim Notice with respect
thereto within 15&nbsp;days following such Indemnified Person&#146;s receipt of such claim (and no fewer than 10&nbsp;days prior to a scheduled appearance date in a litigated matter); <I>provided</I>,<I> however</I>,<I> </I>that any failure by such
Indemnified Person to give such notice will not relieve any indemnification obligations hereunder unless and only to the extent Seller or Purchaser, as applicable, is prejudiced by such failure. Each Claim Notice shall contain the amount or a good
faith estimate of the potential Damages (the &#147;<U>Damage Estimate</U>&#148;) against which such Indemnified Person seeks indemnification, to the extent then ascertainable, and a statement that such Indemnified Person is entitled to
indemnification pursuant to this <U>Article</U><U></U><U>&nbsp;IX</U> with respect to such potential Damages and a reasonable explanation of the basis therefor. If the applicable Indemnifying Person does not notify the Indemnified Person within
30&nbsp;days following its receipt of a Claim Notice (other than a Claim Notice with respect to a Third-Party Claim) that the Indemnifying Person disputes such claim or lacks information to evaluate such claim, such claim shall be conclusively
deemed a liability for which the Indemnified Person is entitled to indemnification under <U>Section</U><U></U><U>&nbsp;9.2</U>, and the amount of such claim shall be paid to the Indemnified Person, on demand, solely with respect to Damages actually
suffered or incurred prior to delivery of the Claim Notice and described in reasonable detail (including the amounts of such Damages) in the Claim Notice (for the avoidance of doubt, disregarding any Damage Estimates or unknown amounts of Damages in
the Claim Notice). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) With respect to each Third-Party Claim that is the subject of a Claim Notice, the Indemnifying Person shall be
entitled, to the extent permitted by applicable Law and subject to the limitations set forth in <U>Section</U><U></U><U>&nbsp;9.3(c)</U>, to assume and control the defense of such Third-Party Claim, at its own expense, with counsel approved by the
applicable Indemnified Person (such approval not to be unreasonably withheld, delayed or conditioned) by notice to such Indemnified Person; <I>provided </I>that Seller shall not be entitled to assume the defense of any Third-Party Claim pursuant to
which indemnification is sought solely pursuant to <U>Section</U><U></U><U>&nbsp;9.2(a)(i)</U> or <U>Section</U><U></U><U>&nbsp;9.2(a)(v)</U> if (i)&nbsp;the amount in dispute in such Third-Party Claim is reasonably likely to
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
erode the Retention or (ii)&nbsp;if an Insurer under the Representation and Warranty Insurance Policy is entitled to assume the defense of such Third-Party Claim pursuant to the Representation
and Warranty Insurance Policy (in each case, so long as Seller has consented to any provisions of or amendments to the Representation and Warranty Insurance Policy that relate to such assumption; it being understood that Seller has consented to the
provisions of the Representation and Warranty Insurance Policy as reflected in the Binder Agreement); <I>provided</I>, <I>further</I>, that the Indemnifying Person shall not be entitled to assume the defense of any Third-Party Claim if the
Third-Party Claim seeks an Order or other equitable relief or relief for other than money damages against the Indemnified Person except where such equitable relief or other relief is immaterial and incidental to claims for monetary damages. The
Indemnifying Person may settle, compromise or offer to settle or compromise any Third-Party Claim that it has elected to assume the defense of but shall not, without the prior written consent of the Indemnified Person (which consent shall not be
unreasonably withheld, conditioned or delayed), settle, compromise or offer to settle or compromise any Third-Party Claim on a basis that would result in or would reasonably be expected to result in (A)&nbsp;the imposition of a consent order,
injunction or decree that would restrict the future activity or conduct of the applicable Indemnified Person or any of its Affiliates, (B)&nbsp;any <FONT STYLE="white-space:nowrap">non-monetary</FONT> condition or obligation being imposed on the
applicable Indemnified Person or any of its Affiliates, (C)&nbsp;any material adverse effect on the business of the applicable Indemnified Person or any of its Affiliates, (D)&nbsp;any admission of fault or liability by any applicable Indemnified
Person or any of its Affiliates, (E)&nbsp;an obligation of the Indemnified Person to pay any amount that is not fully indemnified by the Indemnifying Person or (F)&nbsp;loss of coverage under the Representation and Warranty Insurance Policy (so long
as Seller has consented to any provisions of or amendments to such policy that relate to settlements; it being understood that Seller has consented to the provisions of the Representation and Warranty Insurance Policy as reflected in the Binder
Agreement). Notwithstanding the foregoing, Seller may not settle, compromise or offer to settle or compromise any Third-Party Claim if the Insurer is entitled to consent to such settlement, compromise or offer to settle or compromise under the
Representation and Warranty Insurance Policy and such consent shall not have been obtained. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) In the event that the Indemnifying Person
notifies such Indemnified Person that it desires to defend against a Third-Party Claim, such Indemnified Person shall have the right, but not the obligation, to participate in any such defense and employ separate counsel of its choosing. Such
Indemnified Person shall participate in any such defense at its own expense unless, in the reasonable opinion of outside counsel to such Indemnified Person, (i)&nbsp;a conflict or potential conflict (other than by virtue of delivery of a Claim
Notice) exists or (ii)&nbsp;one or more defenses are available to such Indemnified Person that are not available to the Indemnifying Person that would make such separate representation advisable, in which case the reasonable attorneys&#146; fees,
disbursements and expenses of such separate representation shall be indemnifiable Damages; <I>provided</I>,<I> however</I>, that no Indemnified Persons shall be entitled to reimbursement for more than one such counsel (plus any appropriate local
counsel) in connection with any Third-Party Claim. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) In the event that the Indemnifying Person has elected not to control the defense of
a Third-Party Claim or does not have a right to control the defense of a Third-Party Claim, the Indemnifying Person shall have no liability with respect to a Third-Party Claim settled or compromised without the Indemnifying Person&#146;s consent
(which consent shall not be unreasonably withheld, conditioned or delayed). Subject to the foregoing, for so long as the Indemnifying Person has failed to assume the defense of such Third-Party Claim, the Indemnified
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Person will have the right to undertake the defense, compromise or settlement of such Third-Party Claim, in which case the reasonable attorneys&#146; fees, disbursements and expenses of counsel
employed by the Indemnified Person for any period during which the Indemnifying Person has not assumed the defense thereof (other than during any period in which the Indemnified Person shall have failed to give notice of the claim as provided above)
may be indemnifiable Damages if provided for in this <U>Article</U><U></U><U>&nbsp;IX</U>; <I>provided</I>,<I> however</I>, that the Indemnified Persons shall not be entitled to reimbursement for more than one such counsel (plus any appropriate
local counsel) in connection with any Third-Party Claim. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Purchaser, Seller and the Indemnified Persons shall cooperate in order to
ensure the proper and adequate defense of a Third-Party Claim, including by providing access to each other&#146;s relevant business records and other documents and employees. Purchaser, Seller and the Indemnified Persons shall keep each other
reasonably informed with respect to the status of such Third-Party Claim as either may request from time to time. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Any action to be
taken under this <U>Article</U><U></U><U>&nbsp;IX</U> by any Indemnified Person may be taken by Purchaser on its behalf or the Seller on its behalf, as the case may be. Purchaser and Seller, as the case may be, shall have the right to enforce this
<U>Article</U><U></U><U>&nbsp;IX</U> on behalf of any Indemnified Person. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Notwithstanding the foregoing, in the case of any conflict
between this <U>Section</U><U></U><U>&nbsp;9.3</U> and <U>Section</U><U></U><U>&nbsp;10.5</U> with respect to any Tax dispute, the provisions of <U>Section</U><U></U><U>&nbsp;10.5</U> shall control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;9.4 </U></B><B><U>Final Resolution</U></B>. A Claim Notice, any amounts claimed therein and any
other matters set forth therein shall be deemed to be &#147;finally resolved&#148; for purposes of this <U>Article</U><U></U><U>&nbsp;IX</U> when (i)&nbsp;such Claim Notice, amounts and matters have been resolved by a written agreement executed by
Purchaser and Seller or (ii)&nbsp;such Claim Notice, amounts and matters have been resolved by a final, nonappealable Order of a court of competent jurisdiction or arbitrator with respect to such matter in dispute, or portion thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;9.5 </U></B><B><U>Calculation of Damages</U></B>. (a)&nbsp;The amount of any Damages for which
indemnification is provided under this <U>Article</U><U></U><U>&nbsp;IX</U> shall be calculated net of any amounts recovered by the Indemnified Person under any insurance policies (including the Representation and Warranty Insurance Policy) or
indemnification or reimbursement rights against third parties, in each case relating to such Damages, net of the costs and expenses incurred in seeking such collection; provided that the amount deemed to be recovered under insurance policies will
also be net of the deductible for such policies and any increase in the premium (and retro-premium adjustments) for such policies to the extent arising out of or in connection with such Damages. Purchaser shall use reasonable best efforts to seek
recovery under the Representation and Warranty Insurance Policy to the same extent as it would if such Damage were not subject to indemnification hereunder. In the event that an insurance or other recovery is made by any Indemnified Persons with
respect to any Damage for which any such Person has been indemnified hereunder, then a refund equal to the aggregate amount of the recovery shall be made promptly to the Indemnifying Person. Notwithstanding anything to the contrary in this
<U>Article</U><U></U><U>&nbsp;IX</U>, the Parties agree that no amount shall be due under this <U>Article</U><U></U><U>&nbsp;IX</U> to the extent that it duplicates another amount already paid or accounted for under this
<U>Article</U><U></U><U>&nbsp;IX</U> or in the calculation of the final Cash Amount, Indebtedness Amount, Net Working Capital Amount or Transaction Expenses pursuant to <U>Section</U><U></U><U>&nbsp;2.2</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding anything to the contrary in this <U>Article</U><U></U><U>&nbsp;IX</U>,
no Indemnified Person shall be entitled to indemnification under this <U>Article</U><U></U><U>&nbsp;IX</U> for any (i)&nbsp;consequential, incidental or special (including loss of revenue, income or profits) damages (in each case, to the extent
reasonably foreseeable), (ii)&nbsp;punitive or exemplary damages or (iii)&nbsp;damages based on a multiple of a financial metric (except, in the case of each of clauses&nbsp;(i) through (iii), to the extent awarded to a third party by a court of
competent jurisdiction in connection with a Third-Party Claim). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Indemnified Persons shall be entitled to the indemnification
provided for under this <U>Article</U><U></U><U>&nbsp;IX</U> even if any of them (i)&nbsp;had knowledge at any time of the matter that is later the subject of a claim for indemnity or (ii)&nbsp;waived any of the conditions set forth in
<U>Section</U><U></U><U>&nbsp;7.1</U> or <U>Section</U><U></U><U>&nbsp;7.2</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;9.6
</U></B><B><U>Mitigation</U></B>. Each Person entitled to indemnification hereunder shall take reasonable steps to mitigate such Person&#146;s Damages after becoming aware of any event which could reasonably be expected to give rise to any Damages
that are indemnifiable or recoverable hereunder or in connection herewith. Each of Purchaser and Seller shall use its reasonable best efforts to cause each other Purchaser Indemnified Person or Seller Indemnified Person, respectively, to comply with
this <U>Section</U><U></U><U>&nbsp;9.6</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;9.7 </U></B><B><U>Representation and Warranty
Insurance Policy</U></B>. (a) The Parties acknowledge and agree that Purchaser is entering into the Representation and Warranty Insurance Policy and that the Representation and Warranty Insurance Policy is intended to be a Contract between Purchaser
and the Insurer(s) separate and apart from this Agreement. As such, none of the limitations or exceptions set forth in this <U>Article</U><U></U><U>&nbsp;IX</U> shall in any way limit, affect, restrict, modify or impair the ability of Purchaser to
make claims under or recover under the Representation and Warranty Insurance Policy. The Parties further acknowledge and agree that the denial of any claim of any Indemnified Person by an Insurer shall not be construed as, or used as evidence that,
such Indemnified Person is not entitled to indemnification under this <U>Article</U><U></U><U>&nbsp;IX</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In the event Purchaser
makes a claim under the Representation and Warranty Insurance Policy with respect to any breach or inaccuracy of any of the representations or warranties of Seller set forth in <U>Article</U><U></U><U>&nbsp;III</U> and
<U>Article</U><U></U><U>&nbsp;IV</U> of this Agreement, and any amount of Damages from such claim are not subject to recovery under the Representation and Warranty Insurance Policy by virtue of, or the amount of recovery is reduced due to, the
application of the Retention, then Seller agrees to reimburse Purchaser promptly, upon demand and presentation of documentation evidencing the claim and the application of the Retention, for the amount of such Damages that are in excess of 50% of
the Retention until the Retention has been fully eroded (it being understood that (x)&nbsp;the Indemnified Persons shall bear all Damages constituting the first 50% of the Retention and (y)&nbsp;Seller&#146;s obligation under this
<U>Section</U><U></U><U>&nbsp;9.7(b)</U> shall only apply until the Retention is fully eroded and Seller&#146;s aggregate liability under this <U>Section</U><U></U><U>&nbsp;9.7(b)</U> shall not exceed 50% of the Retention). Notwithstanding anything
to the contrary contained in this Agreement or the Representation and Warranty Insurance Policy, to the extent Purchaser fails to bind the Representation and Warranty Insurance Policy or the Representation and Warranty Insurance Policy is
terminated, Seller shall have no obligation to reimburse Purchaser with respect to any Retention. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding anything to the contrary contained in this
<U>Article</U><U></U><U>&nbsp;IX</U>, except in the case of Fraud, no Indemnified Person shall be able to recover from Seller or any of its Related Parties with respect to any Damages (other than as expressly provided under
<U>Section</U><U></U><U>&nbsp;9.7(b)</U>) so long as recovery under the Representation and Warranty Insurance Policy is available. To the extent any Damages, or any portion thereof, is not recoverable under the Representation and Warranty Insurance
Policy for any reason, Indemnified Persons shall have recourse against Seller pursuant to, and in accordance with, this <U>Article</U><U></U><U>&nbsp;IX</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;9.8 </U></B><B><U>Remedies</U></B>. From and after the Closing, except for any rights and
remedies (i)&nbsp;pursuant to and in accordance with <U>Article</U><U></U><U>&nbsp;II</U>, (ii)&nbsp;pursuant to <U>Section</U><U></U><U>&nbsp;11.9</U> or (iii)&nbsp;under any Ancillary Agreement (other than the certificate delivered pursuant to
<U>Section</U><U></U><U>&nbsp;7.2(d)</U>) or the Collaboration Agreement, the rights to indemnification set forth in this <U>Article</U><U></U><U>&nbsp;IX</U> shall constitute the sole and exclusive monetary remedy of the Parties with respect all
matters under this Agreement and any certificate delivered pursuant to this Agreement; <I>provided</I> that the foregoing shall not prejudice or limit any claim or remedy for Fraud. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE X </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Certain Tax
Matters </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;10.1 </U></B><B><U>Transfer Taxes</U></B>. All transfer, documentary, sales,
use, registration and real property transfer or gains tax, stamp tax, excise tax, stock transfer tax and other similar Taxes with respect to the Transactions (collectively, &#147;<U>Transfer Taxes</U>&#148;) shall be borne fifty percent (50%) by
Purchaser and fifty percent (50%) by Seller; <I>provided</I> that any Transfer Taxes resulting from the <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Transactions shall be borne solely by Seller. All Tax Returns with respect to Transfer Taxes
shall be filed by the Party required to file the Tax Return under applicable Law, and Purchaser and Seller, as applicable, shall reimburse the filing Party for any Transfer Taxes that are borne by the other Party, respectively, pursuant to this
<U>Section</U><U></U><U>&nbsp;10.1</U>. Purchaser and Seller shall cooperate in timely making all filings, returns, reports and forms as necessary or appropriate to comply with the provisions of all applicable Laws in connection with the payment of
such Transfer Taxes and shall cooperate in good faith to minimize the amount of any such Transfer Taxes payable in connection herewith. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;10.2 </U></B><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;338(h)(10) Election</U></B>.
Purchaser and Seller shall jointly make (or cause their Affiliates, including the applicable Group Companies, to make) a timely election under Section&nbsp;338(h)(10) of the Code (and any comparable election under applicable state or local Law) with
respect to the Transactions (the &#147;<U>Section</U><U></U><U>&nbsp;338(h)(10) Election</U>&#148;) for each of the Group Companies that are tax resident in the United States. Purchaser and Seller shall each deliver completed and executed copies of
all forms necessary to make such election, including IRS Form 8023 and any similar state forms, at the Closing (or following the Closing if otherwise agreed by the Parties), each in form and substance reasonably satisfactory to the other Party. If
any changes are required in such forms as a result of information which is first available after such forms are prepared, the Parties shall promptly make such changes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">67 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;10.3 Other Tax Matters</U></B>. (a)&nbsp;The
Parties shall, to the extent permitted or required under applicable Law, treat the Closing Date as the last day of the taxable period of the Group Companies for all Tax purposes. The Parties agree that, to the extent permitted under applicable Law,
any transactions outside the ordinary course of business on the Closing Date, but after the Closing shall be allocated to Purchaser under the &#147;next day&#148; rule of Treasury Regulations
<FONT STYLE="white-space:nowrap">Section&nbsp;1.1502-76(b)(1)(ii)(B)</FONT> (or any similar, or analogous rule under state, local or foreign Tax Law that would allocate such items to Purchaser). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) As promptly as reasonably practicable, but in any event within 75 days after the Closing Date, Purchaser shall notify Seller if Purchaser
determines to make any election under Section&nbsp;338(g) of the Code with respect any Group Company that is a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> corporation for U.S. federal income tax purposes. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) With respect to any Group Company that is a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> corporation for U.S. federal income tax
purposes, and for which no election under Section&nbsp;338(g) of the Code is made in respect of the applicable entity, Seller shall be entitled to make an election under Treasury Regulation
<FONT STYLE="white-space:nowrap">Section&nbsp;1.245A-5(e)(3)(i)</FONT> to close the taxable year of such entity as of the Closing Date for U.S. federal income tax purposes (and any comparable provisions of applicable state, local or <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> Tax Law) (the &#147;245A Election&#148;). If requested by Seller, Purchaser shall cooperate to take all reasonable actions necessary and appropriate (including entering into any agreements and filing such
additional forms, returns or other documents as may be required) to effect and preserve the 245A Election in accordance with the provisions of Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.245A-5(e)(3)(i)</FONT> (or any
comparable provisions of state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> Tax Law). Purchaser and Seller further agree to file all Tax Returns and any other filings in a manner consistent with this
<U>Section</U><U></U><U>&nbsp;10.4</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;10.4 </U></B><B><U>Purchase Price
Allocation</U></B>. (a)&nbsp;The Final Closing Aggregate Consideration (plus any assumed liabilities and other items required to be taken into account for such purpose) shall be allocated among the Shares and the assets of the Group Companies in
accordance with the principles of Sections&nbsp;1060 and 338 of the Code and the Treasury Regulations thereunder and this <U>Section</U><U></U><U>&nbsp;10.4</U> (the &#147;<U>Allocation</U>&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Within 60&nbsp;days after the determination of the Final Closing Aggregate Consideration, Seller shall deliver to Purchaser a draft of the
Allocation (the &#147;<U>Draft Allocation</U>&#148;), together with supporting documentation, to allow Purchaser to review and comment on the Draft Allocation. Purchaser shall review the Draft Allocation and provide Seller with comments within
40&nbsp;days after the date that Purchaser received the Draft Allocation. Seller shall consider in good faith all of Purchaser&#146;s reasonable comments to the Draft Allocation. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Unless Purchaser objects to the Draft Allocation within the 40&nbsp;days after the date that Purchaser received the Draft Allocation, the
Draft Allocation shall be binding on the Parties without further adjustment, absent fraud or mathematical error (the &#147;<U>Final Allocation</U>&#148;). If Purchaser objects to the Draft Allocation within the 40&nbsp;days after receiving the Draft
Allocation, the disputed items shall be resolved pursuant to <U>Section</U><U></U><U>&nbsp;10.5</U> and the resulting allocation shall become the Final Allocation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">68 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Purchaser, Seller and the Group Companies shall file or cause to be filed all Tax
Returns in a manner consistent with the Final Allocation and shall not make any inconsistent statement or adjustment on any Tax Return or during the course of any <FONT STYLE="white-space:nowrap">Tax-related</FONT> matter, or otherwise take any Tax
position inconsistent with the Final Allocation, unless required to do so pursuant to a &#147;determination&#148; within the meaning of Section&nbsp;1313(a) of the Code (or any analogous provision of state, local or foreign Law); <I>provided</I>
that no such determination shall have any effect on the Final Closing Aggregate Consideration and the Parties hereby agree that no adjustment shall be made to any such payment. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) If the Final Closing Aggregate Consideration is adjusted pursuant to this Agreement, the Final Allocation shall be adjusted as appropriate
and Purchaser and Seller shall cooperate in good faith in making any such adjustments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;10.5 </U></B><B><U>Tax Dispute Resolution</U></B>. In the event of any disagreement as to any
Tax matter covered in this Agreement (other than Third-Party Claims), Purchaser and Seller shall negotiate in good faith for a period of 30&nbsp;days to resolve such disagreement. In the event any such disagreement cannot be resolved between
Purchaser and Seller, such disagreement shall be resolved by an accounting firm of international reputation (or, in the case of a disagreement regarding the valuation of any item reflected in the Allocation, by a valuation firm) mutually agreeable
to, and retained by, Purchaser and Seller (any such firm, the &#147;<U>Tax Arbitrator</U>&#148;), and any such determination by the Tax Arbitrator shall be final, absent fraud, mathematical error or failure to make a determination in accordance with
this Agreement. The fees and expenses of the Tax Arbitrator shall be borne by Purchaser and Seller in inverse proportion as they may prevail on the disputed items resolved by the Tax Arbitrator. Such proportional allocations shall be determined by
the Tax Arbitrator at the time its determination is rendered on the disputed items. If the Tax Arbitrator does not resolve any differences between Purchaser and Seller with respect to a Tax Return at least five days prior to the due date therefor
(taking into account any extension of time within which to file that has been granted), such Tax Return shall be filed in a manner consistent with the position of the Party responsible for filing such Tax Return and, to the extent necessary and
permitted under applicable Law, amended to reflect the Tax Arbitrator&#146;s resolution. This <U>Section</U><U></U><U>&nbsp;10.5</U> shall apply to Tax disputes (other than Third-Party Claims) notwithstanding <U>Section</U><U></U><U>&nbsp;9.3</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;10.6 </U></B><B><U>Cooperation</U></B>. (a)&nbsp;Following the Closing, each of Purchaser
and Seller agrees that it shall cooperate with and make available to the other Party, during normal business hours, all books and records, information and employees (without substantial disruption of employment) retained and remaining in existence
after the Closing that are necessary or useful in connection with the preparation and filing of any Tax Returns and the Section&nbsp;338(h)(10) Election, including the computation and verification of any amounts paid or payable under this
<U>Article</U><U></U><U>&nbsp;X</U> (including any supporting workpapers, schedules and documents). The Party requesting any such books, records, information or employees shall bear all
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and expenses (including attorneys&#146; fees, but excluding reimbursement for salaries and employee benefits) reasonably incurred in connection with
providing such books, records, information or employees. Following the Closing, Purchaser shall cause the Group Companies to retain all applicable Tax Returns, books and records and workpapers for <FONT STYLE="white-space:nowrap">Pre-Closing</FONT>
Tax Periods for a period of at least seven&nbsp;years following the Closing Date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">69 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding anything to the contrary contained in this Agreement, nothing in this
Agreement shall grant any Person the right to (i)&nbsp;receive or obtain any information relating to Taxes or Tax Returns of Seller or any of its Affiliates (or any of its successors or predecessors) or any Consolidated Tax Return other than
information relating solely to the Group Companies (which may be provided on a pro forma basis) or (ii)&nbsp;control or participate in any audit or Tax proceeding by any Governmental Authority with respect to Seller or any of its Affiliates or any
Consolidated Income Taxes or any Consolidated Tax Return. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;10.7 </U></B><B><U>Tax
Treatment</U></B>. The Parties agree that any amount paid under <U>Article</U><U></U><U>&nbsp;IX</U> or <U>Section</U><U></U><U>&nbsp;2.4</U> shall be treated as an adjustment to the Final Closing Aggregate Consideration for Tax purposes to the
extent permitted by applicable Law. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE XI </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>MISCELLANEOUS </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;11.1 </U></B><B><U>Release</U></B>. Effective upon the Closing, except for any rights and
remedies (i)&nbsp;pursuant to and in accordance with <U>Article</U><U></U><U>&nbsp;II</U>, (ii)&nbsp;pursuant to and in accordance with <U>Article</U><U></U><U>&nbsp;IX</U>, (iii)&nbsp;pursuant to <U>Section</U><U></U><U>&nbsp;11.9</U>,
(iv)&nbsp;with respect to any covenants or agreements contained in this Agreement that by their terms contemplate performance following the Closing or (v)&nbsp;under any Ancillary Agreement or the Collaboration Agreement, each of Purchaser and
Seller waives, on its own behalf and on behalf of its respective Affiliates, to the fullest extent permitted under applicable Law, any and all rights, claims and causes of action it may have under applicable Law, whether known or unknown, against
the other Party or any of such other Party&#146;s current or former Affiliates or Representatives relating to the operation of the Group Companies or the Business or relating to the subject matter of this Agreement, the Disclosure Letter or the
Transactions;<I> provided</I> that the foregoing shall not prejudice or limit any claim or remedy for Fraud. Each Party shall have the right to enforce this <U>Section</U><U></U><U>&nbsp;11.1</U> on behalf of any Person that would be benefitted or
protected by this <U>Section</U><U></U><U>&nbsp;11.1</U> if they were a party hereto. Notwithstanding the foregoing release or anything herein to the contrary, such release shall not be deemed to include any right of Seller arising out of the
payment of compensation earned prior to the Closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;11.2 </U></B><B><U>Fees and
Expenses</U></B>. Except as otherwise expressly provided herein, whether or not the <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Transactions or the Transactions are consummated, all fees and expenses incurred in connection with the
Transactions and this Agreement shall be paid by the Party incurring or required to incur such fees or expenses; <I>provided</I> that (i)&nbsp;Seller shall be responsible for and shall pay all fees and expenses incurred in connection with the <FONT
STYLE="white-space:nowrap">Pre-Closing</FONT> Transactions and (ii)&nbsp;the Parties shall bear equally any Shared Expenses that are incurred and, with respect to any such Shared Expenses, in the event that the Transactions are not consummated, to
the extent any Party actually pays any such fees and expenses in excess of the share thereof that such Party would have been required to bear if the Transactions had been consummated, such Party shall be entitled to reimbursement from the other
Party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;11.3 </U></B><B><U>Amendment or Supplement</U></B>. Subject to compliance with
applicable Law, at any time prior to the earlier of the Closing or the termination of this Agreement in accordance with its terms, this Agreement (including the Disclosure Letter) may be amended or supplemented in any and all respects, solely by
written agreement of the Parties duly executed and delivered on behalf of each Party by a duly authorized officer of such Party. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">70 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;11.4 </U></B><B><U>Waiver</U></B>. At any
time prior to the earlier of the Closing or the termination of this Agreement in accordance with its terms, any failure of either Party to comply with any obligation, representation, warranty, covenant, agreement or condition herein may be waived by
the other Party (to the extent such other Party is the beneficiary of the applicable obligation, representation, warranty, covenant, agreement or condition). Any such waiver or failure to insist upon strict compliance with such obligation,
representation, warranty, covenant, agreement or condition shall not operate as a waiver of, or estoppel with respect to, any subsequent or other failure. Neither Party shall be deemed to have waived any claim arising out of this Agreement or any
power, right, privilege, or remedy under this Agreement, unless the waiver of such claim, power, right, privilege, or remedy is expressly set forth in a written instrument duly executed and delivered on behalf of such Party by a duly authorized
officer of such Party, and any such waiver shall not be applicable or have any effect except in the specific instance in which it is given. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;11.5 </U></B><B><U>Assignment</U></B>. Neither this Agreement nor any of the rights, interests
or obligations hereunder shall be assigned, in whole or in part, by operation of Law or otherwise, by either Party without the prior written consent of the other Party; <I>provided</I> that Purchaser may assign its right to receive the Shares in
whole or in part to one or more of its Affiliates. Subject to the preceding sentence, this Agreement shall be binding upon, inure to the benefit of and be enforceable by the Parties and their respective successors and permitted assigns. Any
purported assignment not permitted under this <U>Section</U><U></U><U>&nbsp;11.5</U> shall be null and void. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;11.6 </U></B><B><U>Counterparts; Electronic Signatures</U></B>. This Agreement may be executed
in one or more counterparts, each of which shall be deemed to be an original and all of which, when taken together, shall be deemed to be one and the same agreement or document. A signed copy of this Agreement transmitted by email, .pdf, DocuSign or
other means of electronic transmission shall be deemed to have the same legal effect as delivery of an original executed copy of this Agreement for all purposes. This <U>Section</U><U></U><U>&nbsp;11.6</U> shall apply <I>mutatis mutandis</I> to any
signed agreement or instrument entered into in connection with this Agreement or contemplated hereby, and any amendments hereto or thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;11.7 </U></B><B><U>Entire Agreement; Third-Party Beneficiaries</U></B>. This Agreement,
including the Disclosure Letter and the exhibits and schedules hereto, together with the other instruments referred to herein, including the Confidentiality Agreement, the Clean Team Agreement and the Ancillary Agreements, (a)&nbsp;constitute the
entire agreement, and supersede all other prior agreements and understandings, both written and oral, between the Parties with respect to the subject matter hereof and thereof and (b)&nbsp;except for (i)&nbsp;the rights of the <FONT
STYLE="white-space:nowrap">Non-Recourse</FONT> Parties under <U>Section</U><U></U><U>&nbsp;11.15</U>, (ii)&nbsp;the rights of Retained Counsel under <U>Section</U><U></U><U>&nbsp;11.16</U>, (iii)&nbsp;the rights of each Party and their respective
Affiliates or Representatives under <U>Section</U><U></U><U>&nbsp;11.1</U>, (iv)&nbsp;the rights of D&amp;O Indemnitees under <U>Section</U><U></U><U>&nbsp;6.8</U>, (v)&nbsp;the rights of Indemnified Persons under
<U>Article</U><U></U><U>&nbsp;IX</U> and (vi)&nbsp;as otherwise expressly provided herein, is not intended to and shall not confer upon any Person other than the Parties any rights or remedies hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;11.8 </U></B><B><U>Governing Law; Jurisdiction</U></B>. (a)&nbsp;This Agreement shall be
governed by, and construed in accordance with, the Laws of the State of Delaware, without giving effect to any choice or conflict of laws provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the application
of the Laws of any jurisdiction other than the State of Delaware. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">71 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Other than in connection with any post-Closing adjustments to the Closing Aggregate
Consideration (which shall be addressed in accordance with the applicable procedures set forth in <U>Article</U><U></U><U>&nbsp;II</U>), each Party hereto agrees that (i)&nbsp;all actions and proceedings arising out of or relating to this Agreement
shall be heard and determined exclusively in the Court of Chancery of the State of Delaware (the &#147;<U>Chancery Court</U>&#148;) and any state appellate court therefrom sitting in New Castle County in the State of Delaware (or, if, but only if,
the Chancery Court lacks subject matter jurisdiction over a particular matter, any other state or federal court within the State of Delaware), (ii)&nbsp;it shall not attempt to deny or defeat such personal jurisdiction by motion or other request for
leave from any such court and (iii)&nbsp;a final judgment in any action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Each Party hereby agrees that service of any process, summons, notice or document by U.S. registered mail to the respective addresses set
forth in <U>Section</U><U></U><U>&nbsp;11.11</U> shall be effective service of process for any suit or proceeding in connection with this Agreement or any of the Transactions. However, the foregoing shall not limit the right of a Party to effect
service of process on the other Party by any other legally available method. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;11.9
</U></B><B><U>Specific Enforcement</U></B>. The Parties agree that immediate, extensive and irreparable damage would occur for which monetary damages would not be an adequate remedy in the event that any of the provisions of this Agreement are not
performed in accordance with their specific terms or are otherwise breached. Accordingly, the Parties agree that, if for any reason Purchaser or Seller shall have failed to perform its obligations under this Agreement or otherwise breached this
Agreement, then the Party seeking to enforce this Agreement against such nonperforming Party under this Agreement shall be entitled to specific performance and the issuance of immediate injunctive and other equitable relief without the necessity of
proving the inadequacy of money damages as a remedy, and the Parties further agree to waive any requirement for the securing or posting of any bond in connection with the obtaining of any such injunctive or other equitable relief, this being in
addition to and not in limitation of any other remedy to which they are entitled at law or in equity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;11.10 </U></B><B><U>WAIVER OF JURY TRIAL</U></B>. EACH OF THE PARTIES HERETO IRREVOCABLY WAIVES
ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING BETWEEN THE PARTIES HERETO ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;11.11 </U></B><B><U>Notices</U></B>. All notices, requests, claims, demands and other
communications to be given or delivered under or by reason of the provisions of this Agreement shall be in writing and shall be deemed to have been given (a)&nbsp;when personally delivered, (b)&nbsp;when transmitted via email to the email address
set forth below (to the extent that no &#147;bounce back&#148; or similar message indicating <FONT STYLE="white-space:nowrap">non-delivery</FONT> is received with respect thereto) or (c)&nbsp;upon confirmed delivery if being sent by registered mail
or by courier or express delivery service, in each case to the Parties at the applicable address set forth below, or such other address or email address as such Party may hereafter specify by like notice to the other Party: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">72 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">If to Purchaser, to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Illumina, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">5200 Illumina Way </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">San Diego, CA 92122 </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="13%" VALIGN="top" ALIGN="left">Attention:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Chief Legal Officer </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="13%" VALIGN="top" ALIGN="left">Email:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">with a copy (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cravath, Swaine&nbsp;&amp; Moore LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Two Manhattan West </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">375 Ninth Avenue </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">New York, New York 10001 </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="13%" VALIGN="top" ALIGN="left">Attention:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Ting Chen </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="13%" VALIGN="top" ALIGN="left">&#8201;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Daniel Cerqueira </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="13%" VALIGN="top" ALIGN="left">Email:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">tchen@cravath.com </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="13%" VALIGN="top" ALIGN="left">&#8201;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">dcerqueira@cravath.com </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">If to Seller, to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Standard BioTools Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">2 Tower Place, Suite 2000 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">South San Francisco, CA 94080 </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="13%" VALIGN="top" ALIGN="left">Attention:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Michael Egholm, Ph.D. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="13%" VALIGN="top" ALIGN="left">Email:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">with a copy (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Freshfields US LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">3 World Trade Center </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">175 Greenwich Street </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">New York, New York 10007 </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="13%" VALIGN="top" ALIGN="left">Attention:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Damien Zoubek </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="13%" VALIGN="top" ALIGN="left">&#8201;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Jenny Hochenberg </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="13%" VALIGN="top" ALIGN="left">Email:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">damien.zoubek@freshfields.com </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="13%" VALIGN="top" ALIGN="left">&#8201;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">jenny.hochenberg@freshfields.com </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;11.12 </U></B><B><U>Severability</U></B>. If any term or other provision of this Agreement is
determined by a court of competent jurisdiction to be invalid, illegal or incapable of being enforced by any rule of Law or public policy, all other terms, provisions and conditions of this Agreement shall nevertheless remain in full force and
effect. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the Parties shall negotiate in good faith to modify this Agreement so as to effect the original intent of the Parties as closely as
possible to the fullest extent permitted by applicable Law in an acceptable manner to the end that the Transactions are fulfilled to the extent possible. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">73 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;11.13 </U></B><B><U>Definitions</U></B>. As
used in this Agreement, the following terms shall have the meanings ascribed to them below: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Accessing Party</U>&#148; shall have
the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.7</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Accounting Principles</U>&#148; means the accounting methods,
policies, practices, procedures, classifications, conventions, categorizations, principles, judgments, assumptions, techniques and estimation methodologies with respect to financial statements, their classification or presentation or otherwise
(including with respect to the nature of accounts, level of reserves or level of accruals) set forth on <U>Schedule</U><U></U><U>&nbsp;1</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Acquired Business</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.15(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Acquired Competing Business</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.15(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Acquisition Proposal</U>&#148; means any offer or proposal for, or indication of interest in, a merger, consolidation, stock
exchange, business combination, reorganization, recapitalization, liquidation, dissolution or other similar transaction involving the Business or any Group Company, any acquisition of a material portion of the assets of the Business or the Group
Companies, taken as a whole, or capital stock of or other equity interests in any Group Company, other than the Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Affiliate</U>&#148; means, as to any Person, any other Person that, directly or indirectly, controls, or is controlled by, or is
under common control with, such Person. For this purpose, &#147;<U>control</U>&#148; (including, with its correlative meanings, &#147;<U>controlled by</U>&#148; and &#147;<U>under common control with</U>&#148;) means the possession, directly or
indirectly, of the power to direct or cause the direction of management or policies of a Person, whether through the ownership of securities or partnership or other ownership interests, by contract or otherwise. For purposes of this Agreement, each
Group Company shall be considered (i)&nbsp;an Affiliate of Seller (and not of Purchaser) prior to the Closing and (ii)&nbsp;an Affiliate of Purchaser (and not of Seller) after the Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Aggregate Purchaser Retention Amount</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.11</U> of the
Disclosure Letter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Aggregate Seller Retention Amount</U>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;6.11</U> of the Disclosure Letter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Agreement</U>&#148; shall have the meaning set forth in the
preamble. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Allocation</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;10.4(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Ancillary Agreements</U>&#148; means (i)&nbsp;the Royalty Agreement, (ii)&nbsp;the Transition Services Agreement, (iii)&nbsp;the
License Agreement, (iv)&nbsp;the Single SOMAmer Royalty Agreement and (v)&nbsp;such other agreements, documents, certificates and instruments executed and delivered in connection with this Agreement or the Transactions as Seller and Purchaser may
mutually agree. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">74 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Anticorruption Laws</U>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;4.7(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Anti-Money Laundering Laws</U>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;4.7(c)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Assumed Plan</U>&#148; means any Company Plan or any portion thereof that (i)&nbsp;is
contributed to (or required to be contributed to), maintained or sponsored by any of the Group Companies immediately prior to the Closing or (ii)&nbsp;has assets or liabilities Purchaser has explicitly agreed to assume pursuant to this Agreement or
that transfer to Purchaser or its Affiliates under applicable Law as a result of the Transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Bankruptcy and Equity
Exception</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;3.2(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Base Consideration</U>&#148;
means $350,000,000. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Binder Agreement</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.18(a)</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Business</U>&#148; shall have the meaning set forth in the recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Business Consultant Schedule</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;4.9(u)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Business Day</U>&#148; means any day that is not a Saturday, a Sunday or other day on which commercial banks in New York, New York
are required or authorized by Law to be closed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Business Employee</U>&#148; means each employee of Seller and its Affiliates
(i)&nbsp;who became an employee of Seller and its Affiliates at the time of, and as a result of, the consummation of any Prior Transaction, excluding those set forth on <U>Section</U><U></U><U>&nbsp;11.13(a)</U> of the Disclosure Letter (each such
employee, an &#147;<U>Excluded Group Company Employee</U>&#148;), (ii) whose employment will transfer to Purchaser or one of its Affiliates on the Closing Date by operation of applicable Law or (iii)&nbsp;who was hired by Seller and its Affiliates,
or had his or her duties altered by Seller and its Affiliates, following the consummation of any Prior Transaction for the primary purpose of providing services to the Business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Business Employee Schedule</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;4.9(t)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Business Financial Statements</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;4.3(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Business Permits</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;4.6(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Business Products</U>&#148; means all products and services currently marketed for sale or sold in connection with the Business, all
products and services under development for sale in connection with the Business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Cash</U>&#148; means (a)&nbsp;unrestricted
cash and cash equivalents, net of uncleared checks, drafts, wires or other payments outstanding and (b)&nbsp;cash deposited with third parties to secure real property leases, surety bonds, performance bonds, letters of credit or similar obligations
(except to the extent such obligations are drawn). Cash shall be prepared and calculated in accordance with the Accounting Principles. For the avoidance of doubt, Cash (i)&nbsp;shall be calculated without duplication, (ii)&nbsp;including any
components thereof, may be a negative number and (iii)&nbsp;shall not include any amounts included in the calculation of the Net Working Capital Amount. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">75 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Cash Amount</U>&#148; means, with respect to the Group Companies, as of the
Reference Time, all Cash of the Group Companies on a consolidated basis at such time (but giving effect to any subsequent Cash dividends or distributions and uses of Cash to pay Indebtedness of the Group Companies or Transaction Expenses, in each
case subsequent to the Reference Time and prior to the Closing). Cash Amount shall be prepared and calculated in accordance with the Accounting Principles. For the avoidance of doubt, Cash Amount (i)&nbsp;shall be calculated without duplication,
(ii)&nbsp;including any components thereof, may be a negative number and (iii)&nbsp;shall not include any amounts included in the calculation of the Net Working Capital Amount. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Chancery Court</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;11.8(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Change in Control Payments</U>&#148; means the aggregate amount of all &#147;single-trigger&#148; sale, change of control,
transaction, retention, termination, severance or other similar bonuses or payments that are payable by any Group Company to any Person solely as a result of the Transactions (including the Aggregate Seller Retention Amount, but excluding the
Aggregate Purchaser Retention Amount), together with any employer-paid portion of any employment and payroll Taxes (including social security or similar contributions) related thereto, in each case, that remain unpaid as of immediately prior to the
Closing, excluding, for the avoidance of doubt, any &#147;double-trigger&#148; payments arising in combination with any other event or as a result of any further action by or on behalf of Purchaser or its Affiliates (including the Group Companies)
on or following the Closing; <I>provided</I> that Change in Control Payments shall not be deemed to include any amounts which are required to be paid by (or are actually paid by) or which are the contractual or legal responsibility of any member of
the Seller Group. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Claim Notice</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;9.3(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Clayton Act</U>&#148; means the Clayton Act of 1914, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Clean Team Agreement</U>&#148; means that certain Clean Team Agreement, dated as of May&nbsp;23, 2025, by and between Purchaser and
Seller. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;1.2</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing Aggregate Consideration</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.1(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing Date</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;1.2</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Code</U>&#148; means the Internal Revenue Code of 1986, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Collaboration Agreement</U>&#148; means that certain Collaboration Agreement, dated as of December&nbsp;31, 2021, by and among the
Company, Illumina Cambridge, Ltd. and Purchaser, as amended by that certain First Amendment to Collaboration Agreement, dated as of November&nbsp;14, 2022, by and among the Company, Illumina Cambridge, Ltd. and Purchaser, that certain Second
Amendment to Collaboration Agreement, dated as of June&nbsp;15, 2023, by and among the Company, Illumina Cambridge, Ltd. and Purchaser, that certain Amendment No.&nbsp;3 to Collaboration Agreement, dated as of September&nbsp;21, 2023, by and among
the Company, Illumina Cambridge, Ltd. and Purchaser, and that certain Fourth Amendment to Collaboration Agreement, dated as of June 22, 2025, by and among the Company, Illumina Cambridge, Ltd. and Purchaser. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">76 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company</U>&#148; shall have the meaning set forth in the recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company 401(k)</U><U></U><U>&nbsp;Plan</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.10(d)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Associate</U>&#148; means any current or former officer, employee, individual independent contractor, individual consultant
or director of or to any Group Company, and any other current or former Business Employee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company <FONT
STYLE="white-space:nowrap">In-Licensed</FONT> IP</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;4.11(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company IP</U>&#148; means all Intellectual Property used in or necessary for the conduct of the Business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company IT System</U>&#148; means all IT Systems used in or necessary for the conduct of the Business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Leased Real Property</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;4.14(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Material Customers</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;4.13(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Material Suppliers</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;4.13(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Owned IP</U>&#148; means all Intellectual Property owned or purported to be owned by, or exclusively licensed to, any Group
Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Plans</U>&#148; means each &#147;employee benefit plan&#148; (as such term is defined in Section&nbsp;3(3) of
ERISA), whether or not subject to ERISA, and each other employee benefit or compensation plan, program, policy, agreement or arrangement, including equity or equity-based plan, bonus or incentive compensation arrangement, retirement or deferred
compensation plan, profit sharing plan, severance compensation plan or employment, retention or change in control agreement, for the benefit of one or more current or former Business Employees or any of their respective dependents or any current or
former individual consultant or individual independent contractor providing services to any Group Company, that Seller or any of its Subsidiaries or ERISA Affiliates sponsors, maintains or contributes to (or is required to contribute to), or with
respect to which Seller or any of its Subsidiaries or ERISA Affiliates has any liability. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Real Estate Lease</U>&#148;
shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;4.14(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Registered IP</U>&#148; means all
(i)&nbsp;Company Owned IP that is the subject of an application, certificate, filing, registration or other document issued by, filed with or recorded by any Governmental Authority in any jurisdiction and (ii)&nbsp;Internet domain names, URLs,
social media handles, identifiers and accounts and other names and locators associated with Internet addresses and sites, and applications and registrations therefor included in the Company Owned IP. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">77 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Sensitive Data</U>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;4.12(f)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Subsidiary</U>&#148; means a Subsidiary of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Competing Business</U>&#148; means any affinity-based proteomics business greater than 100 plex or with aptamers of any plexity, in
each case other than a Seller Existing Business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Confidentiality Agreement</U>&#148; means that certain Confidentiality
Agreement, dated January&nbsp;10, 2025, by and between Purchaser and Seller. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Consolidated Income Taxes</U>&#148; means any and
all federal, state, local or foreign Income Taxes that are paid on an affiliated, consolidated, combined, unitary or similar basis with respect to Tax Returns that include any Group Company, on the one hand, and Seller or any of its Affiliates
(other than the Group Companies), on the other hand. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Consolidated Tax Returns</U>&#148; means any Tax Return with respect to
Consolidated Income Taxes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Continuing Employee</U>&#148; means each Business Employee who (i)&nbsp;is employed by any Group
Company as of immediately prior to the Closing and continues in employment with Purchaser (or an applicable Affiliate, including any Group Company) following the Closing or (ii)&nbsp;is an Offer Employee who accepts an offer of employment from
Purchaser (or an applicable Affiliate, including any Group Company) and commences employment with Purchaser or its Affiliates (including any Group Company) upon Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Contract</U>&#148; means any loan or credit agreement, debenture, note, bond, mortgage, indenture, deed of trust, lease, sublease,
license, sublicense, contract or other legally binding agreement, whether written or oral. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>D&amp;O Claim</U>&#148; shall have
the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.8(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>D&amp;O Indemnitee</U>&#148; shall have the meaning set forth
in <U>Section</U><U></U><U>&nbsp;6.8(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>D&amp;O Insurance</U>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;6.8(c)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Damage Estimate</U>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;9.3(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Damages</U>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;9.2(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Data Protection Regulations</U>&#148; mean all Laws, regulations, legally binding
rules or standards issued by Governmental Authorities and any legally binding industry standards and guidelines, in each case, relating to the privacy, protection, security or Processing of Personal Data. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Data Room</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;11.14</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>DGCL</U>&#148; means the Delaware General Corporation Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Disclosure Letter</U>&#148; shall have the meaning set forth in the preamble to <U>Article</U><U></U><U>&nbsp;III</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">78 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Disqualified Individual</U>&#148; means any Business Employee who is a
&#147;disqualified individual&#148; (as defined in Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.280G-1)</FONT> with respect to Seller. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>DOL</U>&#148; means the U.S. Department of Labor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Draft Allocation</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;10.4(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Environmental Laws</U>&#148; means all applicable Laws relating to pollution or to the protection of the environment, natural
resources, human health and safety (as it relates to exposure to hazardous or toxic materials) or endangered or threatened species or biota, including Laws relating to exposure to, or Releases or threatened Releases of, Hazardous Materials and
including Laws relating to environmental reporting and disclosure, such as the Emergency Planning and Community Right to Know Act, 42 U.S.C. 11001 et seq. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>ERISA</U>&#148; means the Employee Retirement Income Security Act of 1974, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>ERISA Affiliate</U>&#148; means any trade or business, whether or not incorporated, that is under common control with Seller or any
Group Company within the meaning of Section&nbsp;414(b) or (c)&nbsp;of the Code, and solely with respect to Section&nbsp;412 of the Code or 302 of ERISA, under Section&nbsp;414(m) or (o)&nbsp;of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Estimated Cash Amount</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.1(a)(i)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Estimated Indebtedness Amount</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.1(a)(i)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Estimated Net Working Capital Amount</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.1(a)(i)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Estimated Transaction Expenses</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.1(a)(i)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Exchange Act</U>&#148; means the U.S. Securities Exchange Act of 1934, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Excluded Employee Liabilities</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.10(l)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Excluded Group Company Employee</U>&#148; shall have the meaning set forth in the definition of Business Employee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Export Control Laws</U>&#148; means the applicable Laws or Orders regulating the export, reexport, import, transit, transfer and
brokering of any goods, services, Software or technology, including the International Traffic in Arms Regulations (22 C.F.R. 120 et seq.), the Export Administration Regulations (15 C.F.R. 730 et seq.), the U.K. Export Control Act 2002 and the U.K.
Export Control Order 2008, E.U. Council Regulation&nbsp;(EC) No 428/2009, and all other applicable Laws or Orders relating to export controls and import controls. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>FDA</U>&#148; means the U.S. Food and Drug Administration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>FDCA</U>&#148; means the Federal Food, Drug, and Cosmetic Act, as amended. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">79 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Federal Trade Commission Act</U>&#148; means the Federal Trade Commission Act of
1914, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Final Allocation</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;10.4(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Final Closing Aggregate Consideration</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.1(d)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Final Closing Consideration Resolution Period</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.2(b)</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>First Extended Outside Date</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;8.1(b)(i)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Fraud</U>&#148; means intentional fraud committed by a Party in the making of a representation or warranty by such Party expressly
set forth in this Agreement, any certificate delivered pursuant to this Agreement or any Ancillary Agreement; <I>provided</I> that such intentional fraud shall only be deemed to exist if at the time the representation or warranty was made
(a)&nbsp;such Party had actual knowledge of the inaccuracy of such representation or warranty, (b)&nbsp;such Party intended to induce the Party to whom the representation was made to act or refrain from acting in reliance upon it and (c)&nbsp;the
other Party acted in reliance on such inaccurate representation or warranty and suffered damages as a result of such reliance; <I>provided</I>, <I>further</I>, that &#147;Fraud&#148; shall not include any claim for equitable fraud, promissory fraud,
unfair dealings fraud or any torts (including a claim for fraud) based on negligence or recklessness. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>GAAP</U>&#148; means
generally accepted accounting principles in the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>GDPR</U>&#148; means Regulation&nbsp;2016/679 of the European
Parliament and of the Council on the protection of natural persons with regard to the processing of personal data and on the free movement of such data (General Data Protection Regulation). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Governmental Authority</U>&#148; means any federal, state or local, domestic, foreign or multinational government, court, regulatory,
Tax or administrative agency, commission, authority or other governmental instrumentality. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Governmental Authorization</U>&#148;
means (i)&nbsp;any&nbsp;permit, license, certificate, franchise, permission, variance, exception, exemption, approval, order, clearance, registration, qualification, accreditation, or authorization issued, granted, given or otherwise made available
by or under the authority of any Governmental Authority or pursuant to any Law or (ii)&nbsp;any right under any Contract with any Governmental Authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Granting Party</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.7</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Group Companies</U>&#148; shall have the meaning set forth in the recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Group Company Charter Documents</U>&#148; means the charter or organizational or similar documents of each Group Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">80 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Harmful Code</U>&#148; means any &#147;Trojan horse&#148;, &#147;worm&#148;,
&#147;virus&#148;, &#147;back door&#148;, &#147;drop dead device&#148;, &#147;time bomb&#148;, &#147;malware&#148;, &#147;vulnerability&#148;, &#147;spyware&#148; or &#147;adware&#148; (as such terms are commonly understood in the software industry)
or any other code designed or intended to have any of the following functions: (i)&nbsp;disrupting, disabling, harming or otherwise impeding in any manner the operation of, or providing unauthorized access to, an IT System on which such code is
stored or installed; or (ii)&nbsp;compromising the privacy, protection, security or Processing of any data or damaging or destroying any data or file without consent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Hazardous Materials</U>&#148; means (a)&nbsp;any substance, material or waste that is listed, defined or otherwise characterized as
&#147;hazardous&#148;, &#147;toxic&#148;, &#147;radioactive&#148;, a &#147;biohazard&#148;, a &#147;pollutant&#148;, a &#147;contaminant&#148; or terms of similar meaning or effect under any Environmental Law and (b)&nbsp;any petroleum or its <FONT
STYLE="white-space:nowrap">by-products,</FONT> asbestos, polychlorinated biphenyls, chlorofluorocarbons, hydrofluorocarbons or other <FONT STYLE="white-space:nowrap">ozone-depleting</FONT> substances, perchlorate and
<FONT STYLE="white-space:nowrap">per-and</FONT> polyfluoroalkyl substances. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Health Care Laws</U>&#148; means Laws, rules,
policies, guidelines and regulations applicable to the Business, its products or its services, including (i)&nbsp;Title XVIII of the Social Security Act, 42 U.S.C. &#167;&#167;&nbsp;1395 et seq. (the Medicare statute), (ii)&nbsp;Title XIX of the
Social Security Act, 42 U.S.C. &#167;&#167;&nbsp;1396 et seq (the Medicaid statute), (iii)&nbsp;the Anti-Kickback Statute, 42 U.S.C. <FONT STYLE="white-space:nowrap">&#167;&nbsp;1320a-7b(b),</FONT> (iv)&nbsp;the civil False Claims Act, 31 U.S.C.
&#167;&#167;&nbsp;3729 et seq., (v)&nbsp;the criminal False Claims Act, 18 U.S.C. &#167;&#167;&nbsp;286 and 287, (vi)&nbsp;any criminal Laws relating to health care fraud and abuse, including 42 U.S.C.
<FONT STYLE="white-space:nowrap">&#167;&nbsp;1320a-7b(a)</FONT> and the health care fraud criminal provisions under HIPAA (as defined herein), (vii)&nbsp;the Civil Monetary Penalties Law, 42 U.S.C.
<FONT STYLE="white-space:nowrap">&#167;&nbsp;1320a-7a,</FONT> (viii)&nbsp;the Physician Payments Sunshine Act, 42&nbsp;U.S.C. <FONT STYLE="white-space:nowrap">&#167;&nbsp;1320a-7h,</FONT> (ix)&nbsp;the exclusion law, 42 U.S.C. <FONT
STYLE="white-space:nowrap">&#167;&nbsp;1320a-7,</FONT> (x)&nbsp;the Health Information Portability and Accountability Act, as amended by the Health Information Technology for Economic and Clinical Health Act, 42 U.S.C. &#167;&#167;&nbsp;17921 et
seq., including all implementing regulations (collectively, &#147;<U>HIPAA</U>&#148;), (xi)&nbsp;the FDCA, (xii)&nbsp;the Public Health Service Act, 42 U.S.C. &#167;&#167;&nbsp;201 et seq., (xiii)&nbsp;Clinical Laboratory Improvement Amendments of
1988, 42 U.S.C. &#167;&#167;&nbsp;263a et seq., (xiv)&nbsp;the regulations promulgated pursuant to such laws and (xv)&nbsp;any similar Laws applicable to the ownership, testing, development, manufacture, packaging, processing, use, distribution,
marketing, storage, import, export or disposal of any of the products or services of the Business, in each case as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>HSR
Act</U>&#148; means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Inactive Business Employee</U>&#148;
shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.10(h)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Income Taxes</U>&#148; means all Taxes based on,
measured by, or calculated with respect to net income or profits (or branch profits) or other measures similar to net income or profits (or branch profits). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Indebtedness</U>&#148; means, without duplication, (i)&nbsp;any indebtedness for borrowed money (including the issuance of any debt
security), (ii)&nbsp;any indebtedness evidenced by any note, bond, debenture or other debt security, (iii)&nbsp;any obligations for the deferred purchase price of properties or services with respect to which a Person is liable, contingently or
otherwise, as obligor or otherwise, including [***] (other than trade payables and other current liabilities incurred in the ordinary course of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">81 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
business) and any obligations of a Person under any conditional sale or other title retention agreements, (iv)&nbsp;any finance or capital lease obligations classified as such in the Business
Financial Statements or which should be classified as such in accordance with the Accounting Principles, (v)&nbsp;any underfunded deferred compensation obligations, unfunded pension or other post-retirement or post-termination benefit liabilities,
severance pay and separation benefits relating to terminations prior to the Closing that have not yet been fully paid as of immediately prior to the Closing and, in each case, any employer-paid portion of any employment and payroll Taxes with
respect to any of the foregoing, (vi)&nbsp;any net payment obligations under any interest rate or currency swaps, caps or other derivatives or hedging arrangements, to the extent payable if terminated, (vii)&nbsp;any obligations requiring the
reimbursement of any obligor on any letter of credit, banker&#146;s acceptance or similar instrument, in each case that has been drawn or claimed against (and not reimbursed), (viii)&nbsp;any guarantees by such Person of the obligations of any other
Person of the type referred to in <U>subclauses (i)</U>&nbsp;through <U>(vii)</U> above and any obligations of any other Person of the type referred to in <U>clauses</U><U></U><U>&nbsp;(i)</U> through <U>(vii)</U>&nbsp;above secured by any Lien on
any property or assets owned by such Person, whether or not such obligations secured by such Lien have been assumed by such Person, (ix)&nbsp;the <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Tax Amount and (x)&nbsp;all accrued interest and
prepayment premiums or penalties and breakage costs related to any of the foregoing to the extent triggered by the consummation of the Transactions; provided that the definition of &#147;Indebtedness&#148; shall not include any deferred revenue.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Indebtedness Amount</U>&#148; means, without duplication, the Indebtedness of the Group Companies on a consolidated basis as of
immediately prior to the Closing; <I>provided</I> that, without limiting other liabilities that are not to be included therein, in no event shall the following be considered Indebtedness of the Group Companies: (i)&nbsp;any Indebtedness incurred or
arranged by Purchaser or its Affiliates (and subsequently assumed or guaranteed by any Group Company) on or after the Closing Date, (ii)&nbsp;any intercompany balances between the Group Companies, (iii)&nbsp;[***] (iv)&nbsp;any Transaction Expenses
or any amounts included in the Net Working Capital Amount or (v)&nbsp;any payments or obligations which are required to be paid by (or are actually paid by) or which are the contractual or legal responsibility of any member of the Seller Group.
Indebtedness Amount shall be prepared and calculated in accordance with the Accounting Principles; <I>provided </I>that, to the extent there is any conflict between the Accounting Principles and the definition of &#147;Indebtedness&#148; herein, the
definition of &#147;Indebtedness&#148; shall control. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Indemnified Person</U>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;9.3(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Indemnifying Person</U>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;9.3(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Industry Body</U>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;4.11(i)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Initial Outside Date</U>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;8.1(b)(i)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Insurance Policies</U>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;4.16</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Insurer</U>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;6.18(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Intellectual Property</U>&#148; means all intellectual property or other similar
proprietary rights arising under the Laws of any and all jurisdictions throughout the world, including all such rights in and to any (i)&nbsp;(a)&nbsp;patents and patent applications (provisional and
<FONT STYLE="white-space:nowrap">non-provisional),</FONT> including PCT applications, (b)&nbsp;divisionals, continuations, continuations <FONT STYLE="white-space:nowrap">in-part</FONT> thereof or any other patent
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">82 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
application claiming priority, or entitled to claim priority, directly or indirectly to (A)&nbsp;any such patents or patent applications or (B)&nbsp;any patent or patent application from which
such patents or patent applications claim, or are entitled to claim, direct or indirect priority, (c)&nbsp;patents issuing on any of the foregoing (including from PCT applications), together with all registrations, reissues, <FONT
STYLE="white-space:nowrap">re-examinations,</FONT> patents of addition, utility models or designs, renewals, substitutions, revisions, provisionals, supplemental protection certificates, inventors&#146; certificates and disclosures and extensions of
any of the foregoing and counterparts thereof and (d)&nbsp;other indicia of ownership of an invention recognized or issued by or filed with any Governmental Authority, (ii)&nbsp;inventions, discoveries, Trade Secrets and other <FONT
STYLE="white-space:nowrap">know-how,</FONT> in all cases, whether or not patented or patentable, in written, electronic or any other form now known or hereafter developed, including articles of manufacture, business methods, compositions of matter
machines, methods and processes and new uses for any of the preceding items, (iii)&nbsp;trademarks, service marks, trade dress, trade names, logos, slogans, words, names, symbols, designs, corporate names, doing business designations and other
indicia of origin, and all registrations, applications for registration and renewals of the foregoing, and all goodwill associated with the foregoing, (iv)&nbsp;Internet domain names, URLs, social media handles, identifiers and accounts and other
names and locators associated with Internet addresses and sites, and applications and registrations therefor, (v)&nbsp;published and unpublished works of authorship, including audiovisual works and collective works (whether or not copyrightable),
and copyrights or copyrightable works, including works for hire, rights of authorship, use, publication, reproduction, distribution, performance, transformation, moral rights and rights of ownership of copyrightable works, registrations,
applications for registration and renewals of any of the foregoing and all rights to register and obtain renewals, extensions, restorations, reversions, derivatives, translations, localizations, adaptations and combinations of registrations,
together with all other interests accruing by reason of copyright Law, including copyrights in Software, mask works and databases, together with all common law rights and moral rights therein, (vi)&nbsp;Software, (vii)&nbsp;improvements,
derivatives, modifications, enhancements, revisions and releases relating to any of the foregoing and (viii)&nbsp;instantiations of any of the foregoing in any form and embodied in any media. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Invoices</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.2</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>IRS</U>&#148; means the U.S. Internal Revenue Service. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>IT System</U>&#148; means (i)&nbsp;computers, Software, hardware, firmware, middleware, servers, networks, workstations, routers,
hubs, switches, data communications lines, data storage devices, data centers, operating systems and all other information technology and related assets and equipment and (ii)&nbsp;business systems Software or applications (including CRM, ERP, HR,
IT support and accounting systems), in the case of each of <U>clauses</U><U></U><U>&nbsp;(i)</U>&nbsp;and <U>(ii)</U>, whether used in a defined location or as a cloud-based service or otherwise, and all documentation, including user documentation,
manuals and training materials, relating to any of the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Key Business Employee Retention Program</U>&#148; shall have
the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.11</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">83 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Knowledge</U>&#148; means (i)&nbsp;with respect to Seller and any matter in
question, the actual knowledge of such matter that the individuals set forth on <U>Section</U><U></U><U>&nbsp;11.13(c)</U> of the Disclosure Letter under the caption &#147;Knowledge of Seller&#148; have after reasonable inquiry of the individuals
who as of the date hereof are officers or employees of Seller and its Subsidiaries (including the Group Companies) and who have primary responsibility for the matter in question and (ii)&nbsp;with respect to Purchaser and any matter in question, the
actual knowledge of such matter that the individuals set forth on <U>Section</U><U></U><U>&nbsp;11.13(c)</U> of the Disclosure Letter under the caption &#147;Knowledge of Purchaser&#148; have after reasonable inquiry of the individuals who as of the
date hereof are officers or employees of Purchaser and its Subsidiaries and who have primary responsibility for the matter in question. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Latest Business Balance Sheet</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;4.3(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Laws</U>&#148; means any foreign, federal, state or local law (statutory, common or otherwise), constitution, treaty, convention,
statute, ordinance, code, rule, regulation, or other similar requirement enacted, adopted, promulgated or applied by a Governmental Authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Legal Proceeding</U>&#148; means any action, suit, litigation, arbitration or similar proceeding (including any civil, criminal,
administrative or appellate proceeding) commenced, brought, conducted or heard by or before any court or other Governmental Authority or any arbitrator or arbitration panel. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>License Agreement</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.19</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Liens</U>&#148; means any pledge, hypothecation, lien, charge, license, encumbrance, deed of trust, deed to secure debt, mortgage,
easement, right of way, encroachment, conditional sale agreement or other title retention agreement, option, right of first refusal or offer and security interest of any kind or nature whatsoever in or on any asset, property or property interest.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Material Adverse Effect</U>&#148; means any change, effect, event, occurrence, state of facts or development that, alone or in
combination, is or would reasonably be expected to be materially adverse to the business, condition (financial or otherwise) or results of operations of the Group Companies, taken as a whole, or the Business; <I>provided</I>, <I>however</I>, that
none of the following shall be taken into account in determining whether there has been or is, or would reasonably be expected to be, a Material Adverse Effect: any change, effect, event, occurrence, state of facts or development to the extent
attributable to (i)&nbsp;the negotiation, execution, announcement or performance of this Agreement or the pendency or the consummation of the Transactions, including any employee attrition and any impact on revenues or relationships with suppliers,
customers or any other Persons having business dealings with the Group Companies or the Business to the extent resulting therefrom, or any Legal Proceeding arising out of this Agreement or the Transactions; (ii)&nbsp;conditions affecting the
industry in which the Group Companies and the Business operate, general political or social conditions, the economy as a whole or the financial and capital markets in general (including currency fluctuations and interest rates) or the markets in
which the Group Companies and the Business operate; (iii)&nbsp;the existence, issuance or enforcement of any executive orders by the President of the United States relating to trade regulation (including those generally imposing &#147;most favored
nation&#148; pricing requirements or other pricing restrictions), tariffs, trade policies, trade restrictions or trade wars; (iv)&nbsp;any action by Seller or the Group Companies that is expressly required by this Agreement, or any failure to take
any action that Seller or the Group Companies are expressly not permitted to take under this Agreement (in each case, other than pursuant to <U>Section</U><U></U><U>&nbsp;6.1(a)</U>); (v)&nbsp;any action or failure to take any action at the written
request of Purchaser; (vi)&nbsp;the identity of, or any facts or circumstances </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">84 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
relating to, Purchaser or any of its Affiliates; (vii)&nbsp;any change in, or proposed or potential change in, applicable Laws or the interpretation thereof; (viii)&nbsp;any change in GAAP or
other accounting requirements or principles or the interpretation thereof; (ix)&nbsp;the failure of the Business to meet or achieve the results set forth in any projection or forecast (<I>provided</I> that this <U>clause</U><U></U><U>&nbsp;(ix)</U>
shall not prevent a determination that any change or effect underlying such failure to meet projections or forecasts has resulted in a Material Adverse Effect (to the extent such change or effect is not otherwise excluded from this definition of
Material Adverse Effect)); (x)&nbsp;the commencement, continuation or escalation of a war (whether or not declared), armed hostilities, military activity, sabotage, civil disobedience or terrorism, or any escalation of any such war (whether or not
declared), armed hostilities, military activity, sabotage, civil disobedience or terrorism; (xi)&nbsp;tsunamis, earthquakes, floods, hurricanes, tornados or other natural disasters, weather-related events, force majeure events or other comparable
events, (xii)&nbsp;epidemics, pandemics or other disease outbreaks or Laws or directives issued by a Governmental Authority in response thereto; or (xiii)&nbsp;any actual or potential sequester, stoppage, shutdown, default or similar event or
occurrence by or involving any Governmental Authority; <I>provided</I>, <I>further</I> that, in the case of <U>clauses</U><U></U><U>&nbsp;(ii)</U>, <U>(iii)</U>, <U>(vii)</U>, <U>(viii)</U>, <U>(x)</U>, <U>(xi)</U>, <U>(xii)</U>&nbsp;and
<U>(xiii)</U>&nbsp;above, if such change, effect, event, occurrence, state of facts or development disproportionately affects the Group Companies or the Business as compared to other Persons or businesses that operate in the industry in which the
Group Companies and the Business operates, then the disproportionate effect of such change, effect, event, occurrence, state of facts or development shall be taken into account in determining whether a Material Adverse Effect has occurred or would
be reasonably be expected to occur. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Material Contracts</U>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;4.15(c)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Maximum Amount</U>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;6.8(d)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>NASDAQ</U>&#148; means the National Association of Securities Dealers Automatic
Quotation System. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Net Working Capital Amount</U>&#148; means (i)&nbsp;current assets (including current <FONT
STYLE="white-space:nowrap">non-income</FONT> Tax assets and excluding current assets constituting Cash and deferred tax assets) of the Group Companies as of the Reference Time (which shall only include the line items set forth on
<U>Section</U><U></U><U>&nbsp;11.13(d)</U> of the Disclosure Letter under the heading &#147;Current Assets&#148;, [* * *] and no other assets), <U>minus</U> (ii)&nbsp;current liabilities of the Group Companies as of the Reference Time (which shall
only include the line items set forth on <U>Section</U><U></U><U>&nbsp;11.13(d)</U> of the Disclosure Letter under the heading &#147;Current Liabilities&#148;, and no other liabilities); <I>provided</I> (A) current assets shall be deemed to include
non-current or long term inventory for purposes of the calculation of the Net Working Capital Amount and (B) that, without limiting other liabilities that are not to be included therein, in no event shall the following be considered current
liabilities of the Group Companies for purposes of the calculation of the Net Working Capital Amount: (i)&nbsp;any deferred revenue that represents an upfront payment from Purchaser or any of its Affiliates in respect of the Collaboration Agreement,
(ii)&nbsp;any income or deferred tax liabilities, (iii)&nbsp;any obligations in respect of uncleared checks outstanding, (iv)&nbsp;any liabilities incurred or arranged by Purchaser or its Affiliates (and subsequently assumed or guaranteed by any
Group Company) on or after the Closing Date, (v)&nbsp;any intercompany liabilities between two or more Group Companies, (vi) [* * *]), (vii) any Transaction Expenses or any liabilities constituting Indebtedness or (viii)&nbsp;any payments or
obligations which are required to be paid by (or are actually paid by) or which are the contractual or legal responsibility of any member of the Seller Group. <U>Section</U><U></U><U>&nbsp;11.13(d)</U> of the Disclosure Letter sets forth an
illustrative example of the calculation of the Net Working Capital Amount as of the date of the Latest Business Balance Sheet for reference purposes only. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">85 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">[* * *] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap">Non-Recourse</FONT> Party</U>&#148; means, with respect to either Party, any of such Party&#146;s
former, current and future direct or indirect equity holders, controlling Persons, directors, officers, employees, legal counsel, financial advisors, agents, Representatives, Affiliates, members, managers, general or limited partners (or any former,
current or future equity holder, controlling Person, director, officer, employee, legal counsel, financial advisors, agent, Representative, Affiliate, member, manager, general or limited partner of any of the foregoing); <I>provided</I> that, for
the avoidance of doubt, no Party shall be a <FONT STYLE="white-space:nowrap">Non-Recourse</FONT> Party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Objections
Statement</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.2(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Off-the-shelf</FONT></FONT> Software</U>&#148; means <FONT
STYLE="white-space:nowrap">(i)&nbsp;non-bespoke</FONT> Software licensed under click-wrap or shrink-wrap agreements or (ii)&nbsp;commercially available Software licensed under
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">off-the-shelf,</FONT></FONT> standard terms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Offer
Employee</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.10(i)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Open Source Code</U>&#148;
means any Software, algorithm, code or data library that is licensed (i)&nbsp;as freeware, shareware, community-source software, open-source software or similar licensing models, (ii)&nbsp;under a license identified as an open source license by the
Open Source Initiative (www.opensource.org/licenses) or other license that substantially conforms to the Open Source Definition (www.opensource.org/osd) or (iii)&nbsp;under a license or agreement that requires, as a condition of the use,
modification or distribution of Software subject to such license or agreement, that such Software or other Software linked with, called by, incorporated, integrated, combined or distributed with or otherwise bundled with such Software be
(A)&nbsp;disclosed, distributed, made available, offered, licensed or delivered in source code form, (B)&nbsp;licensed for the purpose of making derivative works, (C)&nbsp;licensed under terms that allow reverse engineering, reverse assembly or
disassembly of any kind or (D)&nbsp;redistributable at no charge. For the avoidance of doubt, Open Source Code includes Software licensed or distributed under any of the following licenses or distribution model terms: GNU&#146;s General Public
License (GPL) or Lesser/Library GPL (LGPL), the Artistic License (<I>e.g.</I>, PERL), the Mozilla Public License, the BSD License and the Apache License. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Order</U>&#148; means any order, judgment, award, decision, decree, injunction, ruling, writ or assessment of, or agreement with, any
Governmental Authority (whether temporary, preliminary or permanent) that is binding on any Person or its property under applicable Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Outside Date</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;8.1(b)(i)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">86 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Overhead and Shared Services</U>&#148; means any ancillary corporate shared
services that are furnished by or on behalf of Seller or any of its Subsidiaries (other than the Group Companies) to both the Business and any other business of Seller or its Subsidiaries, including marketing and brand management, data analytics,
information technology systems and application support, telecommunications, end user computing, information security, human resources, compensation and benefits, talent acquisition, learning and development, corporate finance and accounting systems,
internal audit and finance controls, regulatory reporting, accounting, financial planning and analysis, treasury, foreign exchange management, bank services, tax, risk management, regulatory compliance and training, corporate insurance, legal,
ethics, vendor sourcing and management and real estate, in each case including services relating to the provision of access to information, operating and reporting systems and databases and all hardware and software used in connection therewith.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">[* * *] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Party</U>&#148; means each of Purchaser and Seller, and &#147;<U>Parties</U>&#148; means both Purchaser and Seller. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Permitted Liens</U>&#148; means any (i)&nbsp;Liens for Taxes or other governmental assessments, charges or claims of payment not yet
due and payable or that are being contested in good faith by appropriate Legal Proceedings and for which adequate reserves have been established in accordance with GAAP, (ii)&nbsp;carriers&#146;, warehousemen&#146;s, mechanics&#146;,
materialmen&#146;s, repairmen&#146;s, or other similar Lien arising in the ordinary course of business with respect to liabilities that are not yet due and payable, (iii)&nbsp;zoning, planning, and other limitations and restrictions, including all
rights of any Governmental Authority (but not violations thereof), that are not currently violated by and do not impair or interfere with the use of any property affected thereby in any material respect, (iv)&nbsp;Liens that restrict the transfer or
assignment of a Contract that is included in the terms of such Contract, (v)&nbsp;Liens with respect to this Agreement and Liens created by the execution and delivery of this Agreement, (vi)&nbsp;Liens which are disclosed on the Latest Business
Balance Sheet, or notes thereto, which has been previously provided to Purchaser and <FONT STYLE="white-space:nowrap">(vii)&nbsp;non-exclusive</FONT> licenses of Intellectual Property granted in the ordinary course of business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Person</U>&#148; means an individual, a partnership, a corporation, a limited liability company, an association, a joint stock
company, a trust, a joint venture, an unincorporated organization or a Governmental Authority or any department, agency or political subdivision thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Personal Data</U>&#148; means (i)&nbsp;any data or other information in any media that identifies or, in combination with any other
information or data available to any Group Company, is capable of identifying or being linked to an individual, household or device and (ii)&nbsp;any data or other information that constitutes nonpublic personal information, personally identifiable
information, personal data, personal information, individually identifiable health information or the like under any applicable Law, including any profiles that relate to an individual, household or device created from inferences drawn from any
Personal Data. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>PPACA</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;4.9(i)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">87 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period</U>&#148; shall have the
meaning set forth in <U>Section</U><U></U><U>&nbsp;6.1(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Tax
Amount</U>&#148; means the sum, on a jurisdiction by jurisdiction basis, of the aggregate amounts (with the amount for any jurisdiction never being less than zero, except by reason of the amounts in <U>clause</U><U></U><U>&nbsp;(vi)</U> of this
definition, which may cause such amount for any jurisdiction (or in the aggregate) to be less than zero) of accrued but unpaid Income Taxes of the Group Companies for a <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Tax Period (whether or not
such Taxes are due and payable as of the Closing Date), in each case in respect of solely those jurisdictions in which the Company or a Group Company is filing Tax Returns on the Closing Date and solely in respect of a taxable period for which the
applicable Tax Return required to be filed has not yet been filed as of the Closing Date determined (i)&nbsp;by excluding any Taxes attributable to any action taken by Purchaser or any of its Affiliates (including any member of the Group Companies)
on the Closing Date after the Closing outside the ordinary course of business, (ii)&nbsp;without regard to any deferred Tax assets and liabilities, (iii)&nbsp;on a &#147;closing of the books&#148; basis as if the taxable years of the Group Companies
ended on the Closing Date, (iv)&nbsp;by excluding any liabilities for accruals or reserves established or required to be established under GAAP or other similar methodologies for contingent Income Taxes or with respect to uncertain Tax positions,
(v)&nbsp;except (A)&nbsp;with respect to Tax Returns not yet filed as of the Closing Date, as required under applicable Law or (B)&nbsp;otherwise provided in this definition, in accordance with the past practices (including reporting positions,
elections and accounting methods) of the Company or any Group Company in preparing their Tax Returns, (vi)&nbsp;with regard to any Tax refunds or estimated Income Tax payments for, and overpayments of Income Taxes applied to, in each case, any
taxable periods ending on or before the Closing Date and any taxable period beginning on or before the Closing Date and ending after the Closing Date and giving effect to Tax attributes and transaction tax deductions available to actually reduce any
such Taxes in such Tax period and (vii)&nbsp;by adjusting for any Straddle Period in accordance with the definition thereof. For the avoidance of doubt, the <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Tax Amount shall not include any
Consolidated Income Taxes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Tax Period</U>&#148; means a taxable period
ending on or prior to the Closing Date and, with respect to any Straddle Period, the portion of such Straddle Period ending on and including the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Transactions</U>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;6.13(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Preliminary Closing Statement</U>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2.1(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Prior Plan</U>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;6.10(c)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Prior Transaction</U>&#148; means, as applicable, (i)&nbsp;that combination of Seller
and the Company pursuant to that Agreement and Plan of Merger, dated October&nbsp;4, 2023, which was consummated on January&nbsp;5, 2024, or (ii)&nbsp;the acquisition by Seller of the [* * *] pursuant to the [* * *]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Process</U>&#148; or &#147;<U>Processing</U>&#148; means any operation or set of operations that is performed upon data or
information, whether or not by automatic means, including collection, access, acquisition, creation, derivation, recordation, organization, storage, adaptation, modification, alteration, correction, retrieval, maintenance, consultation, use,
disclosure, distribution, processing, sharing, dissemination, transmission, transfer, making available, alignment, combination, blocking, storage, retention, deleting, disposal, erasure or destruction. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">88 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Proposed Closing Statement</U>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2.2(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Purchaser</U>&#148; shall have the meaning set forth in the preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Purchaser 401(k)</U><U></U><U>&nbsp;Plan</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.10(d)</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Purchaser Cafeteria Plan</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.10(e)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Purchaser Indemnified Persons</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;9.2(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Purchaser Material Adverse Effect</U>&#148; means any change, effect, event, occurrence, state of facts or development that is or
would, individually or in the aggregate, reasonably be expected to prevent, materially impair or materially delay the consummation by Purchaser of the Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Purchaser Restricted Person</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.15(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Recall</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;4.6(e)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Reference Time</U>&#148; means 12:01&nbsp;a.m. New York City time on the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Regulatory Laws</U>&#148; means the Sherman Act, the Clayton Act, the HSR Act, the Federal Trade Commission Act and all other
federal, state or foreign statutes, rules, regulations, Orders, administrative and judicial doctrines and other applicable Laws, including any antitrust, competition or trade regulation laws, that are designed or intended to prohibit, restrict or
regulate actions having the purpose or effect of monopolization or restraint of trade or lessening competition through merger or acquisition or any Laws with respect to foreign investment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Related Parties</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;8.2(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Release</U>&#148; means any release, spill, emission, leaking, dumping, injection, pouring, disposal, discharge, leaching or
migration into or through the indoor or outdoor environment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Remedy Action</U>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;6.4(d)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Representation and Warranty Insurance Policy</U>&#148; shall have the meaning set
forth in <U>Section</U><U></U><U>&nbsp;6.18(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Representatives</U>&#148; means, with respect to any Person, the advisors,
attorneys, accountants, consultants or other representatives (in each case solely to the extent acting in such capacity on behalf of such Person) retained by such Person or any of its controlled Affiliates, together with directors, managers,
officers and employees of such Person and its Subsidiaries. In the case of Purchaser, Purchaser&#146;s Representatives shall not be deemed to include the Insurers and underwriters in respect of the Representation and Warranty Insurance Policy except
for purposes of <U>Section</U><U></U><U>&nbsp;6.6(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Restraints</U>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;7.1(b)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">89 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Retained Counsel</U>&#148; means Freshfields US LLP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Retention</U>&#148; shall have the meaning set forth in the Representation and Warranty Insurance Policy; <I>provided</I> that under
no circumstances shall the Retention exceed $1,050,000. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Reverse Termination Fee</U>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;8.2(c)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Royalty Agreement</U>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;6.19</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Sanctions</U>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;4.7(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Sanctions Authority</U>&#148; means (a)&nbsp;the United States, (b)&nbsp;the United
Nations Security Council, (c)&nbsp;the European Union or any member state thereof, (d)&nbsp;the United Kingdom or (e)&nbsp;the respective governmental institutions of any of the foregoing, including OFAC, the U.S. Department of Commerce, the U.S.
Department of State, any other agency of the U.S. government and His Majesty&#146;s Treasury. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>SEC</U>&#148; means the U.S.
Securities and Exchange Commission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Second Extended Outside Date</U>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;8.1(b)(i)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Section</U><U></U><U>&nbsp;338(h)(10) Election</U>&#148; shall have the meaning set
forth in <U>Section</U><U></U><U>&nbsp;10.2</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Securities Act</U>&#148; means the Securities Act of 1933, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Security Incident</U>&#148; means any unauthorized loss, theft or Processing of data. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Seller</U>&#148; shall have the meaning set forth in the preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Seller Board</U>&#148; shall have the meaning set forth in the recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Seller Business</U>&#148; means the business and operations of Seller and its Affiliates other than the Business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Seller Cafeteria Plan</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.10 (e)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Seller Closing Account</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.1(a)(iv)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Seller Existing Business</U>&#148; means the cytometry by time-of-flight (CyTOF), Olink and Single SOMAmer businesses of Seller. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Seller Fundamental Representations</U>&#148; means <U>Section</U><U></U><U>&nbsp;3.1</U>, <U>Section</U><U></U><U>&nbsp;3.2</U>
(other than <U>Section</U><U></U><U>&nbsp;3.2(d)(ii)</U>&nbsp;and <U>Section</U><U></U><U>&nbsp;3.2(d)(iii)</U>), <U>Section</U><U></U><U>&nbsp;3.4</U>, <U>Section</U><U></U><U>&nbsp;3.5</U>, <U>Section</U><U></U><U>&nbsp;4.1</U>,
<U>Section</U><U></U><U>&nbsp;4.2</U> and <U>Section</U><U></U><U>&nbsp;4.17</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Seller Group</U>&#148; means Seller and its
Affiliates, other than the Group Companies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Seller Indemnified Persons</U>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;9.2(b)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">90 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Seller Marks</U>&#148; means Standard BioTools and any other name or trademark that
incorporates, or is confusingly similar to, Standard BioTools. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Seller Portion of Shared Expenses</U>&#148; means 50% of the
Shared Expenses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Seller Restricted Person</U>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;6.15(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Sengenics Entities</U>&#148; means Sengenics Corporation LLC, Sengenics Corporation
Pte Ltd and Sengenics Malaysia. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Sengenics Malaysia</U>&#148; means Sengenics Sdn Bhd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">[* * *] </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Shared
Expenses</U>&#148; means (i)&nbsp;all filing fees under the HSR Act and any other Regulatory Laws or other applicable Laws in connection with the Transactions as provided in <U>Section</U><U></U><U>&nbsp;6.4(b)</U>, (ii)&nbsp;all fees, costs and
expenses of the insurance broker(s), underwriter(s) or insurer(s) incurred by Purchaser in connection with obtaining the Representation and Warranty Insurance Policy and (iii)&nbsp;all fees, costs and expenses of the insurance broker(s),
underwriter(s) or insurer(s) incurred by Seller in connection with obtaining any D&amp;O Insurance, in the case of each of clauses&nbsp;(ii) and (iii), including all premiums, underwriting costs, brokerage commissions and other fees and expenses. At
least seven Business Days prior to Closing, each Party shall deliver to the other Party any information in its possession relating to the foregoing expenses in reasonable detail (including amounts paid, amounts owed and instructions for payments)
which may be relevant to the preparation of the Preliminary Closing Statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Shares</U>&#148; shall have the meaning set forth
in the recitals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Sherman Act</U>&#148; means the Sherman Antitrust Act of 1890, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Single SOMAmer</U>&#148; shall have the meaning set forth in the Single SOMAmer Royalty Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Single SOMAmer Royalty Agreement</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.19</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Software</U>&#148; means all computer programs, applications, files, firmware, user interfaces, application programming interfaces,
diagnostic tools, network tools, software development tools and kits, systems, templates, menus, analytics and tracking tools, compilers, libraries, version control programs, operating systems, including all software implementations of algorithms,
models and methodologies for any of the foregoing, whether in source code, object code or other form. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Special
Committee</U>&#148; shall have the meaning set forth in the recitals. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">91 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Specified Transaction Expenses</U>&#148; shall have the meaning set forth in the
definition of &#147;Transaction Expenses&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Straddle Period</U>&#148; means any taxable period that begins on or before the
Closing Date and ends after the Closing Date. In the case of any Taxes that are imposed on or with respect to income, gains, receipts, payroll sales or payments and are payable for a Straddle Period, the portion of such Taxes related to the <FONT
STYLE="white-space:nowrap">Pre-Closing</FONT> Tax Period shall be deemed equal to the amount that would be payable if the relevant Tax period ended on and included the date that is one day before the Closing Date, and in the case of any other Taxes
for a Straddle Period, the portion of such Taxes related to the <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Tax Period shall be deemed to be the amount of such Tax for the entire taxable period multiplied by a fraction, the numerator of
which is the number of days in the taxable period prior to and including the date that is one day before the Closing Date and the denominator of which is the number of days in such Straddle Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Subsidiary</U>&#148; when used with respect to any Person, means any corporation, limited liability company, partnership,
association, trust or other entity of which securities or other ownership interests representing more than 50% of the ordinary voting power (or, in the case of a partnership, more than 50% of the general partnership interests) are, as of such date,
owned by such Person or one or more Subsidiaries of such Person or by such Person and one or more Subsidiaries of such Person. For purposes of this Agreement, each Group Company shall be considered (i)&nbsp;a Subsidiary of Seller (and not of
Purchaser) prior to the Closing and (ii)&nbsp;a Subsidiary of Purchaser (and not of Seller) after the Closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Successor
Plan</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.10(c)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Target Net Working Capital
Amount</U>&#148; means $43,500,000. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Tax</U>&#148; or &#147;<U>Taxes</U>&#148; means all federal, state, local or foreign taxes,
charges, fees, imposts, levies or other assessments, in each case in the nature of a tax, imposed by any Governmental Authority, including all interest, penalties, fines, additions to tax or additional amounts imposed by any Governmental Authority
in connection with any of the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Tax Arbitrator</U>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;10.5</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Tax Return</U>&#148; means any return, report, claim for refund, estimate, information
return or statement or other similar document filed or required to be filed with any Governmental Authority with respect to Taxes, including any schedule or attachment thereto, and including any amendment thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Termination Notice</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;8.2(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Third Party</U>&#148; means any Person or group other than Purchaser and its Affiliates or Seller and its Affiliates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Third-Party Claim</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;9.3(a)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">92 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Trade Secrets</U>&#148; means trade secrets, formulae, <FONT
STYLE="white-space:nowrap">know-how,</FONT> confidential or proprietary information, concepts, ideas, instructions, knowledge, methods, practices, procedures, processes, inventions, discoveries, improvements, protocols, skills, Software,
specifications, patterns, techniques, technology, research in progress, algorithms, assembly procedures, data, databases, data collections, designs, drawings, results, schematics, blueprints, flow charts, models, strategies, business and financial
and sales and marketing plans, prototypes, technical assistance, testing procedures and testing results, and other technical business, financial, sales and marketing information, including biological, chemical, structural, pharmacological,
toxicological, clinical, safety, assay, method of screening, study designs and protocol and related <FONT STYLE="white-space:nowrap">know-how</FONT> and trade secrets, and manufacturing data, <FONT STYLE="white-space:nowrap">non-clinical</FONT>
information, <FONT STYLE="white-space:nowrap">pre-clinical</FONT> and clinical data, specifications of ingredients, manufacturing processes, formulation, specifications, sourcing information, quality control and testing procedures and related <FONT
STYLE="white-space:nowrap">know-how</FONT> and trade secrets, in each case, to the extent protected as a trade secret under applicable Law and whether or not embodied in any tangible form. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Transaction Expenses</U>&#148; means an amount equal to, without duplication, all fees, costs, expenses and other obligations payable
or otherwise reimbursable by the Group Companies in connection with the Transactions and the Ancillary Agreements (to the extent unpaid as of immediately prior to Closing), including (i)&nbsp;all fees and expenses of legal counsel, investment
bankers, accountants and other similar advisors payable in connection with this Agreement, the Ancillary Agreements and the Transactions by the Group Companies (excluding any Shared Expenses), in each case that have been incurred prior to and that
remain unpaid as of immediately prior to the Closing (the &#147;<U>Specified Transaction Expenses</U>&#148;), (ii)&nbsp;all Change in Control Payments and (iii)&nbsp;the Seller Portion of Shared Expenses that remain unpaid as of the Closing or were
paid by Purchaser prior to the Closing. To the extent that any Shared Expenses in excess of the Seller Portion of Shared Expenses were paid by Seller or its Affiliates prior to the Closing, such excess amount shall be treated as a reduction in
Transaction Expenses for purposes of calculating the Closing Aggregate Consideration and the Final Closing Aggregate Consideration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Transactions</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;1.1</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Transfer Taxes</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;10.1</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Transition Services Agreement</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.19</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Treasury Regulations</U>&#148; means the United States Department of Treasury regulations, including temporary regulations,
promulgated under the Code, as such regulations may be amended from time to time (including corresponding provisions of succeeding regulations). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Valuation Firm</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.2(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>WARN Act</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;4.9(r)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>willful breach</U>&#148; shall mean a breach of any representation, warranty, covenant or other agreement set forth in this Agreement
that is a consequence of an act or failure to act by a party with the actual knowledge that the taking of such act or failure to act would cause, or would reasonably be expected to result in, a breach of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">93 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;11.14 </U></B><B><U>Interpretation</U></B>.
When a reference is made in this Agreement to an Article, Section, Exhibit or Schedule, such reference shall be to an Article of, a Section of, or an Exhibit or Schedule to, this Agreement unless otherwise indicated. The table of contents and
headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement. Whenever the words &#147;include&#148;, &#147;includes&#148; or &#147;including&#148; are used in
this Agreement, they shall be deemed to be followed by the words &#147;without limitation&#148;. References to &#147;this Agreement&#148;, &#147;hereof&#148;, &#147;herein&#148;, &#147;hereunder&#148; and words of similar import when used in this
Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement and shall include the Disclosure Letter and all Exhibits, Schedules or other attachments to this Agreement. The Disclosure Letter and all
Exhibits, Schedules or other attachments to this Agreement are hereby incorporated in and made a part of this Agreement as if set forth in full herein. All references to &#147;$&#148; and dollars in this Agreement shall mean United States dollars
unless otherwise specifically provided. The word &#147;shall&#148; denotes a directive and obligation, and not an option. The word &#147;will&#148; shall be construed to have the same meaning as the word &#147;shall&#148;. The word
&#147;extent&#148; in the phrase &#147;to the extent&#148; shall mean the degree to which a subject or other thing extends, and such phrase shall not mean simply &#147;if&#148;. The word &#147;or&#148; shall mean &#147;and/or&#148;. Any references
in this Agreement to &#147;the date hereof&#148; refers to the date of execution of this Agreement. When &#147;since&#148; is used in connection with a date, the period covered thereby shall be inclusive of such date. References to &#147;days&#148;
shall mean &#147;calendar days&#148; unless expressly stated otherwise. All terms defined in this Agreement shall have such defined meanings when used in any document made or delivered pursuant hereto unless otherwise defined therein. The
definitions contained in this Agreement are applicable to the singular as well as the plural forms of such terms and to the masculine as well as to the feminine and neuter genders of such term. Any statute defined or referred to herein or in any
agreement or instrument that is referred to herein means such statute as from time to time amended, modified or supplemented, including by succession of comparable successor statutes and references to the rules and regulations promulgated
thereunder. References to a Person are also to its permitted assigns and successors. The phrase &#147;made available&#148;, when used in reference to anything made available by Seller or any of its Representatives, on the one hand, to Purchaser and
its Representatives, on the other hand, shall mean documents (i)&nbsp;uploaded to the electronic data room maintained by or on behalf of Seller or its Representatives for purposes of the Transactions and made accessible to Purchaser and its
Representatives (including any &#147;clean team room&#148; or similar depository within such electronic data room) (the &#147;<U>Data Room</U>&#148;) prior to 11:59&nbsp;p.m. New York City time on the day prior to the date of this Agreement or
(ii)&nbsp;publicly available in the Electronic Data Gathering, Analysis and Retrieval (EDGAR) database of the SEC. The Parties have participated jointly in the negotiation and drafting of this Agreement and, in the event an ambiguity or question of
intent or interpretation arises, this Agreement shall be construed as jointly drafted by the Parties and no presumption or burden of proof shall arise favoring or disfavoring either Party by virtue of the authorship of any provision of this
Agreement. The information contained in this Agreement and in the Disclosure Letter and the Exhibits and Schedules hereto is disclosed solely for purposes of this Agreement and no information contained herein or therein shall be deemed to be an
admission by either Party to any third party of any matter whatsoever (including any violation of Law or breach of contract). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;11.15 </U></B><B><U>No Recourse</U></B>. Notwithstanding any provision of this Agreement or
otherwise, the Parties agree on their own behalf and on behalf of their respective Affiliates that no <FONT STYLE="white-space:nowrap">Non-Recourse</FONT> Party of a Party shall have any liability relating to this Agreement or any of the
Transactions except to the extent agreed to in writing by such <FONT STYLE="white-space:nowrap">Non-Recourse</FONT> Party; <I>provided</I> that this <U>Section</U><U></U><U>&nbsp;11.15</U> shall not prejudice or limit any claim or remedy for Fraud.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">94 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;11.16 </U></B><B><U>Provision Respecting
Legal Representation</U></B>. It is acknowledged by each Party that Seller has retained the Retained Counsel to act as its counsel in connection with the Transactions, that the Retained Counsel has not acted as counsel for Purchaser in connection
with the Transactions and that Purchaser does not have the status of a client of the Retained Counsel for conflict of interest or any other purposes as a result of the Transactions. Purchaser and Seller hereby agree, on their own behalf and on
behalf of their respective managers, directors, equityholders, members, partners, officers, employees and Affiliates, that, in the event a dispute arises after the Closing between Purchaser or its Affiliates (including the Group Companies), on the
one hand, and Seller or any of its Affiliates, on the other hand, the Retained Counsel may represent Seller (or any of its Affiliates) in such dispute, and Purchaser or its Affiliates (including the Group Companies) shall not seek to prevent
Retained Counsel from representing Seller (or any of its Affiliates) in such a dispute, even though the interests of Seller (or any of its Affiliates) may be directly adverse to Purchaser or its Affiliates (including the Group Companies), and even
though the Retained Counsel may have represented the Group Companies in a matter substantially related to such dispute. Purchaser further agrees that, as to all communications among the Retained Counsel, Seller, the Group Companies or any of their
respective Affiliates that relate to the Transactions, the attorney-client privilege (as it relates to the Retained Counsel) and the expectation of client confidence belong to Seller and shall not pass to or be claimed by Purchaser, the Group
Companies or any of their respective Subsidiaries. Notwithstanding the foregoing, in the event that a dispute arises between Purchaser, the Group Companies or any of their respective Affiliates, on the one hand, and a third party (other than Seller
or any of its Affiliates), on the other hand, after the Closing, the Group Companies may assert the attorney-client privilege to prevent disclosure of confidential communications by the Retained Counsel to such third party or the use thereof by the
Retained Counsel in connection with its representation of a party in such dispute; <I>provided</I>, <I>however</I>, that no Group Company may waive such privilege without the prior written consent of Seller. In the event that Seller or any of its
Affiliates are named as defendants in a Legal Proceeding brought by a Third Party that relates to any conduct of the Group Companies that occurred prior to the Closing, Seller shall have access to all privileged materials of the Group Companies
relating to such conduct insofar as granting such access does not jeopardize the protection of the attorney-client privilege and would not reasonably be expected to result in any losses for Purchaser or any Group Company. The Retained Counsel shall
be a third-party beneficiary of this <U>Section</U><U></U><U>&nbsp;11.16</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature page follows</I>] </P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">95 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Parties have caused this Agreement to be duly executed and delivered
by their authorized officers as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">ILLUMINA, INC.,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jacob Thaysen</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Jacob Thaysen</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Chief Executive Officer</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">STANDARD BIOTOOLS INC.,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Michael Egholm</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Michael Egholm</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: President and CEO</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Stock Purchase Agreement</I>] </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>d66921dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g66921dsp01.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Illumina to acquire SomaLogic, accelerating its proteomics </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>business and advancing the company&#146;s multiomics strategy </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Combines highly complementary proteomics expertise with Illumina&#146;s industry-leading </I></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>product innovation and global market reach </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Positions Illumina to achieve growth in a large, expanding market </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Illumina and SomaLogic have partnered in proteomics <FONT STYLE="white-space:nowrap">co-development</FONT> since late 2021 </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SAN DIEGO, June&nbsp;23, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced today it has entered into a definitive agreement with Standard BioTools
(NASDAQ: LAB) under which Illumina will acquire SomaLogic, a leader in data-driven proteomics technology, and other specified assets for $350&nbsp;million in cash payable at closing, subject to customary adjustments, plus up to $75&nbsp;million in
near-term performance-based milestones and performance-based royalties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;The acquisition of SomaLogic will enhance Illumina&#146;s presence in the
expanding proteomics market and advance the multiomics strategy we announced in 2024. This will strengthen the value of the NovaSeq X product today and unlock greater capabilities in the future,&#148; said Jacob Thaysen, chief executive officer of
Illumina. &#147;Illumina and SomaLogic have partnered closely for more than three years, and this combination increases our ability to serve our customers and accelerate our technology roadmap towards advanced biomarker discovery and disease
profiling.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This transaction builds on a <FONT STYLE="white-space:nowrap">co-development</FONT> agreement Illumina established with SomaLogic in
December 2021 to bring the SomaScan<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Proteomics Assay onto Illumina&#146;s high-throughput next-generation-sequencing (NGS) platforms. Illumina Protein Prep is currently in use with nearly 40
early-access customers globally and will become available to all customers starting in the third quarter of 2025. Combining SomaLogic&#146;s proteomics technology with Illumina&#146;s scalable NGS ecosystem, DRAGEN<SUP
STYLE="font-size:75%; vertical-align:top">&#153;</SUP> software, and Illumina Connected Multiomics will accelerate the technology development roadmap for proteomics and reduce time and cost of proteomic research. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We are taking the scalability of NGS into proteomics,&#148; continued Thaysen. &#147;Illumina will remain an open, accessible, and enabling NGS
platform. The Company is committed to maintaining and supporting its existing proteomics partnerships as well as continuing to develop the sequencing ecosystem and supporting a wide variety of multiomics solutions.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Scientific evidence* presented over the past year demonstrates the strength of SomaLogic&#146;s proteomics offerings in the areas of plexity, scalability, and
technical reproducibility. In addition, researchers can generate significant and pivotal insights with high sensitivity, high throughput, and thousands of protein markers in a single experiment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g66921dsp01.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SomaLogic has approximately 250 employees worldwide working in commercial, R&amp;D, lab operations,
manufacturing, and other roles. The company&#146;s Boulder, Colorado, facilities&#151;including a CLIA- and <FONT STYLE="white-space:nowrap">CAP-certified</FONT> lab, office, and manufacturing space&#151;will be part of the purchase. SomaLogic has a
global footprint serving customers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This transaction brings SomaLogic&#146;s aptamer-based affinity proteomics platform into Illumina&#146;s portfolio,
enhancing Illumina&#146;s presence in a high-growth area within the proteomics market. The kitted <FONT STYLE="white-space:nowrap">NGS-based</FONT> panels business will add a high-margin consumables revenue stream. Based on the projected closing
date, Illumina expects this business to become profitable in 2027 on a <FONT STYLE="white-space:nowrap">non-GAAP</FONT> operating income basis, and for <FONT STYLE="white-space:nowrap">non-GAAP</FONT> operating margins to be in line with Illumina in
2028. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Completion of the transaction is subject to customary closing conditions, including the receipt of required regulatory clearance. The parties
intend to make the necessary filing under the Hart-Scott-Rodino Act in the United States in due course. Illumina expects to close the transaction in the first half of 2026. Until then, the companies will continue to operate as separate and
independent entities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Goldman Sachs and Co. LLC is serving as financial advisor and Cravath, Swaine&nbsp;&amp; Moore LLP is serving as legal advisor to
Illumina. Centerview Partners LLC is serving as financial advisor to Standard BioTools, and Freshfields LLP and Richards, Layton&nbsp;&amp; Finger P.C. are serving as its legal counsel. UBS Investment Bank is serving as financial advisor to the
Special Committee of the Standard BioTools Board of Directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Use of forward-looking statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This release may contain forward-looking statements that involve risks and uncertainties. Among the important factors to which our business is subject that
could cause actual results to differ materially from those in any forward-looking statements are: (i)&nbsp;the completion of the proposed transaction on the anticipated terms and timeline, or at all, including the ability of the parties to obtain
required regulatory clearance&#151;such as under the Hart-Scott-Rodino Act in the United States or from government authorities that may have or assert jurisdiction outside the United States&#151;and to satisfy other conditions to closing;
(ii)&nbsp;the future conduct and growth of the business and the markets in which we operate, including the proteomics market; (iii)&nbsp;the success of products and services competitive with our own; (iv)&nbsp;our ability to successfully integrate
SomaLogic into our existing operations and SomaLogic&#146;s technology and products into our portfolio; (v)&nbsp;our ability to sell SomaLogic&#146;s products and further develop SomaLogic&#146;s technology; (vi)&nbsp;our ability to successfully
manage partner and customer relationships in the proteomics market; (vii)&nbsp;our ability to manufacture robust instrumentation and consumables including SomaLogic&#146;s products; (viii)&nbsp;challenges inherent in developing, manufacturing, and
launching new products and services, including expanding or modifying manufacturing operations and reliance on third-party suppliers for critical components; (ix)&nbsp;challenges inherent in developing, manufacturing, and launching new products and
services; and (x)&nbsp;customer uptake of, and satisfaction with, new products and services, together with other factors detailed in our filings with the Securities and Exchange Commission, including our most recent filings on Forms <FONT
STYLE="white-space:nowrap">10-K</FONT> and <FONT STYLE="white-space:nowrap">10-Q,</FONT> or in information disclosed in public conference calls, the date and time of which are released beforehand. We undertake no obligation, and do not intend, to
update these forward-looking statements, to review or confirm analysts&#146; expectations, or to provide interim reports or updates on the progress of the current quarter. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g66921dsp01.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Illumina </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and
array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit
<U>illumina.com</U> and connect with us on <U>X</U>, <U>Facebook</U>, <U>LinkedIn</U>, <U>Instagram</U>, <U>TikTok</U>, and <U>YouTube</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contacts
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investors: </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Brian Blanchett </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>IR@illumina.com </U></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Media: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Christine Douglass </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>PR@illumina.com </U></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">*References: </P> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. Rooney MR, Chen J, Ballantyne CM, et al.
<U>Plasma proteomic comparisons change as</U><U> </U><U>coverage expands for </U><U>SomaLogic</U><U> and </U><U>Olink</U>. <I>medRxiv</I>. Preprint posted online July&nbsp;12, 2024.<U> </U>doi:10.1101/2024.07.11.24310161 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. Kirsher DY, Chand S, Phong A, Nguyen B, Szoke BG, Ahadi S. <U>The current landscape of</U><U> </U><U>plasma proteomics</U>: technical advances, biological
insights, and biomarker discovery<I>. bioRxiv.</I> Preprint posted online February&nbsp;19, 2025. doi: 10.1101/2025.02.14.638375 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>ilmn-20250622.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 6/23/2025 5:06:34 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2024"
  xmlns:ilmn="http://www.illumina.com/20250622"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.illumina.com/20250622"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2024/naics-2024.xsd" namespace="http://xbrl.sec.gov/naics/2024" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ilmn-20250622_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ilmn-20250622_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.illumina.com//20250622/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>ilmn-20250622_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 6/23/2025 5:06:34 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>ilmn-20250622_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 6/23/2025 5:06:34 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.illumina.com//20250622/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="ilmn-20250622.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.illumina.com//20250622/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g66921dsp01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g66921dsp01.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M8E@,_D30![%0!Y#X118?BI=1QC:@>< #TYH [CQ;XQM_#"11>29[N924C!P
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MM4M_(O;=)X_1AG'TH P[?X?^';:X$RV(<CHKL2/RH UKG0=+NY[>:>RB>2W
0$1*_<P<C'XT :- !0!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g66921g0622152128020.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g66921g0622152128020.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  Q ,@# 2(  A$! Q$!_\0
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M_P#&4MEXH71Q9(Z&6./S3(0?FQSC'O775Y5KG_)2E_Z^H/\ V6O5:!A1110
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M3>$+J3QD-;%U"(1.LOEX.[  &/2F(O\ C;_D4;[Z+_Z$*S/AM_R KK_KY/\
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K **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jun. 22, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001110803<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 22,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Illumina, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35406<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">33-0804655<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5200 Illumina Way<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92122<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(858)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">202-4500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ILMN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d66921d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com//20250622/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="d66921d8k.htm">d66921d8k.htm</File>
    <File>ilmn-20250622.xsd</File>
    <File>ilmn-20250622_lab.xml</File>
    <File>ilmn-20250622_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>g66921g0622152128020.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d66921d8k.htm": {
   "nsprefix": "ilmn",
   "nsuri": "http://www.illumina.com/20250622",
   "dts": {
    "inline": {
     "local": [
      "d66921d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "ilmn-20250622.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/naics/2024/naics-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "ilmn-20250622_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ilmn-20250622_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 22
   },
   "report": {
    "R1": {
     "role": "http://www.illumina.com//20250622/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2025-06-22_to_2025-06-22",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d66921d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2025-06-22_to_2025-06-22",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d66921d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.illumina.com//20250622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.illumina.com//20250622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.illumina.com//20250622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.illumina.com//20250622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.illumina.com//20250622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.illumina.com//20250622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.illumina.com//20250622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.illumina.com//20250622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.illumina.com//20250622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.illumina.com//20250622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.illumina.com//20250622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.illumina.com//20250622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.illumina.com//20250622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.illumina.com//20250622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.illumina.com//20250622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.illumina.com//20250622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.illumina.com//20250622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.illumina.com//20250622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.illumina.com//20250622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.illumina.com//20250622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.illumina.com//20250622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.illumina.com//20250622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001193125-25-144290-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-25-144290-xbrl.zip
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M:T=GYQ\NOK;EV9VU".Y1S963P!L5;ZI9IKL#UA- TP57/O^;_1)*P.8 KD*
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M\ZZ-$/<&B^[6:[(^\6"=,^7B+:ZZ#0E^T<D\C*9)P%\@Y_Q.>3\N#%J52+;
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ME"C".&A'#T>E--ZS*34\0]SI\+/5Y]M;_P>\W/ 9_'_*@S<*B"A"L<?=?$S
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MI)?JTWCQADS20IQG%" GD("NQ_?>!0E/..? O9M*2ZEBJ:'.S[N'78>9Q,1
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M35 8C<]PV"^B8)D'-33ON1A= ;-*-86[_BV^IH'1U<R3^E3H;>]6:\@+&46
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M4*D;TG<3T^!?X2S79L;>E:8^RZ="3ZA9#UUL>^78MRT0%I27[2V77,%@EQS
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MAWF/%Y+W4*<OH:M;!(-[7707-K,>WF->UB4:MD06W?U933%"1#:A].'OEB"
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M<P@[VYJDPV K1,ZV\RE@9+EE%YV[R )^M:J Y!X;A6BL.=4KL ( 0AZK2H
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M8Q3K7F78\0/])+:&)_*%R5DR])3\4OA&SFM@H",3^=GFC(XRFXMBO=BM91#
M21/2\W9QK)KWIHJ8&'9UU+B/X &Z[,3G0$3$[*AO#L%Q>>,3NTC"J>$1!47=
MA48D% D!/,1\*%X[CS8I]:>O2:F1@_K )LLW)G@-'>>,_.;CMPE?4OH%.ENM
M8,VVSACH)M91CT6U<&;P6((E*I7A?>&3AGFS(^62S]/Q#R=&;)W-\[COB8/@
MH5-/'41\Z2.(*<%'GLR('_FH==K3N$/AT,=! _)6GRCAD5C3C'515D5S;A7
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MLL\OH;-@!1?.IC/<GX$-N8JQ>T2#I8_!5L7+J@TP+^YCA#ABJDH%3E"XO]E
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MHEIK)S^=A7X:Y-160YNJ.%@L044Y.UK@Y7J5VUS-P?IU_KE:Q#B[;><;K.S
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M5]#9JPAT]@[3.<Y<U#703U+XYA%GOZO7L,Z0G4"Y"5*^?_E1'8K><:' ?6.
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MKG/AUXJ/Z"T;31,>>4ZUPLXM%&H\$!O7:V&2YA\ G."+Y?R+MK&W'E10*/2
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M#MK<=?DVPK*.E,/8,[K<H8$0A+C:J3Z9(3ZY[?S#(9Z<0C)<"E^Y=N/!\;&
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M!\*,/I7 A$()>'0(C>[?VI-CACEVR*+)NS")+1EI$*/"&UY[FY"";+Y\]C*
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MJ0+QK\"?_.[E?X8[Y^5M"/1&>MDY9L-5@1L?R[&8VAY:32Q/VG45(),FI,$
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MGSE'Y$F<_^_3JW<Q?I15MO@M/*"7NU:S2=W"V84(PL&0#?#'VA:90U%^N]A
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M-?")7'/\4(&%&T(<R1M4KACRX0_P**35Q+V]/@>NE^&!5(7JN':G4]95U!O
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MX2[U8.1M8IA1V[]]"W\1D;<N=<-C%GE#0II__E5%WTZ 7:,S@@9NU_][YSR
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M77#V16W1XA:!1W+R@MA#8N(X\#"HGBCVB(1'#X@]S#7O-OQX(375*4'%"XE
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MX9]YBY"7U.J5 +:Z#D<N;L7P,HA#@LJ5N2<- CJ\=!:=^7&^;BNIUAHJM#W
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MUQ'52PKU"A7\@#LAQ Z]+F+-%#>!D\#-\RNFL>'JE(S&6B<4E9@A(<HA&=;
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MLL.K2K#BWHCW@*^I(S4T!5\$_&..61"<826H0T)%30;Q$-A0RLJKJO33&1V
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M":VOC;#H^0Q<<Z3VX-)=7JMY1:5[,"@IZG>Q:U>"1*IB(+4"02EKE=%EDH@
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M I%!"#'EN#';))39.<FDU>S4!OXL)M9')(60TQOE.*6[![MVF%?'<S&2_?
MV>UZ$9[ >6RC8&CC2(AUR7#*95@BKMX);"<*H8%E(J;9K,*"NR#ZD]/\*A,'
MOLWV\-W3C5D=?HM9!</)'\&/OWOQK[Z]?7%;>PM$/Z5F6UR4W]V%A^YA&S6=
M-@ .!.7<\<I-Z$\9HY>'^_N1M"GZU2S!;;?HW!QIWN7FC!I'QT?1V\.#P\/P
MM.CN]\JM[M[%[BUNT[,OQCLYD5O]\.GLW<G9,[,*/AQ]/C_Y3OZQLI%AC_XE
MHMO\SW_9_Y<(:E(_'[T#_\7^??[YZ%C^UBN,VG-&:S'ZG]&_J"6<8YSTNP1@
M+'SA._GQFW]UG?KR+OCRX+E9NO_%:]>,BEW'M"2/%JSZ_IW^K;[$^[$>]\@?
MZNB^%O'[*&C;\26<4SX@WN(30_/@M6%+S?^<P?_ Z_OV(O_E/T]@+WV$+['G
MC6W3Z%+"@G Y7LI!BG88OT!.QNZCV"B.J^0Z@03E^0UD^6F68$X\^KD$*)>9
MG5LWUE]NRNCGI#"^\\*8[5\A[KWM)CU__3+ZF!?FA1^90T63;;U!\,^_E]55
M',F_(F,S]@^^[6K_37:U+W Z.X;SZK>]K.?U_=O_\^9P_^#[Q_?NWD&U_S0Z
MSJI_-%E>)=]>X5-S1Q9CL_+^UYAVT[UQ.?OV"I_<*DS'LOXV>)%;/=U/'(?7
MXX@WG .2%O F/^3EE[*<UH\C[G 8?8&RL.CS-(&XXWF3&_?[T+A%6V_9>=D8
MWQ&B$.^KI!CG]9@C$2_VW^Q_\]G^F_AL/YLS8F(V_I.+RW(ZBZ//EWOO]K[M
M'$]M\W^$6\13C$6\K[+Z<F(<X;2.?CE_%)&'Y]&O935- >J49A$E);;>J(/7
M+Z,?JRPK;N"UGB_,/[<?$.F)/[S^MI?]-]G+WIG+LB+Z_\IFE%U]V\.>W.GG
M+UE1+*.?2CC(CK+JXMLK?&IN2(HK<.\/7('_:^)VTV_QB">Y(G^#%;EW:5?D
MAJ_TL:/-0K+&<X"-D\+V4NFS$2@2<+\.;.EI&8:$1_5PX.DZH?O+M2U(=HD(
M+*^P@F!I>7&=3'/@^YA2$3Y"*\?)G)A7!/ED"QX8?(ZE=HX 9-Z,I@"G+<W_
M+F-5?\R42PK/QN6"A OMA[<5,##F%JPD"0HO )T"*MV(X,%(<4G(^;WH%V0@
M:HN*67!VWUCF]6V'P$=8K]:P P6R,@605=C)DC7VI-(1$%?"<H EK"V2-W,]
ME+=#]5)2HRHG,4FN(QENT9E3"0J SK,YH7>Y#$7@>H@Z[B-A-,^9P$"E@="4
MM.<)%S@^_P86V[)Y#-DBWV63O"!+H0"Y9O8W=;=@!]7?6.9P+)P(R)994186
MU+C*1W8BSPA:^=U]"V=N?7JT185'R.UC"QI<5:'J M7ZB2IN6)6YLFC_-4JA
M;;5[(HOYN3(&-I]/"6?-G20:&03 NBNIFJF.P> 9&Y9GN)N 01K3/Z5"%1'9
M9O1$.0L^*(MK.C+"'\8Z7P IF7P[MVV(;8$>L /6=3.;\S6+;'Q9Y #Y)MK8
M>I&S$@JUJYR6%UVT&%!I:&YN;+E5=D;N4"CK\9O)TBR6#L\KGP$.?LLQTD6]
M05Q%Q 6/0V:>,C4[)_('P5VK:R*0L!^:ZZHFF=:[:NZ4-'>8%Z6ST,Y-G?MX
M6/>9.TRT*VSPG8LCNO/:.'BY,]I]-)T\1H\-.O%/WUU6N_P,LJ5U,FV9 RJL
MFQ"J?LY704=C<M-2)90G3'<1T($DY@;5!>0(QU:F!^DFZT4YO@+9E_%E4@!)
MHA4O-([RB!U'J/0HJPLSM'_8OXU'F"_,=BJ?3(UAL'=-\UK$,)V;*>4,"^=$
M@;=93FTIF!8W0 DCI8&P9"D(-4Q8-@H$TA78%I&0%?K/VLP!2[*A[[P0=04@
M!V!YA9@YQ8A $QCR<$2YDS1*7'*OBKV6CDY0*IF#)@<$&'Z=[!8GF_#IA#,L
M=F+7S BCZ]^5E@*\8S,)%M.ES#SZ*XY8M*JF*5G+WU,F2,$/C<N"U3Y0&T15
M)JAS100I5**!CP)A/RYB9!*SV+$.\*]4%]S^$#N>VW%9$4O"M?-VVG>AYJE[
MP0YG+^IMK>8Z<#LV>/\9DKUYPP0476Z<I+@)T])  H#?T*P3LA7ZC&>U>87&
MAY:J4G$ N'B:WY70O2PNS3R\X K&&W.<J2_S.;*.8A7D@A5%@.W ?BE3VUUO
M9W=,!3V@1S'V:UKI#5D9J0[-$:CO&0Z\=>$1"B [1Y8J!HS"D4\J$8L=*9G4
M,C6[G4(5 8E_>$-7Z:OO28_9C5I"J5M=J%:_RS7Z+./0?W2$HF,/O1NRD KK
MA+1XY+;I,]O1X#EQOZ%  J[-QZ)-J;?5H> %=LNWC^_4N-C)S$4GMM)^*\;^
MH-/W8'_OQ4ZR?6>N@\&PY<QY?']GY3*9^CR)/@T?N@[D]YQ3]60=7*RN'@X^
MF N*.O,OT01UYT"08/[SZ><C4*MJ/9]YY_@7NKI2<3):,62S[6?&_<)S'!\/
M-5]D#W?V1C0C[;A;;76-S-T\'N3A8-:PU@DV\PF'WUY\"[]]I:6YR,$E9"EU
MH*Y[V%WCQ=YKSP)MQ[R:7C[[&;DT/B3HO3+-X5?H['CKG84@%;!K3I.B\\@L
M;B=<(&=+.2X**ZO/P@9'%/1W\Q':+9 O#J2P1JS09J_8C:'^7?0>H20=]*W*
MRN6)>J3]+*\*$GEVN+.>*/ EG%'Y< M:>Y0O@_LX4PC79+]#FB-?B"TD#E <
MJD@K8+8L+@15$Z:]GM#9Q./&"02"NT06A;BE;J8V<],^^VYELOR0%%>P^,?$
M-7N"YWA0AX/\ST.[(\_W#K=O"WX ;@6/!M'UT6R8N$K^Q_.7^_'^/O[_-IN:
MXV2ZJW.[UIU_(V\#-M5M]?%N04RBB!M#.&JKH2,;28,9998W6!$=+'^PU_5B
M[^U.LW5/WG;W7;+LW%O29,G,:\2XG$3GD(8P'T/4]=Q8QV3I8BOXAZBQ0#PI
MJS Q,C)6J1;V2Q\\.1Q HMGN/+!].8DRHDB4[0@2XO?GNGN P3J9S:?E,FN%
M%XGL)>-OM4(I'!B\?06R/99Z![HW1@F'8K-?"WD,*FF!$A(2D7J;$J5'K0JA
MHM_ZC'NPVJ]B8DME<OL21%C#=-%J6L;G;'=Z(PG1#HX,'+.& ^DAM-K%($^P
M">:=^Z&T]E SY2B$L8$C'+_'K?W&G$G[MW54[0BU7X1Q43R1=Q!\"75O@KV?
MO!7]\F[,R%_F[ CUOK,8F8- 'Q(\DA*Y\Z.T(;C'E B&5OX^\E6R-WJUD=##
M&<=K!@=V#F4RZ^1USCHW?.)FQTPF^J.P3#(#OIX97CP>,_S>YI+/;2[Y@?O[
M_!$$D&Q_/R-RZ:&[^,H[M&V[BU69-N.. !EJU_"7Q.DFRY#5UJ= XE5=97#^
M@G5<)Z1L59?37CY'>2SB\I")LN/^=*9) 290SBV+)-Y^S6VWN/L>)_5E:PPM
MQUU30"8'1 E!I6ELKB7P(?P#?(MKTSD,Y!49'MF:8CS-4)G86)7Q%03[JF0"
M%]SD%66/&#U(0N(UL));K7-/XP2?D6;&K.8+H9Y;@, -L6V36<7$%/@Y";YT
ML[\LEA$JGB.M<I4MB*<3L"J*IY0_FN(NBOFGL6DS$1I+PEF1M!JO@A57NG0E
M%9DK^%RFPS>@^@@#J]2RD4>78YGC9 IDX:)=VT$@WXGSD;RF<6@ PRP$JVG9
MC!8Q/<]Z/RY7YIXES*II8\48/)YQ"Y-!=2: O)K='7GR*=H16R%> &M2;K1H
M9B/>5]7V[4K%M,!\@MF66CY+Y8 B351Y^(]F.OUJW%CDI.!T.B5KGG!P]N6W
MX.Q7,V'M5!XC$[H@7T$H#>$+DKD\ Y$J4">,X(&$P\8'](3A0 A'P6/ VTSJ
M'(\2:![P++$SZM-E45*J^)0T!Q9[($,%FM.\IDBA17TWG"[':X%5VBQ(D H:
MF0<72H*]U4K???5DXRG5CER:JC4\5/YPL+9$.]@H]H[>PI]N]OBQM[9^<%SL
M-'_1H[9^VW&]^O0Z'B(!>[#WYA&@Z8X1S0;-/6:TSF=V4[HAMA980.\6CXMF
M).A^-:9*GYD%?'&153)4"6#$"#5'=27X') ?T8&#2A *L5;I-AX-EKH4XZR-
MCS,N#1D'Y5M1Y8;Q2<PG(H_:@IOYP"WP@JD\8F4H7H&F:.&NPUB0VHH.B(!
MVP8XE=U06Q 5C.GP6CV;)WFJ,7SN2YN--GT'I%;T)?D]\]I=EX0N)FS34OM^
M-D4#?=TEO9PL%<9CGX XIF'F^IJFP";1AM*7HAD.V&RJ$%%L8PI=5@[Z1=,*
M/FA-*_O&1>L'SQL6B:F$V F&>,U9\N MHZJ[\.-;Z1B,\BBYZE5IG6!:!-O0
M[G! T$X_Y,*#T2-9W+\H?;%KQ]C=974I=NK%1"G\B:_+]'*'M2%,OPD*P%\@
MO;7[-8>($-+64)T3%3R!BP'9$JI#D]&<9;A!@'H!PB=H<>"P;//,AXKKQ-+^
MH';\[:,(@YCN+1=@0,8M?Y#GF_T>WM/!VX,7Z *B0FSV &K,]VEZ6^&THP]F
M60!R!@Q.UR_,J3LAX6KHW\_)DM[.X?,X.MP_?!G3/I!:=5*WHK$@D&;I5N<G
M&H2'=3'V#K<_+P.=N;[\Z@-T]W#OX!%$ZW0"X)_N;99I.U,%W3F% S/4H)YE
M1.T*5Y*A>?/JT1@:LP,GHY+3,9O:FNX?^>;F73;&38^Q# =H<PZLS3$;LKA_
MMM[!,KL?)[-1E:=04?)A8<;'@^KIH8.[>4U[GU?UPKB,K/$-F_M&K?U87JO6
MPD9@6GO8;FUTZ\9ZS3-3N033>OL&_J415N6#E]BXYP_>.->HC^4>O[:-VW>>
MS1=J! \/NAK)ZHJW?M]216W?,IP\+^_PFF$4(WBOWOYWYP%\PD'(5]^"D%_)
MH.(,>J+X'(D%O-@_V+G:[=IQ YCD@P"K]G?2[;LHW/.C&N,![>(V"@=2ZI#.
MKM4,CW0H_!!'#G<!=5KF\-H@_42:S3-LFSTNHNRLNV1LD5"(8*"BK;+B>D$.
MRK1J&5-UC&\WJI7=WZ83SP-+HE/F5-$O.W5:/./*@U14ITX_/W#R^N#@,008
M>4R\WKFT-7B.YNA%D87/DLX4G@;SFDD/$0 G$BP"MZ(9VQC=8X"8V$Y^B<Z7
MM7$.NOLJW]9/MH,?(,^<&C=?O:V'GK4O'M&L_5F*IH^;VCPBJQX:8'+P**)'
M86_/&T"J?97>/IYW^^D&R@]N99?*&ZY80/!;M; A5?J"R[:U8OR4C7P$,72[
MO=F#X"/8K,#+:2=[,-9/UUH<Z2@KLDF^B.;F%U)(+DJ!2)25@W+A!*LZZ  (
M,X%/5SO/=S$F?')V>GZTZPJPP0*6"ZLX;X83KZ"-'UO! ?RP%65%%&5%3<<@
M:!4RNUQ4R2QVI&*>$G=5062=#DLN;L\<!:6P%3P;H96C.V*6B<F]($USG?G/
M]>Y990N1TV69>N.OI(0L:;=T0CKW6')$'[IL5^L7I-(H>1Z5,,.1L!D#*;I/
MW*E0]A4[<A/"L%;1#.2*-O"I+-$$;4EYI478K=MGKW)W1$UVN&6G%RB,""L]
MR!YT:8>KB.=FSC>X]D*ZYKP9U>869J2I*SC%=!*'*Y!J5YE4TP23NJ5:*IM0
M&]2E4]P55-A44LIN.%#X"TJEW*UA6,14+&WYTF.P&+C[GR!%$3D$NDSF*[@
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MF'/8N'+^T>1S"_1P+JYU;N0AFIW2#Z,X:W9\]G,<G9Q]CJ.?SDS'S=C#"0(
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MPSGM8,ZS=*VDQHWI*TEC: :C2GD7,^9PB'?E?DUM93?M 8& H@+&&"TMCYT
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MHVG$ W(>36N!)7@A0+P;&A\0SOF Y#!8#D4@'</80HF7G(M:<^") S90*'B
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MJYDL8FG"N-OB\K@1M@$5[@+Q;2>@:[?C3!!+--YY4Y332FQ 2:-C\1K[%Y5
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MZ[!H?GQR<';T'[CX?O3SR=O_ U!+ P04    "  82]=:COC^7$@0  #[,P
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MUH&J**+01X<ZD=R[JW3NC4!3$*HS8&4IS? AUTW$KHTALA4D,WB-R7S-QKU
M[NF<RV$]9,"?PFB(QJ::4N<<<W+)''9+_?R9_4NQP,-ATL,AYS+Q$:321;JP
M0IXY(M5KJWOYI"\N#J78398%;5Y5L;(,P"9[S<8377>#GWOSS30SYZ-'S[,*
MBUT[(^;!/9,LKCT^K*Y460AN&G^-FNTA!JYM#\OR/-$WSR2"WXAA![]PF*C,
M'SDQFZ @ME<QK;0H%KHY!?=K3G+#P\Q,34DVH%1MD$O^QU/5D&?5B5P?V9=T
MM#:HXY%!*6NU4L5J(=A=<M&TZ+9QR$KM29ZR[\H1TCURT#[Z\P;@O@I]=CF[
M\D/#HJT@+/):\T3K+D+-6]VQUZH% CI9! ME 7APS@?RU7%VG2VO8N1.8_@=
MRRU1XHQ1*&;T+,Q#*43,QQN)N\7UYK'9,!(@.:-]8D#PK>%5#]C5X14?QP#P
MEI[8UGN\&W$"^VD^T6*8TL ^,O.2IWM&4\DG6AU2JH=<; '.,0$BA>^GOZ*>
MN%N[9J-4;X_O?%)M5+H]1PMW2071+^5QHP!<2K+@/HME=JHX2'TZ\L>RU$0*
MF&K\X1T%BN>VQ42-"8$*\P+X:-6C3U >FGOFX!P/[E8NH27F-. FWDT5K5@.
M8KZAXXRB8:G&][>U+)VMUD_5<<^7M/YXX.>@:G#X"%K'?$C+]J'C,,-EBEX<
MR,<&>(+HGI#?$ AP,_$UTC4JZ+ ?U@/A/%P2%2LX0"3\W LVB-KB5^4+#/LF
MI@)E]%3Z828?O5E<S81O)@*FFWD2%4<)J,)WEU^ZF9I4(J.6*P.(/\VAI5FZ
MS/GL*YJ&8AXC/+U##- ,F#=-]9Q&K@ Z+FI^;U=K<Z=I >5<W_UY4GFJ\_<=
M>F[_?^CY/SGT1-?0&X-XK;KJK]$BK(8ECJ@\I1]2>9937SM3T@!'Q\OBA8:*
M9MDK?VQ*7Z8J!L:WQ1G!KP7D"V[WJY?+^*V>VAEWSB=9LGSA;/7>S>%IKWY\
MQ85%IJE<%I._BHIHJ@IK$\N2393', $HJ.9S&X]FDBMD5-))+_"JY  D<]J%
MZB??&A9EMUC6Z F=,VH"74*K."S>!2H/A9@Q>HL%=,ZO0[0R>7E4Z\L6T)&\
M!:A44P;*MAA9,D$:\PL9@5C06S'P]_NN+CM[%/']S??=DM;00:^O;][4N/4W
M^CV@3V]06,: X^K"B8XO532(JPL#D"5()^?5E9&^')5/<,%ZW_U@\U$^5G3M
MJW3+?6I+X09"O+6W?Q\ZXNG%69X[@$#LWO:Z\4-O>( &-A8'!L1MIK+LOA/5
MAP$2>/GBG_7X$>3)K^#'=RK2<O>KX%9_EG(KI<2AS:<&3>P]@?I09CV_PZQW
MG8\_B%U_N% %V>-PO4O'!YEH=MKXA(YA*=Y=!*)/+[[]&(@#<$P99TL8N_\N
M$/1RG6DS2)W#\'-9>QF$A[?P#"%G0;6E8S.][XKB7WZ[BUI$WP'YGJ7XK>K0
MRF<8D?SG,^#Y98%)@^Y<11>?]()>?&WS2T5\D)6 O?-1"!\'_)B;I:_>G>W
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M5V+WA':4LWWI7QCE DUZQWKF>BA]FDS[38#G/#L5P])H3-P=?17>CE%35X*
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M"J\)<L&U1A )VZP"Y"4@K0&JB#/ +;9>!KEY_VY(G_%@I>=FJKJW)7D[IR.
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M2P$"% ,4    "  82]=:Q0398V,=  !QF@  #0              @ $
M9#8V.3(Q9#AK+FAT;5!+ 0(4 Q0    ( !A+UUI^U<PDF((! &"5"  /
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M2P$"% ,4    "  82]=:P>>$YUX&  "^0P  %0              @ 'HO0$
M:6QM;BTR,#(U,#8R,E]L86(N>&UL4$L! A0#%     @ &$O76HB7#RZU!
M?"H  !4              ( !><0! &EL;6XM,C R-3 V,C)?<')E+GAM;%!+
4!08     !P ' ,$!  !AR0$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>d66921d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ilmn-20250622.xsd" xlink:type="simple"/>
    <context id="duration_2025-06-22_to_2025-06-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
        </entity>
        <period>
            <startDate>2025-06-22</startDate>
            <endDate>2025-06-22</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2025-06-22_to_2025-06-22" id="ixv-297">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2025-06-22_to_2025-06-22"
      id="Hidden_dei_EntityCentralIndexKey">0001110803</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2025-06-22_to_2025-06-22" id="ixv-308">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2025-06-22_to_2025-06-22" id="ixv-309">2025-06-22</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2025-06-22_to_2025-06-22" id="ixv-310">Illumina, Inc.</dei:EntityRegistrantName>
    <dei:EntityFileNumber contextRef="duration_2025-06-22_to_2025-06-22" id="ixv-311">001-35406</dei:EntityFileNumber>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2025-06-22_to_2025-06-22" id="ixv-312">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2025-06-22_to_2025-06-22" id="ixv-313">33-0804655</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2025-06-22_to_2025-06-22" id="ixv-314">5200 Illumina Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2025-06-22_to_2025-06-22" id="ixv-315">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2025-06-22_to_2025-06-22" id="ixv-316">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2025-06-22_to_2025-06-22" id="ixv-317">92122</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2025-06-22_to_2025-06-22" id="ixv-318">(858)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2025-06-22_to_2025-06-22" id="ixv-319">202-4500</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2025-06-22_to_2025-06-22" id="ixv-320">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2025-06-22_to_2025-06-22" id="ixv-321">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2025-06-22_to_2025-06-22" id="ixv-322">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2025-06-22_to_2025-06-22" id="ixv-323">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2025-06-22_to_2025-06-22" id="ixv-324">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2025-06-22_to_2025-06-22" id="ixv-325">ILMN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2025-06-22_to_2025-06-22" id="ixv-326">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2025-06-22_to_2025-06-22" id="ixv-327">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
